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Depression 
With a lifetime prevalence of around 20% major depressive disorder (“depression”) is 
a common disease and it is associated with a large amount of morbidity due to its 
highly recurrent and chronic nature(1). It is projected that by 2020 depression will 
cause the highest amount of morbidity in developed countries, and will be second 
only to cardiovascular disease worldwide(1). In 2030 depression will probably be 
leading the disease burden list (2). 
 
Diagnosis and classification 
A patient is diagnosed with depression according to the Diagnostic and Statistic 
Manual of Mental Disorders, currently the text revision of the fourth edition (DSM IV 
TR). The DSM IV TR defines major depressive disorder as a condition with 
depressed mood and/or anhedonia (the inability to experience pleasure from usually 
pleasurable activities), and at least five symptoms in total, with a minimum duration of 
two weeks. The other possible symptoms are changes in appetite and/or weight, 
insomnia or hypersomnia, psychomotor agitation or retardation, fatigue and/or energy 
loss, feelings of guilt and/or worthlessness, trouble concentrating and/or deciding, 
thoughts of death and/or suicidal thoughts or plans. The symptoms may not be 
caused by another physical or psychiatric disease or by drug use. The depressive 
episode may not be part of a manic depressive disorder. The symptoms are not a 
logical consequence of certain recent events, such as bereavement and they cause 
significant suffering and/or dysfunction in daily life.  
Depression can be mild, moderate or severe and may have melancholic, 
atypical or psychotic features. Melancholic features are anhedonia, lack of mood 
reactivity (no improvement of mood in response to positive events), excessive guilt 
and vegetative symptoms: severe weight loss or loss of appetite, psychomotor 
agitation or retardation, early morning awakening and worse mood in the morning. In 
contrast, atypical features are presence of mood reactivity (mood does improve in 
response to positive events) and “reversed vegetative symptoms”, namely increased 
appetite and/or weight and increased sleepiness. Patients with psychotic features 
experience severe depression with delusions and hallucinations, they often also have 
agitation. Women are twice as likely to get a depression compared to men. Fifty 
percent of those with a depression in the general population recover within three  
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months (3). Others take longer to recover or have (frequent) relapses or recurrences. 
A minority (15 20%) has a chronic depression, i.e. lasting over two years (3).  
 
Treatment of depression 
Depression treatment may comprehend several modalities. Watchful waiting or 
guidance by the general practitioner (GP) is an effective strategy in the first three 
months of a depression, as a substantial percentage of patients, also in primary care, 
have a spontaneous recovery within three months. This holds especially true for 
patients with a first mild depressive episode. In patients with longer lasting, more 
severe or recurrent depression, treatment is recommended. Treatment can be largely 
divided into two strategies: antidepressant drugs and various forms of psychotherapy. 
Both modalities have been shown to be effective in acute treatment as well as in 
continuation treatment to prevent relapses; both in primary and in secondary/tertiary 
care settings (4,5). Guidelines for the treatment of depression in primary care such as 
the 2003 NHG standaard depressive disorder from the Dutch Society for General 
Practitioners (NHG) recommend treatment with antidepressant drugs in case of major 
depressive disorder dependent on degree of dysfunctioning and/or suffering and on 
patient preference. After response to the antidepressant, treatment should be 
continued for at least six months, in order to prevent relapse (return of symptoms of 
the index episode). In case of a recurrent or chronic depression, maintenance 
treatment can be considered for one or more years) to prevent recurrences (the 
appearance of next episodes). In case the patient has a preference for psychological 
treatment, the GP may refer the patient for this treatment (6). 
 
Depression in general practice 
Most patients with depression are treated in primary care (7,8). It is therefore 
important to optimize recognition and treatment of depression in primary care, in 
order to prevent morbidity and also costs due to loss of work hours and long term 
treatment.  
  In studies before the year 2000 recognition of depression and care for 
depressed patients in primary care was found to be poor (9 13). Many patients with 
depression were not recognized and diagnosed as such in primary care, and many of 
those who were diagnosed did not receive treatment or were treated inadequately, 
e.g. with too low dose of an antidepressant, at time in most cases a tricyclic General introduction 
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antidepressant (9 11,14). However, in these years the first selective serotonin 
reuptake inhibitors (SSRIs) made their appearance on the market for the treatment of 
depression and many projects and postgraduate programs for GPs focusing on 
diagnosis and treatment of depression were initiated with the ultimate goal to improve 
recognition and treatment for depressed patients in primary care.  
  Unfortunately, recent reports in the media and scientific literature still claim 
that recognition and treatment of depression in primary care is poor (13,15 22). The 
scientific literature mainly reports underrecognition and undertreatment, while the 
public media recently spoke about overrecognition and overtreatment (23 26). These 
discrepancies point out the importance of assessing current care, in order to find 
areas for improvement and future research.  
  This thesis set out to study current care for depressed patients in primary care, 
focusing on both recognition and treatment of depression in primary care.  
 
Netherlands study of depression and anxiety  
All studies from this thesis, with the exception of the literature review presented in 
chapter 4, were performed using data from the Netherlands Study of Depression and 
Anxiety (NESDA, www.nesda.nl) Chapters 2,3 and 5 used baseline data on the 
primary care respondents, chapter 6 used data on primary care patients from 
baseline, two year  and four year follow up.  
  NESDA is a large prospective cohort study on depression and anxiety 
disorders among 2981 respondents between 18 and 65 years of age, recruited from 
the community, primary and secondary mental health care settings. Detailed 
information on the objectives and methods of NESDA were published elsewhere (27). 
In short, recruitment in primary care for NESDA was as follows. A screening 
questionnaire was sent to a random sample of 23,750 patients (registered with 65 
GPs), who consulted their GP in the past four months irrespective of the reason for 
consultation. The screener (consisting of the K 10 with 5 added questions about 
anxiety) was returned by 10,706 persons (45%). The non responders showed no bias 
with regard to psychopathology (28). Those screening positive were approached for a 
telephone interview consisting of the Composite International Diagnostic Interview 
(CIDI) short form (CIDI SF), which has proven diagnostic quality for screening 
purposes (29,30). Respondents fulfilling criteria for a current disorder on the CIDI SF 
were invited to participate, as were a random selection of screen negatives (both General introduction 
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from the written screener and the CIDI SF). In total 1610 persons were recruited who 
underwent an extensive baseline interview, including the CIDI. The GP was not 
aware of the results of the screening or of the interview.  
 
Outline of this thesis 
By exploring different aspects, this thesis will outline the current care for depressed 
patients in primary care. The first step in depression care is recognition of the 
disorder. Recently, a lot of attention has focused on recognition of depression in 
primary care. In the 1980s and 1990s several studies reported that recognition by 
general practitioners (GPs) was poor. However, it is quite difficult to study recognition 
in primary care, as in the Netherlands where all patients are registered with a single 
GP ( practice), they do not necessarily visit the GP for their depressive symptoms. 
Therefore, it is important to know which depressed patients do visit their GP without 
being recognized as such. In chapter 2 we present our study of recognition and 
determinants of recognition and will further discuss this topic. 
 
The next step in depression care is treatment, of which we investigated several 
aspects. First, we studied referral of depressed patients to a mental health specialist. 
We were especially interested whether GPs based their referral decisions on the 
criteria of their own guideline criteria or on other factors (Chapter 3).  
  Next we studied the major treatment option for GPs: the use of 
antidepressants. Most antidepressants are prescribed by GPs and not by physicians 
in secondary care. Moreover, when started with an antidepressant, many patients 
continue them for months or even years. 
  Chapter 5 focuses on the use of antidepressants in primary care, with a focus 
not on possible undertreatment (as done many times before) but on possible 
overtreatment with, i.e. whether they are prescribed to patients without a justification 
according the Dutch primary care guideline for depression. Chapter 4 discusses 
guideline recommendations and evidence for maintenance treatment with 
antidepressants in primary care, while chapter 6 describes the characteristics of 
patients on maintenance treatment with antidepressants.  
 
  Chapter 7 summarizes all results, and discusses the findings from this thesis 
in the light of findings from past and present research and the new Dutch general  General introduction 
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practitioners guideline depressie (NHG standaard depressie) that was published in 
2012. The chapter ends with implications for clinical practice and future research.  
 General introduction 
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Patient case A “Recognition of depression”  
Mr. A. consulted me with classic depression symptoms: he was sad and unable to 
enjoy previous enjoyable activities. In addition he had trouble sleeping although he 
felt tired. He had no appetite and had lost some weight. Concentrating was also a 
problem. He did not have any thoughts about death or suicide. Until that day he had 
even been able to work, although he had experienced these symptoms for about six 
weeks. He was given information about depression and treatment. In addition, we 
talked about daily structuring, since he had taken sick leave as of the day of first 
consultation. Part of his daily routine would be to walk for an hour. We made a follow 
up appointment the next week.  
 
Unfortunately, not every patient presents him/herself with this classical picture of 
depression. Presenting with somatic symptoms or atypical depressive symptoms is 
not uncommon and can be the cause of non recognition. In the following chapter 
determinants of non recognition are discussed.  
 Determinants of (non )recognition 
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Abstract 
Background 
Although most depressed patients are treated in primary care, not all are recognized 
as such. This study explores the determinants of (non )recognition of depression by 
general practitioners (GPs), with a focus on specific depression symptoms as 
possible determinants. 
Methods 
Recognition of depression by GPs was investigated in 484 primary care participants 
of the Netherlands Study of Depression and Anxiety, with a DSM IV diagnosis of 
depression in the past year. Recognition (yes/no) by GPs was based on medical file 
extractions (GP diagnosis of depressive symptoms/depressive disorder and/or use of 
antidepressants/referral to mental health care). Potential determinants of (non 
)recognition (patient, depression, patient GP interaction, and GP characteristics) 
were bivariately tested and variables with a p value <0.2 entered into a multilevel 
multivariate model. Subgroup analysis was performed on 361 respondents with more 
reliable GP diagnosis data. 
Results 
60.5% of patients were recognized by their GP. Patients who did not consult their GP 
for mental problems, and without comorbid anxiety disorder(s) were less often 
recognized. In the subgroup, where 68.7% was recognized, in addition to these, 
decreasing number of symptoms of depression and increased appetite were 
associated with decreased recognition. No GP characteristics were retained in the 
final model. 
Limitations 
Some data on recognition were collected retrospectively.  
Conclusions 
In addition to patients without a comorbid anxiety disorder or who did not consult their 
GP for mental problems, GPs less often recognized patients with fewer depression 
symptoms or with increased appetite. Recognition may be improved by 
informing/teaching GPs that also increased appetite can be a symptom of 
depression.  
 Determinants of (non )recognition 
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Introduction 
Depression is a common condition, associated with a large burden for patients and 
society due to its chronic or recurrent nature (1). Most patients with depression are 
treated in primary care, although often in a non specific way (2,3). Adequate 
recognition and treatment can decrease the burden of disease (4 6). It is reported 
that general practitioners (GPs) recognize depression poorly, perhaps due to their 
more physical and demand led orientation (7 9). However, various definitions of 
‘recognition’ were used in these studies. Those that applied a cross sectional design 
and relied solely on GP diagnosis at time of consultation found lower recognition 
rates compared to studies that used medical file extraction over extended time 
periods (10,11).   
Recognition alone does not necessarily imply appropriate treatment (12). 
However, it seems obvious that recognition of a patient as having depression or as ‘a 
psychological case’, or at least a discussion of the symptoms, is essential for 
adequate treatment. Documentation of an International Classification of Primary Care 
(ICPC) code of depression in the GP’s records might not be required to ensure 
appropriate treatment, as GPs might decide not to diagnose depression because 
they (or the patient) might consider a diagnosis of depression as stigmatising (13). 
Also, not all GPs code every consultation with an ICPC code. Finally, not every 
patient with depression needs (immediate) treatment. With a reasonable chance of 
spontaneous recovery within three months, several guidelines recommend ‘watchful 
waiting’ or a minimal intervention as an option during the first months, especially for 
patients with a first and mild depression (14 16). On the other hand, many patients 
with depression do need treatment, and recognition alone might not be sufficient to 
ensure adequate follow up and treatment in these patients (4 6). Therefore a 
definition of recognition measuring ‘active recognition’ i.e. receiving treatment such 
as antidepressants or a referral to mental health care might be more suitable.   
When it is established which patients remain unrecognized, GPs can be 
advised to focus on these groups, which in turn, might improve recognition. Although 
some studies examined determinants of recognition of depression, the results were 
ambivalent and the sample sizes small. As possible determinants, mostly depression 
severity and demographics were investigated. 
Some studies reported that depression severity predicts recognition 
(7,9,17,18), or that patients presenting with mental problems were better recognized Determinants of (non )recognition 
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(7,19,20). Patient characteristics such as age, gender, ethnicity and marital status 
have also been investigated, but with mixed results. Some found that women and 
older persons were identified more easily, whereas others found no differences (7,21 
23). An elderly primary care sample showed that clinical clues to better identify 
depression were female gender, the presentation of vague symptoms, and 
gastrointestinal symptoms  (24). Another study performed in the Netherlands found 
that not only patients with low severity of depression, but also those without chronic 
somatic comorbidity, with lower educational level and with fewer visits to the GP, 
were at higher risk for non recognition (25).  
Physician factors such as gender, experience, depression interest and 
courses on depression were also investigated, again with mixed results. Wittchen et 
al. found that physician experience of more than 5 years increased recognition. Tylee 
and Walters found that interest in psychiatry and empathy increased recognition, 
while pre occupation with organic disease decreased recognition (7,17).  
Only one recent study investigated the different symptoms of depression as 
possible determinants, and found that only ‘loss of self confidence’ was associated 
with recognition (7).    
It is unclear which determinants predict GP’s recognition of depression when 
using a broader, longitudinal measured definition of recognition and examining a 
wide spectrum of potential predictors.  
The main aim of the present study was to identify determinants of (non 
)recognition of depression by GPs (longitudinally measured) in patients with DSM IV 
diagnosed depression. Characteristics of the patient, depression, patient GP 
interaction and GP were investigated. Of the depression characteristics, we focused 
on the influence of specific depression symptoms on recognition rate. We 
hypothesized that GPs would less often recognize less severe cases (including 
patients without suicidal tendency), those who did not present with mental problems, 
and/or patients with few(er) visits to their GP.  
 
Methods 
This study was conducted with data from the Netherlands Study of Depression and 
Anxiety (NESDA, www.nesda.nl), a large prospective cohort study (n=2981) on the 
course of depression and anxiety disorders among respondents aged 18 65 years, 
recruited from the community, primary care and secondary mental health care. Determinants of (non )recognition 
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Detailed information on the objectives, study population and methods of NESDA has 
been published (26).  
 
Study sample and reference standard 
The present study included only those respondents recruited from primary care with 
(at baseline) a major depressive disorder (MDD) or dysthymia in the past year 
(n=503) according to the DSM IV criteria and measured with the Composite 
International Diagnostic Interview (CIDI). In the Netherlands, access to secondary 
(mental) health care is not possible without referral by a GP. Moreover, all inhabitants 
are listed with a single GP (practice).  
Details on the recruiting methods have been published (26). Briefly, a 
screening questionnaire was sent to a random sample of 23,750 patients (registered 
with 65 GPs) who consulted their GP in the past four months irrespective of the 
reason for consultation. The screener was returned by 10,706 persons (45%). The 
non responders showed no bias with regard to psychopathology (27). 
 Those screening positively were approached for a telephone interview 
consisting of the CIDI short form (CIDI SF), which has proven diagnostic quality for 
screening purposes (28,29). Respondents fulfilling criteria for a current disorder on 
the CIDI SF were invited to participate, as were a random selection of screen 
negatives (both from the written screener and the CIDI SF). In total 1610 persons 
were recruited who underwent an extensive baseline interview, including the CIDI 
(30,31). The GP was not aware of the results of the screening or of the interview. Of 
these 1610 persons, we included only those with a MDD or dysthymia in the past 
year: i.e. 503 patients registered with 64 GPs. 
In addition to the interview/questionnaire data, we also used data from the 
GP’s electronic patient file (EPF) and from questionnaires filled in by the GPs 
(available for all 64 GPs). Excluded were 15 respondents who refused permission to 
use their EPF data (as we could not determine the GP’s diagnosis in these cases), 
and four respondents with missing values on one or more of the determinants 
studied. Finally, 484 respondents were included in this study. 
Figure 1 displays the recruiting process of this study in detail.  Determinants of (non )recognition 
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Figure 1 Recruiting flow chart* 
 
*Flow chart derived and adjusted from Penninx, Beekman et al. The Netherlands Study of 
Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr 
Res. 2008;17:121 140. 
 
CIDI SF = Composite International Diagnostic Interview – Short Form 
MHO = Mental Health Organization 
MDD = Major Depressive Disorder 
Dysth = Dysthymia 
 
Definition of recognition by GPs 
We used a definition of recognition by GPs (hereafter called ‘recognition’) constructed 
from extraction from the EPF (extraction period: 1 year before until 1 year after the 
baseline interview). This method is similar to that of Joling et al., who used different 
indicators of recognition to construct the most reliable definition (best combination of 
sensitivity (0.693) and specificity (0.811)) of recognition of depression by GPs (32). 
 
23.750  
screeners sent 
10.706 screeners  
returned 
4592 screen positive  6085 screen negative 
2995 phone screen CIDI SF 
898 included  196 included 
646 randomly selected 
278 randomly selected 
1162 phone screen positives  1325 phone screen negatives 
516 included 
1610 included 
503 with MDD or Dysth in past year included 
484 included 
55% not returned 
57%  43% 
2440 written 
refusal 
1172 written refusal 
425 not contacted 
91 refusal 
7 language problem 
32 not contacted 
264 refusal 
82 refusal 
1007 without MDD or 
Dysth in past year not 
included 
15 without EPF data excluded 
4 with other missing data 
excluded 
267 refusal 
86 language problem 
155 treated in MHO Determinants of (non )recognition 
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  The CIDI diagnosis from the baseline interview was used as reference 
standard for the diagnosis of depression. The following indicators were used: 1) Use 
of antidepressants (measured by report in the EPF), 2) Referral to mental health care 
(psychologist, psychiatrist, psychotherapist, social worker or professional at an 
institute for mental health care; referral letter available in the EPF), 3) presence of 
ICPC P03 (depressive symptoms) or ICPC P76 (depressive disorder) or other 
relevant P-code (P indicating a psychological problem) in the EPF.   
  These three indicators were combined to construct the most sensitive 
definition of recognition; i.e. if any of these indicators were present, we considered 
this patient “recognized” (yes/no). Sensitivity of this definition was 0.605. 
  ICPC codes were missing in all GP contacts for 123 respondents (25.4%). 
Because of this, respondents that did not receive antidepressants or referral, i.e. in 
particular the less severe cases, might have been defined as not recognized. We 
performed subgroup analysis in a subsample with at least one contact with the GP 
with an ICPC code. Sensitivity of the definition in this subgroup was 0.687.  
 
Determinants of recognition 
A detailed description of the measures applied in NESDA has been published (26). 
Patient characteristics including demographic data (age, gender, education in 
years), number of chronic diseases and self reported disability due to these diseases 
(yes or no) were assessed during the baseline interview.  
Depression characteristics including current and lifetime diagnosis based on 
the DSM IV, the number of and all separate symptoms, and number of previous 
episodes, were assessed with the CIDI during the baseline interview. Severity was 
measured with the Inventory for Depressive Symptomatology (IDS), and suicidal 
tendency with the Beck Suicide Ideation Scale (33,34).  
Patient-GP interaction characteristics were assessed at the baseline interview; 
the number of contacts with the GP and whether any contact about mental problems 
had taken place was based on self report. The Perceived Need for Care 
Questionnaire (PNCQ) and the Trimbos/iMTA questionnaire for Costs associated 
with Psychiatric Illness (Tic P) were administered to assess the need for care (e.g. 
perceived need for psychotherapy) and the care received (35). Based on the answers 
to these questionnaires we constructed the variable ‘perceived need for more or 
other care’ (yes or no). Determinants of (non )recognition 
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Finally, GP characteristics (years of experience as a GP, special interest in 
depression, training in psychiatry and/or depression/anxiety in the past year) were 
derived from the GPs’ questionnaires.  
 
Ethical considerations 
The study protocol of NESDA was centrally approved by the Ethical Review Board of 
the VU University Medical Center and subsequently by the local review board of each 
participating center. After receiving full verbal/written information about the study, 
written informed consent was obtained from all participants before baseline 
assessment. A full ethics statement of NESDA has been published (26). 
 
Statistical methods 
Descriptive statistics were used to describe the study population and the number of 
respondents recognized, with the Statistical Package for the Social Sciences version 
16.0 (SPSS Inc., Chicago, USA). The definition of recognition (constructed with the 3 
indicators described above) was used as the dependent variable ‘Recognition’ 
(yes/no) in the subsequent analyses. The prediction of all independent variables on 
our dependent variable ‘Recognition’ was analysed with bivariate logistic regression. 
All variables with a bivariate correlation with a p value <0.2 were then selected for the 
multivariate logistic regression. To prevent multicollinearity, we excluded from these 
one of each pair of continuous variables with a mutual correlation >0.7 and 
dichotomous variables with ≤ 5.0% of respondents in one of the categories. 
  To determine which variables independently predicted recognition, logistic 
multilevel analysis was conducted using MLwiN 2.23. Multilevel analysis was used 
because the patients in this study were nested within the GP practices. Multilevel 
models are hierarchical systems that estimate regression coefficients and their 
variance components while at the same time correct for the dependency of the 
measurements. The first level was defined as patient, the second level as GP. The 
outcome variable represented the logit of the probability (i.e. natural log of the odds) 
of recognition of depression by the GP. Regression coefficients were transformed 
into odds ratios by taking the EXP[regression coefficient]. The Wald test was used to 
obtain a p value for each regression coefficient. The Wald test was also used on the 
variance parameters to obtain an indication of the necessity for allowing a random 
intercept or regression coefficient into the model (36).  Based on a stepwise Determinants of (non )recognition 
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backward selection procedure a final model was fitted consisting of only significant 
factors that constituted the predictors for recognition of depression by the GPs in the 
present study. 
 
Results 
Study sample 
Table 1 lists the characteristics of the study sample. Compared with the total NESDA 
sample (mean age 41.9 years; 33.6% male), the present sample was slightly older 
(mean 44.7 years) and with fewer males (29.8%). As expected in a sample with 
depression in the past year, the average number of depression symptoms was high 
(7.7). Several symptoms were very common (depressed mood, loss of interest, 
fatigue and trouble concentrating; all >90%), whereas others were less so: e.g., 
change in appetite (more appetite 37.8%; less appetite 47.3%) or weight (weight gain 
22.1%; weight loss 28.3%), psychomotor agitation (46.7%), psychomotor retardation 
(50.8%), feelings of worthlessness/guilt (82.9%), problems with sleep (trouble 
sleeping 79.3%; sleeping too much 37.6%; early awakening 42.8%) and thoughts of 
death (63.2%).  
The average age of the 64 GPs was 48.7 (SD 8.4) years, 56% were male, and 
their average length of GP experience was 18 years. In the past year, 69% had 
followed a course on psychiatry and 48.3% on depression and/or anxiety; 36% had a 
special interest in depression. Determinants of (non )recognition 
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Table 1 Characteristics of primary care participants with major depression/dysthymia (n=484) and 
GPs (n=64). 
Patient characteristics/comorbidity 
Age in years, mean (SD)
   44.7 (11.8)
  
Gender (male)
   144 (29.8%)
  
Education: no. of years  11.7 (3.4)
  
Comorbid anxiety  318 (65.7%) 
No. of chronic somatic diseases, mean (SD)  1.2 (1.2)
  
Disability due to chronic somatic diseases   291 (60.1%) 
Depression symptoms 
Feeling depressed/sad/empty  446 (92.1%)
  
Anhedonia/loss of interest  455 (94.0%) 
Fatigue/loss of energy  453 (93.6%) 
Trouble sleeping  384 (79.3%) 
Sleeping too much  182 (37.6%) 
Waking up 2 hours early  207 (42.8%) 
More appetite  183 (37.8%) 
Weight gain  107 (22.1%) 
Less appetite  229 (47.3%) 
Weight loss  137 (28.3%) 
Psychomotor retardation  246 (50.8%) 
Psychomotor agitation  226 (46.7%) 
Feelings of worthlessness/guilt  401 (82.9%) 
Trouble concentrating/deciding  469 (96.9%) 
Thoughts of death  306 (63.2%) 
Other Depression Characteristics 
Depression severity (IDS), mean (SD)  29.9 (12.0)
  
No. of symptoms (CIDI), mean (SD)  7.7 (1.2)
  
Major depressive disorder/dysthymia (MDD)  469 (96.9%) 
Chronic depression in past 5 years  99 (20.5%) 
Suicide attempt in the past  96 (19.8%) 
Suicidal thoughts in the past week  90 (18.6%) 
Patient –GP Interaction Characteristics 
Contact with GP in past 6 months  440 (90.9%) 
No. of contacts with GP past 6 months, mean (SD)  3.5 (4.3)
  
Contact with GP about mental problems  243 (50.2%) 
Perceived need for more or other treatment  308 (63.6%) 
GP characteristics 
GP gender (male)  33 (55.9%) 
GP age in years, mean (SD)
   48.7 (8.4) 
GP experience as GP (in years)  18.0 (9.8) 
GP special depression interest (yes/no)  21 (35.6%) 
GP training in psychiatry past year (yes/no)  42 (71.2%) 
GP training depression/anxiety past year (yes/no)  31 (52.5%) 
All numbers are number of participants with characteristic (percentage) unless otherwise specified. 
 
Recognition 
In 293 out of 484 respondents (60.5%) depression was recognized according to our 
definition in the total sample. In the subgroup of individuals with ICPC data in 248 out Determinants of (non )recognition 
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of 361 respondents (68.7%) depression was recognized. Based on a sensitivity 
analysis, this subgroup population generated a higher recognition rate. If ICPC data 
had been complete in all respondents, probably even more patients would have been 
recognized.  
 
Determinants of recognition 
Bivariate analysis 
Using bivariate multilevel logistic regression (Table 2), seven variables were 
significantly (p<0.05) associated with recognition. Decreasing depression severity 
and decreasing number of depression symptoms were associated with poorer 
recognition, and dysthymia was less often recognized compared with MDD. 
Recognition became also less likely when patients had no contact or fewer contacts 
with the GP in the past 6 months, or no contacts about mental problems. Finally 
patients without comorbid anxiety disorders were recognized less often. None of the 
depression symptoms or GP characteristics was found to be significant. 
 Determinants of (non )recognition 
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Table 2 Results of bivariate multilevel logistic regression 
 
  Total sample (n=484)  Subgroup with ICPC 
(n=361) 
  Odds ratio  p-value  Odds ratio  p-value 
Patient characteristics/comorbidity 
Age (years)  1.001  0.901  0.995  0.960 
Gender (female)  0.869  0.501  0.985  0.953 
Education (no. of years)  1.001  0.972  1.001  0.976 
Comorbid anxiety disorder   1.586  0.021  1.770  0.016 
No. of chronic somatic diseases  1.000  1.000  0.919  0.345 
Disability due to chronic somatic diseases
   1.069  0.728  1.090  0.710 
Depression symptoms 
Feeling depressed/sad/empty  1.141  0.705  1.660  0.186 
Anhedonia/loss of interest  1.857  0.114  2.024  0.159 
Fatigue/loss of energy  1.586  0.229  1.564  0.274 
Trouble sleeping  1.317  0.177  1.257  0.436 
Sleeping too much  1.276  0.216  1.342  0.219 
Waking up 2 hours early  1.275  0.213  1.132  0.590 
More appetite  0.775  0.191  0.717  0.151 
Weight gain  0.887  0.597  0.755  0.276 
Less appetite  0.905  0.597  1.017  0.941 
Weight loss  0.992  0.970  1.139  0.610 
Psychomotor retardation  1.397  0.077  1.452  0.102 
Psychomotor agitation  1.025  0.896  1.117  0.626 
Feelings of worthlessness/guilt  1.553  0.076  1.608  0.111 
Trouble concentrating/deciding  1.234  0.696  1.931  0.247 
Thoughts of death  0.966  0.859  1.182  0.474 
Other Depression Characteristics 
Depression severity (IDS score)  1.019  0.018  1.029  0.004 
No. of symptoms (0 9)  1.177)  0.047  1.294  0.008 
MDD
1/dysthymia (MDD)  2.241  0.184  6.488  0.076 
Chronic depression in past 5 years  1.297  0.279  1.344  0.316 
Suicide attempt in the past  1.149  0.564  1.608  0.128 
Suicidal thoughts in the past week  1.114  0.659  1.051  0.829 
Patient –GP Interaction Characteristics 
Contact with GP in past 6 months  2.705  0.003  2.757  0.008 
No. of contacts with GP past 6 months  1.096  0.002  1.077  0.040 
Contact with GP about mental problems  3.547  0.000  3.607  0.000 
Perceived need for more/other treatment  0.906  0.619  0.976  0.916 
GP Characteristics 
GP age (years)  1.004  0.790  1.001  0.943 
GP gender (male)  1.031  0.905  0.851  0.502 
GP experience as GP (years)  1.007  0.590  1.008  0.467 
GP training in psychiatry past year   1.669  0.074  1.514  0.181 
GP training depression/anxiety past year   0.954  0.857  1.083  0.745 
GP special depression interest   0.902  0.707  0.839  0.501 
Dependent variable recognition, defined as: diagnosis of depression or depressive symptoms or other 
psychiatric ICPC code by GP/use of antidepressant and/or referral to mental health care. 
All variables are yes/no unless otherwise specified 
p values < 0.2 are printed italic as these variables were selected for multivariate analysis. 
1 Major Depressive disorder 
 Determinants of (non )recognition 
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Multivariate analysis   
  Next, multivariate multilevel logistic regression was performed (Table 3) 
including all significant characteristics from the bivariate analyses as well as 
characteristics with a p value of 0.05 to 0.20.  Two variables were retained in the final 
multivariate model. Discussing mental problems with the GP was a strong predictor 
of recognition: patients who did not discuss their mental problems with the GP were 
much less likely to be recognized as having a depression. In addition, patients 
without a comorbid anxiety disorder in the past year were less likely to be recognized. 
None of the depression symptoms or GP characteristics remained significant in the 
final model. 
 
Table 3 Results of multilevel logistic regression analysis of all participants (n=484) with dependent 
recognition
* 
  Odds ratio  95% CI for odds ratio  p-value 
Comorbid anxiety disorder past year  1.565  1.043   2.348  0.030 
Contact with GP about mental problems  3.532  2.378   5.248  0.000 
 
*Definition of recognition: diagnosis of depression or depressive symptoms or other psychiatric ICPC 
code by GP/use of antidepressant and/or referral to mental health care. 
 
Ancillary (subgroup) analysis 
We repeated the analysis on the subsample of 361 respondents with at least 
one ICPC coded GP contact. In this subsample the same seven variables were 
significantly (p<0.05) associated with recognition using bivariate analysis.  
Multivariate multilevel logistic regression was also performed for this 
subsample. The final model in this analysis consisted of four variables. Again, 
patients not discussing their mental problems with he GP and patients without a 
comorbid anxiety disorder in the past year were less likely to be recognized. This 
subgroup also identified a decreasing number of depressive symptoms and 
increased appetite as predictors of poorer recognition (table 4). 
 
Table 4 Results of multilevel logistic regression analysis of subgroup with ICPC code (n=361) with 
dependent recognition
* 
  Odds ratio  95% CI for odds ratio  p-value 
Comorbid anxiety disorder past year  1.837  1.106   3.052  0.019 
Contact with GP about mental problems  3.564  2.205 – 5.762  0.000 
Number of symptoms of depression  1.313  1.064 – 1.619  0.011 
Increased appetite  0.553  0.331 – 0.922  0.023 
 
*Definition of recognition: diagnosis of depression or depressive symptoms or other psychiatric ICPC 
code by GP/use of antidepressant and/or referral to mental health care. Determinants of (non )recognition 
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Discussion 
Summary of main findings 
Several characteristics of the patient, depression and patient GP interaction were 
found to be associated with (non )recognition. Remarkably, no GP characteristics 
were retained in the final model. As expected, especially patients without contact with 
the GP about mental problems were less often recognized. Notably, those without a 
suicide attempt in the past or suicidal thoughts in the past week were not less well 
recognized. Therefore, our hypotheses were partially confirmed. The presence of a 
comorbid anxiety disorder led to better recognition. 
  It is likely that our definition of recognition was not sensitive enough to detect 
all recognized cases in the total sample because of missing ICPC codes. The 
sensitivity analysis showed that in the subgroup of individuals with ICPC codes, in 
addition to the other predictors, increased appetite was associated with poorer 
recognition. As increased appetite is an atypical symptom of depression, this 
suggests that GPs are more attentive to patients with typical features of depression 
than to those without (or with atypical features). None of the other depression 
symptoms were significantly associated with recognition.  
  Moreover, all the GP characteristics were non significant; for the GP 
demographics, this was not unexpected. However, we (for example) expected that 
training in psychiatry, and especially depression, would lead to better recognition. It 
should be noted that probably many (if not all) GPs had received training in 
psychiatry in the past (although not all in the past year). As a consequence, training 
in psychiatry during the past year was confounded by previous trainings.  
 
Strengths and limitations 
The present study has several strong points. First, our reference standard for 
depression diagnosis was the CIDI and not a self report questionnaire, making 
comparison with GP recognition more reliable. Second, recognition was not based on 
GP coded diagnosis only but on a wider definition, thereby increasing sensitivity. 
Also, recognition was not measured cross sectionally as in most studies (in which 
GPs filled in a questionnaire about each patient), but longitudinally by evaluating EPF 
data over a 2 year period. We believe information gathered during this period 
provides a more accurate estimation of the depressed population in primary care. 
Many patients do not seek help from the GP right at the start of an episode and may Determinants of (non )recognition 
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therefore go unrecognized in cross sectional studies. Also, we expected many GPs 
not to code a depression at their first encounter with a patient. Since they may initiate 
a watchful observation period in the hopes symptoms subside without administering 
an active treatment and labelling the patient as depressed. These patients would also 
go unrecognized in a cross sectional study. Fourth, the data collected within NESDA 
are extensive, enabling to examine many possible determinants of recognition. 
Finally, the GPs were unaware of the CIDI diagnoses; all had to rely on their own 
judgment for diagnosis and treatment, which prevents a GP assessment biased by 
the interviews.  
  Some limitations also need addressing. First, our group constructed our 
outcome variable ‘recognition’; we did not ask GPs directly whether they had 
recognized their patients as being depressed. Although asking about recognition can 
lead to higher recognition, because of increased awareness. Next, we did not take 
into account whether the respondent had discussed (or had wanted to discuss) 
depression with their GP. Third, some data on recognition (e.g. referral to mental 
health care) were collected retrospectively. In addition, the ICPC codes were missing 
in about 30% of the GP contacts, making them less reliable for assessing recognition. 
We dealt with this limitation by performing a subgroup analysis on the group of 
patients with at least one contact with the GP with an ICPC code. Fourth, our 
definition of recognition was partially based on the use of antidepressants and 
referral to mental health care. As a consequence, we partially measured ‘active 
recognition’. Not all patients need treatment and some do not want treatment (or 
even a diagnosis of depression) because they consider it as stigmatising (13). We 
perhaps missed patients that were recognized by their GP as being depressed but 
who did not receive treatment (neither a prescription for an antidepressant or a 
referral to mental health care) or were fitted with an ICPC diagnosis of depression, 
but on the other hand recognition alone might not be sufficient to ensure adequate 
follow up and treatment (4 6).  
 
Comparison with literature 
As our definition of recognition differed from those used in other studies, our 
percentage of recognized cases (60.5%) did too: Mitchell et al. 33.6% and Klinkman 
et al. 35% (9,10,18). It was however comparable to that of Wittchen et al., who 
reported that 59% (ICD 10) to 75% (DSM IV) of the patients in their study were Determinants of (non )recognition 
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recognized (7). The results of a later study on recognition of depression in primary 
care, by Joling et al. indicated that the used definition of recognition influences the 
percentage of recognition found (32).  
Patient characteristics: In the present study age did not affect recognition, in 
contrast to others who found that older patients were better recognized (7). This may 
have been the result of including only patients between 18 and 65 years of age in our 
study. We did not find any gender differences either, in line with the results of Rifel et 
al. (21). Patients without comorbid anxiety disorders were less often recognized. 
Comorbid anxiety and depression are common and have a worse prognosis 
compared to depression or anxiety alone (37). It could be that these patients are 
more symptomatic and are therefore easier to recognize for the GP. In the current 
study however, this could also be an artefact. Our definition included the ICPC codes 
for feelings of anxiety and anxiety disorder. This is justifiable, as a substantial 
proportion of our population had comorbid anxiety disorder and depression and a 
correct ICPC code might not be required to ensure appropriate treatment. This brings 
us to the other part of the definition, i.e. the use of antidepressants and referral to 
mental health care, both of which are accepted treatment modalities for anxiety 
disorder as well. This in turn could lead to the increased recognition of patients with 
comorbid anxiety disorder. 
Depression characteristics: Less severe depression was less recognized in 
many studies (7,9,17,18). And although less severe depression was also less often 
recognized in our bivariate analysis, we found no significant independent association 
in the multivariate model. This is interesting, as we had expected severity to predict 
recognition. Perhaps patients with more severe depression presented more often 
with mental problems or more often suffered from comorbid anxiety disorders, 
thereby minimizing or neutralizing the independent effect of severity in the 
multivariate model. In our subgroup a decreasing number of depression symptoms 
led to decreasing recognition. 
In the present study, no specific depression symptoms were associated with  
(non )recognition in the total sample, while in the subgroup increased appetite led to 
worse recognition. The effect of specific symptoms on recognition was also 
investigated by Wittchen et al. (7). In their multivariate analysis only ‘loss of 
confidence’ remained significant; however, because this item is in the ICD 10 but not 
in the DSM IV it was not investigated in our study. Wittchen et al. found no other Determinants of (non )recognition 
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associations between recognition and specific depression symptoms. Clearly this 
issue, with two different results, warrants further investigation.  
Patient-GP-interaction characteristics: In line with studies by Menchetti et al, 
Wittchen et al. and Furedi et al., as expected, we found that patients presenting with 
mental problems were better recognized (7,19,20).   
None of the GP characteristics was associated with recognition, whereas 
Wittchen et al. found that physician experience of more than 5 years increased 
recognition and Tylee et al. reported that interest in psychiatry also increased 
recognition (7,17).   
 
Implications for clinical practice and future research 
In addition to the reason for the encounter, and comorbid anxiety disorder, the 
number of symptoms of depression and increased appetite were associated with 
(non )recognition of depression in primary care. Mental problems as the reason for 
encounter experienced the strongest correlation with recognition. It would therefore 
seem logical to prompt patients to present their mental problem to the GP. However, 
the GP’s routine workday may be more somatically oriented than they are aware of. 
In a ±10 minute consultation, GPs often assess/exclude several somatic illnesses 
and manage the care of frequently multi morbid patients. Such a busy schedule may 
not be optimal for an open discussion of sensitive issues sometimes charged with 
guilt and/or shame. A separate directly accessible pathway to cognitive behavioural 
therapy (as implemented in the UK) might be a better option. 
The fact that GPs less often recognized patients with atypical features such as 
increased appetite, suggests that recognition may be improved by emphasising to 
GPs that depression may also have atypical features. More studies on the effect of 
specific depression symptoms on the recognition of depression are needed to 
confirm (or contradict) the current findings. Determinants of (non )recognition 
  36 
Acknowledgement 
The infrastructure for the NESDA study (www.nesda.nl) is funded through the 
Geestkracht program of the Netherlands Organisation for Health Research and 
Development (Zon Mw, grant number 10 000 1002) and is supported by participating 
universities and mental health care organizations (VU University Medical Center, 
GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University 
Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute 
for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services 
Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos 
Institute).  Determinants of (non )recognition 
  37 
References  
(1) Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global 
Burden of Disease Study. Lancet 1997;349:1436 1442. 
(2) Wilson I, Duszynski K, Mant A. A 5 year follow up of general practice patients experiencing 
depression. Fam Pract 2003;20:685 689. 
(3) Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of 
major depressive disorder: results from the National Comorbidity Survey Replication (NCS R). JAMA 
2003;289:3095 3105. 
(4) Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to 
antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 
1998;55:1128 1132. 
(5) Claxton AJ, Li Z, McKendrick J. Selective serotonin reuptake inhibitor treatment in the UK: risk of 
relapse or recurrence of depression. Br J Psychiatry 2000;177:163 168. 
(6) Hirschfeld RM. Clinical importance of long term antidepressant treatment. Br J Psychiatry Suppl 
2001;42:S4 8. 
(7) Wittchen HU, Hofler M, Meister W. Prevalence and recognition of depressive syndromes in 
German primary care settings: poorly recognized and treated? Int Clin Psychopharmacol 2001;16:121 
135. 
(8) Berardi D, Menchetti M, Cevenini N, Scaini S, Versari M, De Ronchi D. Increased recognition of 
depression in primary care. Comparison between primary care physician and ICD 10 diagnosis of 
depression. Psychother Psychosom 2005;74:225 230. 
(9) Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. 
Arch Fam Med 1995;4:99 105. 
(10) Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta analysis. 
Lancet 2009;374:609 619. 
(11) Kessler D, Bennewith O, Lewis G, Sharp D. Detection of depression and anxiety in primary care: 
follow up study. BMJ 2002;325:1016 1017. 
(12) Dowrick C, Buchan I. Twelve month outcome of depression in general practice: does detection or 
disclosure make a difference? BMJ 1995;311:1274 1276. 
(13) Barley EA, Murray J, Walters P, Tylee A. Managing depression in primary care: A meta synthesis 
of qualitative and quantitative research from the UK to identify barriers and facilitators. BMC Fam Pract 
2011;12:47. 
(14) Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA. Duration of major depressive 
episodes in the general population: results from The Netherlands Mental Health Survey and Incidence 
Study (NEMESIS). Br J Psychiatry 2002;181:208 213. 
 Determinants of (non )recognition 
  38 
(15) Meeuwissen JAC, Fischer E, Hagemeijer E, van Rijswijk HCAM, in den Bosch HJH, Poot EP, et 
al. Multidisciplinaire richtlijn depressie (eerste revisie). 2009; Available at: 
http://www.cbo.nl/Downloads/1065/rl_depr_update_10.pdf. 
(16) National Collaborating Centre for Mental Health. Depression: the treatment and management of 
depression in adults. 2009; Available at: 
http://www.nice.org.uk/nicemedia/pdf/Depression_Update_FULL_GUIDELINE.pdf. 
(17) Tylee A, Walters P. Underrecognition of anxiety and mood disorders in primary care: why does 
the problem exist and what can be done? J Clin Psychiatry 2007;68 Suppl 2:27 30. 
(18) Klinkman MS, Coyne JC, Gallo S, Schwenk TL. False positives, false negatives, and the validity 
of the diagnosis of major depression in primary care. Arch Fam Med 1998;7:451 461. 
(19) Furedi J, Rozsa S, Zambori J, Szadoczky E. The role of symptoms in the recognition of mental 
health disorders in primary care. Psychosomatics 2003;44:402 406. 
(20) Menchetti M, Belvederi Murri M, Bertakis K, Bortolotti B, Berardi D. Recognition and treatment of 
depression in primary care: effect of patients' presentation and frequency of consultation. J 
Psychosom Res 2009;66:335 341. 
(21) Rifel J, Svab I, Ster MP, Pavlic DR, King M, Nazareth I. Impact of demographic factors on 
recognition of persons with depression and anxiety in primary care in Slovenia. BMC Psychiatry 
2008;8:96. 
(22) Fernandez A, Pinto Meza A, Bellon JA, Roura Poch P, Haro JM, Autonell J, et al. Is major 
depression adequately diagnosed and treated by general practitioners? Results from an 
epidemiological study. Gen Hosp Psychiatry 2010;32:201 209. 
(23) Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the 
prevalence and detection of depressive and anxiety disorders in general health care settings: report 
from the World Health Organization Collaborative Study on Psychological Problems in General Health 
Care. Arch Gen Psychiatry 1998;55:405 413. 
(24) van Marwijk HW, de Bock GH, Hermans J, Mulder JD, Springer MP. Prevalence of depression 
and clues to focus diagnosis. A study among Dutch general practice patients 65+ years of age. Scand 
J Prim Health Care 1996;14:142 147. 
(25) Nuyen J, Volkers AC, Verhaak PF, Schellevis FG, Groenewegen PP, Van den Bos GA. Accuracy 
of diagnosing depression in primary care: the impact of chronic somatic and psychiatric co morbidity. 
Psychol Med 2005;35:1185 1195. 
(26) Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, et al. The Netherlands 
Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr 
Res 2008;17:121 140. 
(27) Van Der Veen WJ, Van Der Meer K, Penninx BW. Screening for depression and anxiety: 
correlates of non response and cohort attrition in the Netherlands study of depression and anxiety 
(NESDA). Int J Methods Psychiatr Res 2009;18:229 239. 
 Determinants of (non )recognition 
  39 
(28) Sunderland M, Andrews G, Slade T, Peters L. Measuring the level of diagnostic concordance and 
discordance between modules of the CIDI Short Form and the CIDI Auto 2.1. Soc Psychiatry 
Psychiatr Epidemiol 2011;46:775 785. 
(29) Patten SB, Brandon Christie J, Devji J, Sedmak B. Performance of the composite international 
diagnostic interview short form for major depression in a community sample. Chronic Dis Can 
2000;21:68 72. 
(30) Tacchini G, Coppola MT, Musazzi A, Altamura AC, Invernizzi G. Multinational validation of the 
Composite International Diagnostic Interview (CIDI). Minerva Psichiatr 1994;35:63 80. 
(31) Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross cultural feasibility, 
reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The 
Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 1991;159:645 53, 658. 
(32) Joling KJ, van Marwijk HW, Piek E, der Horst HE, Penninx BW, Verhaak P, et al. Do GPs' 
medical records demonstrate a good recognition of depression? A new perspective on case extraction. 
J Affect Disord 2011;133:522 527. 
(33) Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The Inventory for 
Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986;18:65 87. 
(34) Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide 
Ideation. J Consult Clin Psychol 1979;47:343 352. 
(35) Meadows G, Harvey C, Fossey E, Burgess P. Assessing perceived need for mental health care in 
a community survey: development of the Perceived Need for Care Questionnaire (PNCQ). Soc 
Psychiatry Psychiatr Epidemiol 2000;35:427 435. 
(36) Twisk JWR. Applied multilevel analysis: A practical guide. Cambridge: Cambridge University 
Press; 2006. 
(37) Penninx BW, Nolen WA, Lamers F, Zitman FG, Smit JH, Spinhoven P, et al. Two year course of 
depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety 
(NESDA). J Affect Disord 2011;133:76 85.  
 
  
 
 
 
 
 
 
Chapter 3 
 
Referral of Patients with Depression to Mental Health Care by Dutch General 
Practitioners: an Observational Study 
  
  42 
Referral of Patients with Depression to Mental Health Care by Dutch General 
Practitioners: an Observational Study 
 
Ellen Piek
1, Klaas van der Meer
1, Brenda WJH Penninx
2,3,4, Peter FM Verhaak
1,5, 
Willem A Nolen
2 
 
Biomed Central Family Practice 2011;12:41  
 
1 Department of General Practice, University Medical Center Groningen, University of 
Groningen, Postbus 196, 9700 AD Groningen, The Netherlands 
2 Department of Psychiatry, University Medical Center Groningen, University of 
Groningen, Postbus 30.001, 9700 RB Groningen, The Netherlands 
3 Department of Psychiatry, EMGO Institute for Health and Care Research, VU 
University Medical Center, AJ Ernststraat 887, 1081 HL Amsterdam, The 
Netherlands 
4 Department of Psychiatry, Leiden University Medical Center, Postbus 9600, 2300 
RC Leiden, The Netherlands 
5 Netherlands Institute for Health Services Research, Postbus 1568, 3500 BN 
Utrecht, The Netherlands 
 Referral of patients with depression 
  43 
Patient case B “Referral of a depressed patient” 
Mr. B. made an appointment because of depressive symptoms after a break up with 
his girlfriend. She did not want to have any contact with him anymore. Mr. B. had a 
depression after a similar life event in the past and recognized the symptoms. He felt 
very sad, was unable to enjoy anything and unable to work. Most days he would do 
nothing but lie in bed and sometimes try to call his ex girlfriend. When I asked him 
about thoughts about death, he told me he thought a lot about dying. He did think 
about suicide, but did not want to do this, because he did not want to hurt his mother 
and sister. I made an appointment with a psychiatrist for him the next day. 
In case of suicidal intentions the Dutch General Practitioners Guideline Depression 
(NHG standaard depressieve stoornis) recommends to refer patients, such as in this 
case, to secondary mental health care. Unfortunately, mr. B. committed suicide a few 
months later despite intensive therapy in secondary care.  
 
Chapter 3 describes whether general practitioners take the guideline 
recommendations for referral to primary and secondary mental health care into 
account when making decisions about referral.Referral of patients with depression 
  44 
Abstract 
Background  
Depression is a common illness, often treated in primary care. Guidelines provide 
recommendations for referral to mental health care. Several studies investigated 
determinants of referral, none investigated guideline criteria as possible 
determinants.  
We wanted to evaluate general practitioner’s referral of depressed patients to mental 
health care and to what extent this is in agreement with (Dutch) guideline 
recommendations. 
Methods  
We used data of primary care respondents from the Netherlands Study of Depression 
and Anxiety with major depressive disorder in the past year (n=478). We excluded 
respondents with missing data (n=134). Referral data was collected from electronic 
patient files between 1 year before and after baseline and self report at baseline and 
1 year follow up. Logistic regression was used to describe association between 
guideline referral criteria (e.g. perceived need for psychotherapy, suicide risk, 
severe/chronic depression, antidepressant therapy failure) and referral. 
Results  
A high 58% of depressed patients were referred. Younger patients, those with 
suicidal tendency, chronic depression or perceived need for psychotherapy were 
referred more often. Patients who had used ≥2 antidepressants or with chronic 
depression were more often referred to secondary care. Referred respondents met 
on average more guideline criteria for referral. However, only 8 11% of variance was 
explained.  
Conclusion  
The majority of depressed patients were referred to mental health care. General 
practitioners take guideline criteria into account in decision making for referral of 
depressed patients to mental health care. However, other factors play a part, 
considering the small percentage of variance explained. Further research is 
necessary to investigate this. Referral of patients with depression 
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Introduction 
Most patients with depression are treated in primary care (1,2). Primary care 
guidelines for the treatment of depression, including the Dutch guideline, recommend 
antidepressants and/or various forms of psychotherapy (3 7). When psychotherapy 
or counselling is indicated, a general practitioner (GP) can choose to counsel the 
patient himself or refer the patient to another health professional (3).  In case of 
depression with psychotic features, a depressive episode in the course of bipolar 
disorder, a severe depression with social impairment or high suicide risk, or 
insufficient response to two or more antidepressants or other treatment, most 
guidelines recommend referral to secondary care (3 7). In addition, most guidelines 
recommend referral for psychological interventions in certain cases, although criteria 
differ between guidelines (3 7). Finally, patients with seasonal affective disorder may 
be referred for light therapy (3). For the current study, we used the Dutch primary 
care depression guideline, which is comparable to international primary care 
depression guidelines. 
A few studies investigating referral behaviour of GPs suggest that multiple 
factors play a role in whether or not a patient is referred to mental health care, 
including disease characteristics (diagnosis, severity of symptoms, psychiatric 
comorbidity, personality characteristics, somatic comorbidity), patient characteristics 
(age, gender, race, education, insurance policy), whether the patient presented with 
psychological complaints, and lastly characteristics of the GP (e.g. organization of 
practice, experience of the GP, and degree of urbanization) (8 15). However, none of 
these studies evaluated specifically the criteria for referral as mentioned in the 
guidelines.  
The aim of this study was to evaluate the referral practice by GPs to primary 
(i.e. psychologist, psychiatric nurse or social worker affiliated with the GP practice) 
and secondary mental health care (i.e. psychiatrist or psychotherapist in free 
practice, or health care professional affiliated with hospital/ institute for mental health 
care), of patients with depression who had visited their GP, irrespective of the 
reason, during the past four months. First, we wanted to know how many patients 
with depression were referred to primary and secondary mental health care. Second, 
if any differences existed between non referred and referred patients, and between 
patients referred to primary and secondary mental health care. Third, we wanted to Referral of patients with depression 
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know if the Dutch guideline recommendations for referral to primary and secondary 
mental health care corresponded with clinical practice.  
We hypothesized that all criteria for referral mentioned in the Dutch guideline 
would independently increase the likelihood of referral. We had no hypothesis as to 
where most patients would be referred i.e. primary or secondary mental health care. 
 
Methods 
This study was conducted with baseline  and 1 year follow up data from the 
Netherlands Study of Depression and Anxiety (NESDA, www.nesda.nl), a large 
prospective cohort study (n=2981) on the course of depression and anxiety disorders 
among respondents aged 18 65 years, recruited from the community, primary care 
and secondary mental health care, that started in 2004. Detailed information on the 
objectives and methods of NESDA were published elsewhere (16).  
In The Netherlands access to secondary (mental) health care is impossible 
without a referral from a GP. Moreover, in The Netherlands all patients are listed with 
a single GP or GP practice.  
At baseline an extensive interview was conducted. At 1 year follow up all 
respondents filled in an elaborate questionnaire. In addition, we used data collected 
from the electronic patient file (EPF) of the GP for the period of one year before until 
one year after the baseline interview. Finally, we used data from questionnaires filled 
in by the GPs themselves. 
 
Study sample 
Details on recruiting methods were published elsewhere (16). In short a screening 
questionnaire was sent to a random sample of 23,750 patients from 65 GPs, who 
consulted their GP in the past four months irrespective of reason for consultation. 
The screener was returned by 10,706 persons (45%). Those screening positive were 
approached for a telephone interview consisting of Composite International 
Diagnostic Interview (CIDI) short form, which has proven diagnostic quality for 
screening purposes (17,18). Those fulfilling criteria for a current disorder on the CIDI 
short form were invited to participate in NESDA, as was a random selection of 
screen negatives (both from the written screener and telephone interview). In total 
1610 persons were recruited, and underwent an extensive baseline interview, Referral of patients with depression 
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including the CIDI (19,20). The GP was not aware of the results of the screening and 
interview.   
  From these, we included in our study only respondents with a major 
depressive disorder in the past year (n=478). 
We excluded respondents who did not give permission to use their EPF (n=15) 
or did not fill in the 1 year follow up questionnaire (n=98), as we did not have full 
referral data on these respondents. We also excluded respondents of whom the GP 
had not filled in the GP questionnaire (n=21), as we would be unable to determine 
the influence of GP characteristics on referral in these cases. We thus included 344 
respondents in our analysis. Excluded respondents were on average younger and 
had a higher Inventory of Depressive Symptomatology (IDS) score at baseline.  
 
Definition of referral 
We constructed the variable “referral”, indicating whether or not referral had taken 
place. Referral was considered present when a letter to or from a mental health 
professional was present in the EPF or when the respondent reported contact with a 
mental health professional in the past 6 months at baseline as measured with the 
PNCQ and Tic P and in the past year with the Tic P at 1 year follow up.  
We also created a variable indicating whether referral had been to primary (i.e. 
a psychologist, psychiatric nurse or social worker affiliated with the GP practice) or 
secondary mental health care (i.e. a psychiatrist or psychotherapist in free practice, 
or any health care professional affiliated with a hospital or institute for mental health 
care). Exact content of treatment by each mental health professional could not be 
determined.  
 
Indicators/guideline criteria for referral 
A detailed description of all measures can be found elsewhere (16). Demographic 
data (age, gender, education) were assessed during the baseline interview. Current 
and lifetime diagnoses of MDD based on DSM IV were assessed with the CIDI, as 
well as duration of symptoms and number of previous episodes, we constructed from 
these data the variable chronic depression defined as >12 months with depression in 
the past two years. Suicidal tendency (suicidal ideations past week, suicide attempt 
ever) was measured with the Beck Suicide Ideation Scale (21). Current and past use Referral of patients with depression 
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of antidepressants were based on self report, we derived from these data, which 
patients had stopped two or more antidepressants.  
During the baseline interview number of chronic somatic diseases was 
recorded. The Perceived Need for Care Questionnaire (PNCQ) and Trimbos/iMTA 
questionnaire for Costs associated with Psychiatric Illness (Tic P) were administered 
during the baseline interview to assess need for care and care received (22). From 
these questionnaires we used the answers to the questions of perceived need for 
psychotherapy and perceived need for any other treatment. 
Finally, we used several GP and practice characteristics (years of experience 
as a GP, self reported interest in depression, presence of a social worker, social 
psychiatric nurse or psychologist in the GP practice), derived from the GP 
questionnaires. Table 1 shows a summary of indicators/guideline criteria used. 
 
Table 1 Indicators/guideline criteria for referral 
Guideline criteria for referral  Other patient characteristics  GP/practice characteristics 
Stopped two or more 
antidepressants 
Age   Years of experience as a GP 
Perceived need for (more) 
psychotherapy/counselling 
Gender  Special interest in depression 
Perceived need for more or 
other treatment other than 
psychotherapy/counselling 
Presence of chronic somatic 
diseases 
Presence of mental health 
professional in GP practice 
More than 12 months with 
depression in past two years 
Comorbid anxiety disorder past 
year 
 
Suicidal ideations past week or 
suicide attempt ever 
   
 
Ethical considerations 
The study protocol of NESDA was approved centrally by the Ethical Review Board of 
the VU University Medical Center and subsequently by local review boards of each 
participating center. After full verbal and written information about the study, written 
informed consent was obtained from all participants at the start of baseline 
assessment. A full ethics statement of NESDA is found elsewhere (16). 
 
Statistical methods 
Results were presented with descriptive statistics: qualitative variables with absolute 
and relative frequencies, quantitative variables with means and standard deviation. 
Differences between two groups were tested with Chi square test (qualitative Referral of patients with depression 
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variables) and Student's t test (quantitative variables). Logistic regression was used 
to estimate association of referral with observed parameters. Differences were 
considered significant when the p value was <0.05. All variables with a bivariate 
correlation with p value ≤0.150 were eligible for multivariate analysis. We excluded 
from these variables one of each pair with a mutual correlation >0.7 and dichotomous 
variables < 5.0% of respondents in one of the groups. For this multivariate analysis, 
logistic regression was used, with the dichotomous variable “referral” as dependent 
variable. We used a manual stepwise backward method to remove non significant 
variables.  
All statistical analyses were performed with the “Statistical Package for the 
Social Sciences” version 16.0 (SPSS Inc., Chicago). 
 
Results 
Study sample 
Of the 344 respondents with MDD, 241 were female and 103 were male with an 
average age of 45.5 years (SD 11.7).  
 
Referral 
199 (57.8%) were referred to mental health care and 145 (42.2%) were not. Of the 
199 referred, 93 (46.7%) were referred to primary mental health care and 106 
(53.3%) to secondary mental health care. 
 
Comparison between non referred and referred respondents 
We compared referred and non referred respondents on the guideline criteria and 
patient and GP/practice characteristics (table 2). Suicidal tendency, chronic 
depression (≥12 months with depression in past two years) and perceived need for 
psychotherapy were more often present in the referred group, these patients were on 
average younger. None of the GP or practice characteristics were significantly 
different between groups.  Referral of patients with depression 
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Table 2 Differences between respondents with and without referral to mental health care 
  No referral   Referred   Total  OR  
(95% CI) 
p value 
N (%)  145 (42.2%)  199 (57.8%)  344(100%)  N/A  N/A 
Guideline criteria 
Stopped two or more 
antidepressants 
 
10 (6.9%)  23 (11.6%)  33 (9.6%)  1.76 (0.81 – 3.83)  0.147 
Perceived need for (more) 
psychotherapy/counselling 
 
59 (40.7%)  118 (59.3%)  177 (51.5%)  2.12 (1.37 – 3.28)  0.001 
Perceived need for (more) treatment 
other than 
psychotherapy/counselling 
 
81 (55.9%)  110 (55.3%)  191 (55.5%)  0.98 (0.64 – 1.50)  0.914 
More than 12 months with 
depression in past two years 
 
31 (21.4%)  63 (31.7%)  94 (27.3%)  1.70 (1.04 – 2.80)  0.035 
Suicidal ideations past week or 
suicide attempt ever 
35 (24.5%)  79 (39.7%)  114 (33.3%)  2.03 (1.26 – 3.27)  0.003 
Patient characteristics 
Age* 
 
47.10 (11.93)  44.32 (11.48)  45.49 (11.74)  N/A  0.031 
Gender, male 
 
38 (26.2%)  65 (32.7%)  103 (29.9%)  0.73 (0.46 – 1.18)  0.197 
Chronic diseases  
 
102 (70.3%)  127 (63.8%)  229 (66.6%)  0.74 (0.47 – 1.18)  0.205 
Comorbid anxiety disorder past year  89 (61.4%)  128 (64.3%)  217 (63.1%)  1.13 (0.73 – 1.77)  0.577 
 GP characteristics 
Years of experience as a GP* 
 
18.21 (10.49)  19.89 (9.88)  19.18 (10.16)  N/A  0.133 
Special interest in depression 
 
40 (29.9%)  52 (27.8%)  92 (28.7%)  0.91 (0.56 – 1.48)  0.690 
Presence of mental health 
professional in GP practice 
101 (69.7%)  147 (73.9%)  248 (72.1%)  1.23 (0.77 – 1.98)  0.390 
N = absolute number of respondents; (%) = percentage within variable referral; OR = Odds Ratio; 
(95% CI) = 95% Confidence Interval for Odds ratio, p value is from chi square test 
* Numbers are mean (standard deviation); p value is from independent samples t test 
 
Next, we tested whether the number of criteria present would predict the 
chance of referral. Indeed, referred respondents met significantly more criteria 
(median 2.00) than non referred respondents (median 1.00), p=0.000. Respondents 
with one or more criteria had an odds ratio of referral compared to respondents 
without any criteria of 2.70 (95% CI for odds ratio 1.49 – 4.87). Relation between 
referral and number of criteria is graphically depicted in figure 1. 
 Referral of patients with depression 
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Figure 1 Number of respondents (not) referred in relation to number of criteria for referral 
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Comparison between respondents referred to primary and secondary mental health 
care 
We compared the groups referred to primary and to secondary mental health care 
(table 3). Having stopped two or more antidepressants and chronic depression, were 
more common in respondents referred to secondary mental health care.  
 Referral of patients with depression 
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Table 3 Differences between respondents referred to primary and secondary mental health care 
  Primary mental 
health care  
Secondary mental 
health care 
Total  OR (95% CI)  p value 
N (%)  97 (46.2%)  113 (53.8%)  210 (100%)  N/A  N/A 
Guideline criteria 
Stopped two or more 
antidepressants 
 
5 (5.4%)  18 (17.0%)  23 (11.6%)  3.60 (1.28–10.12)  0.011 
Perceived need for (more) 
psychotherapy/counselling 
 
54 (58.1%)  64 (60.4%)  118 (59.3%)  1.10 (0.62 – 1.94)  0.740 
Perceived need for (more) 
treatment other than 
psychotherapy/counselling 
 
47 (50.5%)  63 (59.4%)  110 (55.3%)  1.43 (0.82 – 2.52)  0.208 
More than 12 months with 
depression in past two years 
 
20 (21.5%)  43 (40.6%)  63 (31.7%)  2.49 (1.33 – 4.67)  0.004 
Suicidal ideations past week or 
suicide attempt ever 
32 (34.4%)  47 (44.3%)  79 (39.7%)  1.52 (0.86 – 2.70)  0.153 
Patient characteristics 
Age* 
 
43.42 (11.64)  45.10 (11.34)  44.32 (11.48)  N/A  0.304 
Gender, male 
 
29 (31.2%)  36 (34.0%)  65 (32.7%)  0.88 (0.49 – 1.60)  0.677 
Chronic diseases  
 
57 (61.3%)  70 (66.0%)  127 (63.8%)  1.23 (0.69 – 2.19)  0.487 
Comorbid anxiety disorder 
past year 
54 (58.1%)  74 (69.8%)  128 (64.3%)  1.67 (0.93 – 3.00)  0.084 
GP characteristics 
Years of experience as a GP* 
 
20.97 (9.33)  18.94 (10.28)  19.89 (9.88)  N/A  0.147 
Special interest in depression 
 
23 (26.4%)  29 (29.0%)  52 (27.8%)  1.14 (0.60 – 2.16)  0.696 
Presence of mental health 
professional in GP practice 
65 (69.9%)  82 (77.4%)  147 (73.9%)  1.47 (0.78 – 2.78)  0.232 
N = absolute number of respondents; (%) = percentage within variable referral; OR = Odds Ratio; 
(95% CI) = 95% Confidence Interval for Odds ratio, p value is from chi square test  
* Numbers are mean (standard deviation), p value is from independent samples t test 
 
Logistic regression analysis 
Finally, we tested all variables from table 1 bivariately against the dependent variable 
“referral”. Age and gender were tested, in order to control for them in the model, if 
they where significant. All variables with a bivariate p value ≤0.150 were entered into 
the model, after step wise backward deletion, only need for (more) psychotherapy 
and suicidality remained significant, when controlled for age. This model explained 
eight to eleven percent of variance (table 4). 
 
Table 4 Results of multivariate binary logistic regression analysis with referral as dependent variable 
  Odds ratio*  95% Confidence 
interval 
P value 
Age  0.974  0.955 – 0.994  0.010 
Stopped two or more antidepressants  1.634  0.706 – 3.784  0.252 
Perceived need for (more) psychotherapy/counselling  1.865  1.187 – 2.930  0.007 
More than 12 months with depression in past two years  1.713  0.995 – 2.948  0.052 
Suicidal ideations past week or suicide attempt ever  1.810  1.098 – 2.985  0.020 
 
* Odds ratio for referral in case criterion present, except for criterion age, where odds ratio represents 
odds for referral with each year increase in age. Referral of patients with depression 
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Discussion 
Summary of main findings 
The majority (210/363; 57.9%) of patients with depression in primary care was 
referred to a mental health professional while GPs seem to apply the guideline 
criteria when making decisions about referral. Our hypothesis that all guideline 
criteria independently increased referral chance, was rejected, still suicide risk, 
chronic depression and patient preference for psychotherapy rendered referral more 
likely. Failure of treatment (chronic depression and/or stopped treatment with ≥2 
antidepressants) led more often to referral to secondary mental health care.  
 
Strengths and limitations of the study 
Our study has several strong points. First, as a screening method was used to recruit 
participants and independent interviewers interviewed all respondents, GPs were 
unaware of the psychiatric diagnosis. They could only rely on their own judgement in 
their treatment decisions, including referral. Second, the use of a structured interview 
(CIDI) for diagnosis. Third, with the extensive interview of NESDA, almost all relevant 
criteria for referral could be assessed. 
There are also limitations. First, the specific Dutch situation where GPs are 
gatekeepers to mental health care, rendering it unclear if these results can be 
generalized to countries with other referral systems. Second, we were unable to 
examine certain criteria presented in the guideline, such as comorbid personality 
disorders (also a guideline criterion for referral), as these were not assessed in 
NESDA. Third, missing data on diagnoses in 30% of the GP EPFs, rendering it 
impossible to clarify the influence of “recognition” on referral practice. Fourth, we 
were unable to investigate the influence of symptom severity on referral, as referral 
was initiated at a different point in time for each participant, while symptom severity 
was measured at baseline and 1 year follow up only. The symptom severity at time of 
referral could be very different from the symptom severity at any of these set points in 
time. 
 
Comparison with existing literature 
Referral rate in our study (almost 58% of patients with MDD in the past year) was 
high compared to the previous studies. Kendrick et al. reported an overall percentage 
of 22.8%, including patients with minimal or mild depressive symptoms according to Referral of patients with depression 
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either the 9 item Patient Health Questionnaire or the depression subscale of the 
Hospital Anxiety and Depression Scale (23). In the study by Wang et al. 26% of 
patients with a “mental health visit” and 25% with any visit to their GP were referred 
to a psychologist or psychiatrist (14). Finally, Grembowski et al. found that 23% of 
patients with depressive symptoms were referred, while 38% had contact with a 
mental health specialist, as this was also possible without referral (24). These 
differences are probably a result of different populations of patients and methods for 
diagnosing depression: GP diagnosis, questionnaires such as Hospital Anxiety and 
Depression Scale or structured interviews like the CIDI, and different definitions of 
referral and mental health care. Kendrick et al. included patients with minimal or mild 
depressive symptoms; Grembowski et al. patients with depressive symptoms, from 
both groups at least some patients would probably not fulfil criteria for MDD as used 
in our study  (23,24). Wang et al. only considered referrals to psychiatrists or 
psychologists, while we also investigated social workers, social psychiatric nurses, 
psychotherapists and professionals in institutes for mental health care (14). Lastly, 
the study by Grembowski et al. was performed in the United States where a referral 
from a GP is not required to see a specialist (24). 
Although none of the studies investigated all of the determinants we did, 
several of our determinants were investigated by others. Younger age was 
associated with more referral in our study, and in the study of Wang et al. and 
Grembowski et al. (14,24). The incidence of comorbid anxiety disorder did not differ 
between groups, in line with the study by Simon et al. (25). Referral rates for males 
and females were the same in our study in concordance with the studies of Miller et 
al. and Simon et al., but in contrast to the studies by Grembowski et al. and Kendrick 
et al. (23 26). Chronic somatic disease did not significantly differ between referred 
and non referred patients in our population either, in contrast to the study of Kendrick 
et al. and Miller et al. (23,26). 
 
Implications for future research and clinical practice 
Our study shows that Dutch GPs use guideline criteria in their decision to refer 
depressed patients to mental health care. However, the small percentage of 
explained variance by the guideline criteria for referral in our multivariate model 
suggests that there is room for further improvement in clinical practice. If GPs would 
adhere strictly to the guidelines, a higher percentage would have been expected. At Referral of patients with depression 
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the same time, the small percentage of explained variance opens a door toward 
future research: it shows that also other factors (including patient factors) play a part 
in the decision making process. Future research should focus on investigating these 
factors. If we better understand why patients are referred (or not referred), courses 
on recognition and treatment of depression could educate GPs in these areas so that 
they might be able to take even better care of their patients. Also, while 
recommendations towards the need for secondary mental health care in depression 
are quite clear in most guidelines, the indications and possibilities of primary mental 
health care are less so. This could also be an interesting field of research. 
 Determinants of (non )recognition 
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Patient case C "Guideline recommendations for maintenance treatment with 
antidepressants" 
Mrs. C. had an episode of major depressive disorder in the past. In addition, and 
prior to that episode, she was diagnosed with a dysthymic disorder that had lasted for 
many years. She was a housewife with a disabled husband and a son with 
psychological problems that still lived with his parents. Her husband and son were 
both not very talkative and tended to fight quite a lot. At first glance the dysthymic 
disorder seemed to stem from her surroundings. She was advised to search for 
hobbies out of the house and talk with friends to cope with the situation at home. 
Unfortunately, she did not achieve remission with these advises. Psychological 
therapy (counselling and psychotherapy) were tried. Nonetheless, she remained 
dysthymic. In 2010 we decided to try treatment with an antidepressant. After only a 
few weeks of sertraline 50mg she started to feel better, and after 8 weeks she told 
me she was ‘happy’. At home things ran smoother as well, as she would less often 
react irritated to her husband and son.  
At the moment she consults me every six months to discuss her mood and the need 
for further continuation of the antidepressant. Unfortunately, she is very anxious to 
stop the sertraline. According to the guideline, this could be considered 
overtreatment. From the view of Mrs. C. who has had a dysthymic disorder for many 
years it is understandable that she is anxious and maybe even unwilling to stop. I 
estimate that attempts at tapering off an antidepressant without the patients full 
consent are likely to fail. In this case, we discuss the medication twice a year and 
maybe in the future a good moment will be found to stop the sertraline. 
 
In this chapter it becomes clear that although most guidelines would not recommend 
maintenance treatment in this case, evidence concerning (indications for) 
maintenance treatment is scarce. 
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Abstract  
Background  
Long term treatment with antidepressants is considered effective in preventing 
recurrence of major depressive disorder (MDD). It is unclear whether this is true for 
primary care. We investigated whether current guideline recommendations for long 
term treatment with antidepressants in primary care are supported by evidence from 
primary care. 
Methods  
Data sources for studies on antidepressants: PubMed, Cochrane Library, Embase, 
PsycInfo, Cinahl, articles from reference lists, cited reference search. Selection 
criteria: adults in primary care, continuation or maintenance treatment with 
antidepressants, with outcome relapse or recurrence, (randomized controlled) 
trial/naturalistic study/review. Limits: published before October 2009 in English.   
Results  
Thirteen depression guidelines were collected. These guidelines recommend 
continuation treatment with antidepressants after remission for all patients including 
patients from primary care, and maintenance treatment for those at high risk of 
recurrence. Recommendations vary for duration of treatment and definitions of high 
risk. We screened 804 literature records (title, abstract), and considered 27 full text 
articles. Only two studies performed in primary care addressed the efficacy of 
antidepressants in the long term treatment of recurrent MDD. A double blind RCT 
comparing mirtazapine (n=99) and paroxetine (n=98) prescribed for 24 weeks 
reported that in both groups 2 patients relapsed. An open study of 1031 patients 
receiving sertraline for 24 weeks, who were naturalistically followed up for up to 2 
years, revealed that adherent patients had a longer mean time to relapse.  
Conclusions 
No RCTs addressing the efficacy of maintenance treatment with antidepressants as 
compared to placebo were performed in primary care. Recommendations on 
maintenance treatment with antidepressants in primary care cannot be considered 
evidence based. Guideline recommendations for antidepressant treatment 
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Introduction  
Major depressive disorder is a common illness. According to the WHO major 
depressive disorder will be one of the leading causes of disability worldwide by 2020, 
second only to ischemic heart disease (1). The high level of disability associated with 
depression is mainly caused by it’s chronic or recurrent course (2,3). To prevent 
chronicity, relapses or recurrences after remission has been achieved during 
treatment of the acute episode, guidelines recommend long term treatment with 
antidepressants (AD) (4 6). Two recent meta analyses based on a considerable 
number of placebo controlled trials in which patients were randomized to either 
continuation of AD or placebo during the first three months after remission, have 
shown that continuation treatment with AD significantly decreases relapse rates 
within the first three months after randomization (7,8). This evidence supports the 
recommendation for continuation treatment with AD during the first months after 
remission to prevent relapse. Far less research has investigated the efficacy of 
longer term maintenance treatment for prevention of recurrence (7,8). Although 
guidelines also recommend maintenance treatment with AD for several years, or 
even lifelong, for patients with previous recurrences the scientific basis for these 
recommendations is meagre, since only few studies have addressed the efficacy of 
AD in patients randomized more than three months after remission (4 6,8). For 
registration of an AD (e.g. by the European Agency for the Evaluation of Medicinal 
Products) the manufacturer is required to provide efficacy data from placebo 
controlled acute treatment studies as well as continuation studies lasting up to six 
months (http://www.emea.europa.eu/pdfs/human/ewp/051897en.pdf).   
The majority of patients with depression are treated in primary care (9). One 
may assume that treatment of depression might not be that different between primary 
and secondary care, but without proof we cannot simply extrapolate the guidelines 
from secondary care to primary care. Also, some studies did find, although small, 
differences between patients in primary and secondary care. For example, psychotic 
features and suicidality are less often present in primary care (10). Second, primary 
care patients with depression seem to be less accepting of treatment, possibly 
leading to a lower effectiveness (11). Third, patients in primary care less often 
receive psychotherapy (12). As the majority of studies of long term AD treatment 
have been carried out in secondary care, their generalizability to primary care Guideline recommendations for antidepressant treatment 
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remains uncertain (7,8).  
We sought to investigate the current depression guideline recommendations 
on long term treatment with AD in primary care in order to determine if the 
recommendations are supported by studies representative of the primary care 
population. This review therefore addressed the following questions. 1. What is, 
according to current guidelines, the recommended duration of treatment with AD after 
remission for patients with major depressive disorder treated in primary care? 2. Are 
these recommendations for long term treatment with AD in primary care supported 
by evidence from literature? 
 
Methods 
Guideline recommendations 
For the first question our aim was to collect current guidelines, from Europe and 
English speaking countries in other parts of the world, which provided 
recommendations for primary care about AD treatment in major depressive 
disorders. Therefore, we searched PubMed, Cochrane, PsycInfo, Embase, Cinahl, 
and the National Guideline Clearinghouse as well as with the search machine Google 
with the keywords “depression”, “guideline” and “treatment”. In addition we searched 
the website of WONCA for links to primary care organizations in European countries; 
on the websites of these organizations we searched for depression guidelines. We 
excluded guidelines that were based on other guidelines and guidelines over ten 
years old. 
 
Studies on efficacy of long term treatment with AD in primary care 
For the second question, we used four systematic search strategies. First, we 
searched PubMed, Embase, PsycInfo, Cinahl and the Cochrane library with 
keywords and free text words. Articles written in English and published until October 
2009 were included. We used the following inclusion criteria: participants: adult 
primary care patients (no children and not only elderly people aged >64 years); 
intervention: continuation or maintenance treatment with antidepressant agents in 
primary care; comparison: placebo or no comparison; outcome: relapse or 
recurrence of depression; study design: randomized controlled trial, controlled trial, 
open trial, clinical trial, naturalistic study, (systematic) review, all with a duration of at 
least six months. The search string in PubMed was as follows: Depressive disorder, Guideline recommendations for antidepressant treatment 
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major (Mesh) AND Antidepressive agents (Mesh) AND ("Primary Health Care"[Mesh] 
OR "Physicians, Family"[Mesh] OR "Family Practice"[Mesh] OR "primary care" OR 
"general care" OR "general health care" OR “general practice” OR “general 
practitioner”). In the other databases we used comparable search strings.  
  In order to exclude the possibility that we might have missed articles with the 
chosen strategy, especially because not all primary care studies mentioned that they 
were performed in this setting, we did two additional searches in one database 
(PubMed) by adding the text word “depression” and without all search terms referring 
to “primary care”, respectively. Either search did not reveal any additional paper. 
Third, we used the so called “snowball method” whereby we searched the reference 
lists of all retrieved articles for possible other relevant articles. Finally, we used Web 
of Science searching for articles citing the retrieved articles from our original search. 
 
Data extraction 
The search results were first screened on title and abstract for studies on long term 
treatment with AD of major depressive disorder in primary care. All retrieved articles 
were obtained and the full text articles were read using the inclusion criteria 
described earlier. 
  Studies in specific groups of depressed patients (e.g. post stroke depression, 
post myocardial infarction depression), in children (aged less than 18 years) or the 
elderly (aged above 65 years) were excluded because depression course and 
response to AD can be different in these patients (13 15). We excluded duplicates 
after retrieval of full text articles, because of practical reasons. 
All searches were performed by the first author, who also did most of the title 
and abstract screening. She consulted the other authors in case she doubted about 
an article. Eventual full text article selection and data extraction was done during a 
meeting with all authors. 
 
Results  
Guideline recommendations for long term treatment with AD in primary care 
We collected 13 depression guidelines specifically addressing or at least mentioning 
treatment of depression with AD in primary care. An overview of the 
recommendations in the guidelines for the long term treatment with AD in primary 
care is found in table 1 (4 6,16 25). Although all guidelines recommended Guideline recommendations for antidepressant treatment 
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continuation treatment with AD after remission for all patients, recommendations for 
duration of continuation treatment varied from 4 to 12 months. Maintenance 
treatment of varying durations (between 1 year and lifelong) was recommended for 
patients at high risk of recurrence, which each guideline defined differently. Almost all 
cited references in guidelines were based on studies carried out in secondary or 
tertiary care settings; most of these studies randomized patients within 3 months 
after remission and the difference between antidepressant and placebo was already 
achieved within 3 months after randomization (4 6,16 25). Relapse risk was 25% in 
the first year after remission, 42% after two years, 60% after five years and 50 85% 
after 15 years (3,26). The risk of relapse or recurrence increased after each 
subsequent episode (26). 
None of the guidelines specified whether recommendations for primary care 
should be different than those for secondary care and no guideline referred 
specifically to any controlled study performed in primary care. 
 
Studies on efficacy of long term treatment with AD in primary care 
The database searches identified a total of 716 titles, including duplicates, because 
titles were retrieved in more than one database. Reference checking and the cited 
reference search rendered a total of 88 records. Screening titles and abstracts 
yielded 27 potentially relevant articles after removing duplicates (see Figure 1).  Guideline recommendations for antidepressant treatment 
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Of these, 18 articles were excluded because they did not concern the efficacy of 
long term treatment with AD in primary care or did not have relapse risk as an 
outcome measure; two studies were not performed (solely) in primary care; and one 
article, which was the only study from primary care frequently referred to in 
guidelines, proved to be a retrospective case note audit conducted in primary care, 
not addressing the relationship between AD use and relapse (27). We were unable to 
acquire four articles. In summary, after reading the full text articles, two publications 
remained (28,29). Neither of them was a placebo controlled study performed in 
primary care that addressed the efficacy of AD in the prevention of relapse or 
recurrence in major depressive disorder. 
One study was an RCT involving 197 patients comparing the efficacy and 
tolerability of mirtazapine (n=99) and paroxetine (n=98) during 24 weeks in patients 
with a major depressive episode. Only 91 patients (46.1%) completed the study, 
while remission was obtained in 35 patients (35%) receiving mirtazapine and 22 
patients (22%) receiving paroxetine. After remission, in both groups 2 patients 
relapsed before the end of the study at 24 weeks. The authors did neither mention 
how many patients were actually followed after remission nor for how long (29). 
The second study involved 1031 primary care patients with DSM IV major 
depression who had been participants in another study (30). All patients were treated 
with sertraline for 24 weeks, which resulted in remission in 59% of patients. Patients 
(including non remitters and non responders) were naturalistically followed up for up 
to 2 years. During this follow up the general practitioner made all decisions about 
treatment. Depression outcome was compared for patients who were adherent to 
treatment with AD versus non adherent patients. Overall relapse or recurrence rates 
were not statistically different between groups, but adherent patients (mean time to 
relapse 302 days) had a longer mean time to relapse or recurrence than non 
adherent patients (mean time to relapse 249 days) (28).  
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Figure 1 Flow diagram 
 
 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for 
Systematic Reviews and Meta Analyses: The PRISMA Statement. PLoS Med 2009;6:e1000097.  
 
Discussion  
Our main findings are that the available guidelines do not specify that 
recommendations in primary care might be different from recommendations in 
secondary care with respect to continuation and maintenance treatment with AD. 
Moreover, there is a paucity of research investigating the efficacy of long term 
treatment with antidepressants in primary care.  
A limitation of this review is that we were unable to acquire all existing 
guidelines. Furthermore, we could not acquire all potentially interesting full text 
articles. Finally, we limited our search to articles published in the English language. 
The strength of this review is the comparison between guideline recommendations 
and evidence. Guidelines are used in everyday practice of primary care, and they are 
often thought to contain a high level of evidence. However, it is not always clear 
whether primary care guidelines are based on evidence from primary care. 
Overall, guidelines recommend the continuation of treatment with AD for all Guideline recommendations for antidepressant treatment 
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patients for a period of 4, 9 or even 12 months.  Maintenance treatment for a longer 
period (i.e. between 1 year and lifelong) is recommended for patients at high risk of 
recurrence, which each guideline defines differently. However, the guidelines do not 
specify that recommendations are actually based on studies in secondary or tertiary 
care.  
Our systematic search did not identify any placebo controlled RCT to support 
the efficacy of continuation or maintenance treatment with AD in primary care. The 
two studies we found provided only circumstantial evidence suggesting that long 
term treatment with AD can reduce relapse or recurrence rates (28,29). This raises 
the question on which studies the guidelines base their ‘level 1’ evidence. Guidelines 
refer to many studies with respect to optimal duration of treatment with AD after 
having achieved remission. In their recent meta analysis of 30 placebo controlled 
RCTs on long term treatment with tricyclic antidepressants (TCAs) or selective 
serotonin reuptake inhibitors (SSRIs), Kaymaz et al. found a significant relapse 
reducing effect of antidepressants compared to placebo at 3, 6, 9, as well as 12 
months of follow up.  However, they also showed that the difference between 
antidepressant and placebo was achieved within 3 months after randomization, while 
no additional reduction in risk was observed at further follow up (8). With the 
exception of two very small trials including a total of 32 patients, there were no 
studies in which patients were randomized after 3 months of remission  (8). Thus, it 
can be concluded that the recommendations for the use of antidepressants in 
continuation treatment (i.e. during the first 3 6 months after remission to prevent 
relapse) are evidence based. However, good quality evidence is lacking for 
recommendations on the category of patients for whom maintenance treatment is 
appropriate, and on the duration of maintenance treatment. Furthermore, guideline 
recommendations for long term treatment are only based on studies in patients 
treated in secondary care or specialized research settings and not for patients 
treated in primary care. Although one could argue that there are no strong arguments 
that recommendations on maintenance treatment with antidepressants in primary 
care should be different form secondary care, we conclude that they cannot be 
considered evidence based. Hence, clinicians should be cautious with too strictly 
following the guidelines and instead may adjust the indication for long term treatment 
to fit each patient’s need. Finally, we conclude that further studies on the long term 
treatment with antidepressants in primary care are warranted. Guideline recommendations for antidepressant treatment 
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Conclusion  
Whereas depression guidelines recommend long term (maintenance) treatment with 
antidepressants for both primary and secondary care patients with recurrent 
depressive episodes, it remains unclear whether these recommendations apply for 
patients in primary care.   
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Patient case D "Overtreatment with antidepressants" 
In the daily lists of repeat prescriptions was a prescription for paroxetine 20mg for 
Mrs. D. According to her file she had had an severe episode of major depressive 
disorder about 10 years ago after her first husband had suddenly died. Her 
psychiatrist had prescribed her the paroxetine then. She was asked to make an 
appointment to discuss current situation and possible phasing out of the paroxetine. 
During the consultation she told she had been fine ever since she had started the 
paroxetine. Her live at that moment was very stable, she had remarried about 18 
months before. She had never really thought about stopping the paroxetine and was 
a bit anxious about it, afraid it would lead to a new episode of depression. After some 
discussion and counseling, she decided to try and phase it out. She used 10mg for a 
month and then stopped the paroxetine. Six months later her mood had been stable. 
Mrs. D. is a good example of a patient that is overtreated with antidepressants, 
although she started with a good indication. 
 
In this chapter overtreatment with antidepressants according to the guideline is 
described. Overtreatment with antidepressants 
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Abstract 
Background  
Depression is a common illness, often treated in primary care. Many studies have 
reported undertreatment with antidepressants in primary care. Recently, some 
studies also reported overtreatment with antidepressants. 
The present study was designed to assess whether treatment with antidepressants in 
primary care is in accordance with current guidelines, with a special focus on 
overtreatment. 
Methods  
We used baseline data of primary care respondents from the Netherlands Study of 
Depression and Anxiety (NESDA) (n=1610). Seventy nine patients with treatment in 
secondary care were excluded. We assessed justification for treatment with 
antidepressant according to the Dutch primary care guidelines for depression and for 
anxiety disorders. Use of antidepressants was based on drug container inspection or, 
if unavailable, on self report. Results were recalculated to the original population of 
primary care patients from which the participants in NESDA were selected 
(n=10,677). 
Results  
Of 1531 included primary care patients, 199 (13%) used an antidepressant, of whom 
188 (94.5%) (possibly) justified. After recalculating these numbers to the original 
population (n=10,677), we found 908 (95% CI 823 to 994) antidepressant users. 
Forty nine (95% CI 20 to 78) of them (5.4%) had no current justification for an 
antidepressant, but 27 of them (54.5%) had a justified reason for an antidepressant 
at some earlier point in their life. 
Conclusions  
We found that overtreatment with antidepressants in primary care is not a frequent 
problem. Too long continuation of treatment seems to explain the largest proportion 
of overtreatment as opposed to inappropriate initiation of treatment. 
 Overtreatment with antidepressants 
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Introduction 
Depression is a common disorder that is associated with a great amount of morbidity 
because of its highly recurrent and chronic nature (1). Most patients with depression 
are treated in primary care (2,3). Guidelines on the treatment of depression in 
primary and secondary care consider treatment with antidepressants and/or 
psychotherapy indicated for all patients with major depressive disorder (MDD) (4 10). 
According to these guidelines the treatment should be continued for 6 months after 
remission (continuation treatment) of a first episode, while it should be continued for 
one or more years (maintenance treatment) in patients with a recurrent MDD or 
chronic depression (4 10).  
Various studies reported that treatment of depression in primary care is not 
according to guideline recommendations (11 16). Most studies reported 
undertreatment, especially with antidepressants of patients with MDD (11 16). 
However, in recent years there has also been a lot of attention for overtreatment with 
antidepressants (17 19). The fact that in the last 6 months of 2005 760,000 people in 
the Netherlands (population 16.500.000) were prescribed an antidepressant, 
according to the Dutch Foundation for Pharmaceutical Statistics (SFK, www.sfk.nl) 
led to discussions in the Dutch media and among professionals. High numbers were 
recently also reported in the US and UK, which also led to discussions (20 22). A few 
studies on overtreatment with antidepressants suggested that this is mainly due to 
prescription of these drugs to patients with milder forms of depression, such as 
dysthymia (Dysth) or minor depression (miD) (17,18,23 26). Especially the 
prescription of antidepressants to patients with miD is controversial, as there is no 
evidence for the efficacy of antidepressants in this condition (27 29). On the other 
hand, even patients without a depression might receive antidepressants for another 
justified indication such as anxiety disorders and pain, for which several 
antidepressants are also registered.  
The aim of this study was to evaluate whether the statements reported in the 
media and a few articles in the literature about widespread overtreatment with 
antidepressants were true. Therefore, we wanted to assess to what extent the use of 
antidepressants is in accordance with the Dutch primary care guideline for 
depression (which is comparable to other international guidelines) as well as for 
anxiety disorders, with a focus on overtreatment.  
 Overtreatment with antidepressants 
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Methods 
This study was conducted with baseline data from the Netherlands Study of 
Depression and Anxiety (NESDA, www.nesda.nl), a large prospective cohort study 
on depression and anxiety disorders among respondents aged between 18 and 65 
years, recruited from the community, primary care and (secondary) mental health 
care. Detailed information on the objectives and methods of NESDA were published 
elsewhere (30).  
 
Study sample 
For this study we selected from the NESDA database only those respondents who 
were recruited in primary care. In short the recruitment in primary care was as 
follows. A screening questionnaire was sent to a random sample of 23,750 people 
from 65 general practitioners (GPs) who had consulted their GP in the past four 
months, irrespective of reason for consultation. In the Netherlands patients are listed 
with a single GP or GP practice. The GP is the gatekeeper to secondary care; access 
to secondary (mental) health care is impossible without a reference from a GP.  
The screening questionnaire consisted of the Kessler-10 (K 10), which has 
proven screening qualities for affective disorders, and five additional questions 
asking about the presence of specific anxiety disorders (31,32). A positive score was 
defined as a validated K 10 score of ≥20, or a positive score on any of the five 
anxiety questions (32). Almost half of the sample (n=10,706; 45%) returned the 
screener. Responders to the screener were slightly more often female and older than 
non responders (30,33). Although having to take small age and sex differences into 
account, we consider this sample representative of patients consulting their GP in the 
Netherlands (33).  
Those who screened positive (n=4592) were approached for a telephone 
interview with the short form sections of the CIDI (CIDI SF), which has proven 
screening qualities with a high sensitivity for detecting mental disorders (34). 
Specifically trained research staff (mainly psychologists and research nurses) 
conducted the telephone interview. 
All persons who screened positive on the CIDI SF (n=898), as well as 196 out 
of 278 randomly selected persons with a positive K 10 plus, but not fulfilling CIDI SF 
criteria and a random selection of 516 screen negatives (healthy controls) Overtreatment with antidepressants 
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participated in the baseline assessment of NESDA (n=1610), which consisted of a 
face to face interview.  
The 79 respondents already receiving treatment for psychiatric conditions in 
secondary care (defined as more than one contact with either an institute for 
mental/psychiatric health care or an independent psychiatrist) were excluded from 
our study sample, yielding a total sample of 1531 respondents for the present 
analyses.   
 
Description of Procedures or Investigations undertaken 
Measures 
As part of the screening procedure, all respondents filled out the K-10 plus. 
Demographic data (age, gender, ethnicity, education) were assessed during the 
baseline interview.  
Current and lifetime diagnoses of MDD, Dysth, current diagnosis of miD, 
comorbid anxiety disorders (social phobia, panic disorder, agoraphobia, generalized 
anxiety disorder) based on DSM IV were assessed with a structured interview, the 
World Health Organization Composite International Diagnostic Interview – lifetime 
version 2.1 (CIDI), which is considered the gold standard for diagnosing depressive 
and anxiety disorders in large epidemiological studies (35 37). Specifically trained 
research staff (mainly psychologists and research nurses) conducted the baseline 
interview including the CIDI. 
From the data of the CIDI interview, in which all depressive symptoms were 
listed separately, we created a variable for depressive symptoms, defined as having 
had one or more DSM IV symptoms of depression during at least two weeks lifetime 
with at least either anhedonia or depressed mood, without fulfilling the criteria for 
diagnosis of MDD or dysthymia. From this data we also created a variable “chronic 
MDD”, defined as having had a lifetime diagnosis of MDD and 24 months of 
(probably uninterrupted) symptoms of depression in the past five years as recorded 
with the life chart method. The life chart is a method for recalling depressive 
symptomatology, the respondent was asked during the interview to mention several 
important (personal) events from the last several years and was subsequently asked 
to recall if there was some depressive symptomatology at that point. The life chart 
has been proven useful to assess the course of illness in patients with mood 
disorders (38 40).Overtreatment with antidepressants 
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Outcome variables 
Whether respondents used antidepressants was based on drug container inspection 
of all drugs used in the past month at baseline and classified according to the World 
Health Organization Anatomical Therapeutic Chemical (ATC) classification. If 
respondents had forgotten to take the medication to the interview, their use was 
based on self report (done for 35.3% of all subjects). The use of two different 
methods for assessing antidepressant drugs was not a problem in the current study, 
as we were not interested in patient compliance, for which self report and drug 
container inspection can give very different results, but only in physician prescription 
behaviour. We therefore used the drug container inspection only to assess which 
medications were used and not for pill counts. Use of antidepressants included 
selective serotonin reuptake inhibitors (ATC code N06AB), tricyclic antidepressants 
(N06AA) and other antidepressants (N06AF/N06AX). St John’s wort was not 
considered an antidepressant.  
 
Justification for treatment with an antidepressant  
To determine the justification for treatment with an antidepressant, we followed the 
recommendations from the guidelines for depression and for anxiety disorders of the 
Dutch General Practitioner’s Association (NHG) (7,41). Treatment was considered 
justified when it was mentioned in the guideline as (one of the) first step option(s) and 
considered possibly justified when it was mentioned as (one of the) second step 
option(s). For depressive disorders the depression guideline recommends the use of 
an antidepressant during six months after response for a first episode of MDD as one 
of the first step treatment options, although dependent on the degree of suffering or 
dysfunction. As dysfunction is a criterion for the diagnosis of MDD and patients 
consulted their physician, we assumed that probably most had at least some degree 
of suffering or dysfunction. Therefore, we considered treatment with antidepressants 
justified when a respondent had suffered an episode of MDD in the past year. In case 
of recurrent or chronic MDD the guideline recommends one to five years of 
maintenance treatment, with the option for longer in patients with previous 
recurrences after withdrawal of antidepressants. Therefore, treatment of chronic or 
recurrent MDD for up to two years was considered justified, all treatment longer than 
two years was considered possibly justified. In case of dysthymia an antidepressant 
is mentioned in the depression guideline as (one of the) second step option(s) and Overtreatment with antidepressants 
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therefore considered possibly justified. Antidepressants were not considered justified 
for depressive states not fulfilling criteria for MDD or dysthymia. 
As antidepressants are also registered for the treatment of anxiety disorders, 
we also considered treatment with antidepressants justified in case the guideline 
recommendations from the anxiety disorder guideline were followed. This guideline 
recommends treatment with an antidepressant in case of the presence of an anxiety 
disorder in the last year, with the option (i.e. possibly justified) to continue the 
treatment for a longer period.  
Overtreatment was considered present when a respondent received an 
antidepressant without justification or possible justification, i.e. without a non 
recurrent (i.e. single) episode of MDD or dysthymia in the past year, or an anxiety 
disorder or recurrent MDD or chronic depression in lifetime.   
 
Ethical considerations 
The study protocol of NESDA was approved centrally by the Ethical Review Board of 
the VU University Medical Center and subsequently by local review boards of each 
participating center. After full verbal and written information about the study, written 
informed consent was obtained from all participants at the start of baseline 
assessment. A full ethics statement of NESDA is found elsewhere (30).  
 
Statistical methods 
Descriptive statistics and frequencies were used to describe the use of AD and 
psychological treatment. We recalculated the found numbers and percentages of 
justified and unjustified treatment with antidepressants in our sample to the original 
population of 10,677 persons who returned a completed K 10 plus screener 
questionnaire. This backward projection was done in several steps, which can be 
derived by reading Figure 1 from the bottom up, or from table 1.  
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Figure 1 Recruitment flow respondents 
 
 
 
In the first step, we split our sample into four groups; no use of an 
antidepressant, justified use, possibly justified use and unjustified use. We will refer 
to these groups as “justification groups”. After that, we registered the number of 
screen positives and screen negatives in each of the justification groups. These 
numbers were then multiplied by a correction factor (respectively total screen 
positives divided by screen positives in sample (4592/1024) or total screen negatives 
divided by number of screen negatives in our sample (6085/506)) to calculate the 
estimated number of persons from each justification group in the original screen 
positive and screen negative groups. Finally, we added up the estimated numbers 
screen positives and negatives for each justification group.  
A 95% confidence interval (95% CI) was calculated for all estimated numbers. 
This was done by first calculating the standard error of the proportion with the proper 
mathematical formula. This number was then multiplied by 1.96 and subtracted and 
added to the proportion in order to get the 95% CI of the proportion, which could then 
be recalculated to the 95% CI of the absolute number by multiplying by n. Overtreatment with antidepressants 
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We used a Chi square statistic to test for significant differences in justification 
for an antidepressant between antidepressant users with no/mild/moderate/severe 
MDD. 
All statistical calculations were performed using SPSS for Windows Release 16.0. 
 
Table 1 Results of recalculation of justified and unjustified antidepressant use to screener population 
  Study sample 
(n=1531) 
Screen positive 
(n=4592) 
Screen negative 
(n=6085) 
Screener 
population 
(n=10,677) 
Definitely justified  95 (47.7%)  94 * 4.5
(1) = 422  1* 12.0
(2) = 12  434 (394 474)
(3) 
Possibly justified   93 (46.7%)  92 * 4.5
(1) = 413  1* 12.0
(2) = 12  425 (385 465)
(3) 
Unjustified  11 (5.5%)  11 * 4.5
(1) = 49  0 * 12.0
(2) = 0  49 (20 78)
(3) 
Total  199 (100%)  197 * 4.5
(1) = 884  2 * 12.0
(2) = 24  908 (823 994)
(3) 
(1) Correction factor screen positive group: total number of screen positives divided by number of 
screen positives in the study sample (4592/1024=4.5) 
(2)Correction factor screen negative group: total number of screen negatives divided by number of 
screen negatives in the study sample (6085/506=12.0) 
(3) 95% Confidence Interval 
 
Results 
Study sample  
The average age of the population was 45.8 years, 1054 (68.8%) of respondents 
were female and 477 (31.2%) male. 
The diagnoses of the respondents with lifetime depression/depressive 
symptoms (n=1064, of whom 651 with a comorbid anxiety disorder) were as follows: 
807 respondents had a lifetime MDD of whom 428 in the past year; 23 had a lifetime 
Dysth without history of MDD of whom 16 in the past year; and 234 had a lifetime 
miD or depressive symptoms in lifetime without a history of MDD or Dysth, of whom 
44 had a miD in the past month (incidence in last year unknown). The diagnoses of 
the respondents with a lifetime anxiety disorder (n=762) were: 345 patients with 
social phobia; 344 patients with a panic disorder (with or without agoraphobia); 131 
patients with agoraphobia; and 330 patients with a generalized anxiety disorder (324 
patients had more than one anxiety disorder).  
 
Justified and non justified treatment 
Of the respondents with a depression/depressive symptoms (MDD, dysthymia, miD 
or depressive symptoms, n=1064), 189 (17.8%) used an antidepressant, of whom 75 
(39.7%) had a justification, 68 (36.0%) a possible justification and 46 (24.3%) did not 
have a justification. Overtreatment with antidepressants 
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However, of the 46 antidepressants users with a depression/depressive 
symptoms without a justification for treatment with an antidepressant (non recurrent 
MDD, miD or depressive symptoms) nine had only a depression/depressive 
symptoms and 37 had a lifetime anxiety disorder (26 in the past year), which means 
that the antidepressant may have been prescribed for the anxiety disorder rather 
than the depression. This means that in only nine patients (4.5%) with a 
depression/depressive symptoms treatment was not justified.  
Of the 111 respondents with a lifetime anxiety disorder without a 
depression/depressive symptoms eight patients (10.1%) used an antidepressant, in 
three this was justified and in five possibly justified.  
Only 2 (0.6%) of the 356 respondents without a lifetime depression or anxiety 
disorder used an antidepressant. This treatment obviously was not justified. 
Table 2 shows a summary of justified and not justified treatment in our 
sample. In total 11 respondents used an antidepressant without a definite or possible 
justified reason. Eight of them used a SSRI, one a TCA (at low dose) and two 
another antidepressant; the duration of antidepressant use varied from 0 to 120 
months, with a median of 48 months. Nine of these respondents had a 
depression/depressive symptoms (six a single episode of MDD more than one year 
ago, three miD or depressive symptoms). They represent 0.77% of the 1175 
respondents with a lifetime depression or anxiety disorder. The other two represent 
0.56% of the 356 respondents without a depression/depressive symptoms or anxiety 
disorder. Thus, 6 of the 11 respondents (54,5%) had a justified reason for treatment 
with an antidepressant at some earlier point in their life because of an episode of 
MDD. 
 
Table 2 Treatment with antidepressants and justification for treatment 
 
 
 
 
 
 
Treatment was considered definitely justified in case of a MDD in the past year, or recurrent or chronic 
MDD with antidepressant treatment ≤ 24 months, or an anxiety disorder in the past year.  
Treatment was considered possibly justified in case of dysthymia in the past year, or a recurrent or 
chronic MDD with antidepressant treatment >24 months, or an anxiety disorder over one year ago.  
All other antidepressant treatment was considered unjustified. 
All numbers are absolute number of respondents (percentage of total respondents in row) 
AD=antidepressant 
  No AD  AD  Total 
Unjustified  566 (98.1%)  11 (1.9%)  577  
Possibly justified  225 (70.8%)  93 (29.3%)  318  
Definitely justified  541 (85.1%)  95 (14.9%)  636  
Total  1332 (87.0%)  199 (12.9%)  1531  Overtreatment with antidepressants 
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Table 3 shows the relation between severity of depression at baseline and 
antidepressant use. This table shows that antidepressant users with a mild 
(recurrent) MDD are less often classified as definitely justified AD use. We performed 
a Chi square test comparing the justification groups for antidepressant users with 
moderate to severe (recurrent) MDD to antidepressant users with no MDD or mild 
(recurrent) MDD. The difference was significant (p=0.015), antidepressant users with 
moderate to severe (recurrent) MDD more often had a justified reason for the use of 
an antidepressant compared to antidepressant users with no MDD or mild (recurrent) 
MDD. 
 
Table 3 Severity of depression at baseline and indication for treatment with an antidepressant, based 
only on depression diagnosis 
  Definitely 
justified AD 
users (n,%) 
Possibly 
justified AD 
users (n,%) 
Unjustified 
AD users 
(n,%) 
Total (n) 
MDD Single Mild  7 (24%)  6 (21%)  16 (55%)  29 
MDD Recurrent Mild  12 (39%)  19 (61%)  N/A  31 
MDD Single Moderate  19 (54%)  7 (20%)  9 (26%)  35 
MDD Recurrent Moderate  9 (64%)  5 (36%)  N/A  14 
MDD Single Severe  11(33%)  8 (24%)  14 (42%)  33 
MDD Recurrent Severe  17 (53%)  15 (47%)  N/A  32 
Dysthymia  N/A  8 (100%)  0 (0%)  8 
miD/depressive symptoms  N/A  N/A  7 (100%)  7 
Total  75  68  46  189 
N/A= not applicable 
Respondents with a recurrent MDD and possibly justified AD use had a possible justification because 
they had used an antidepressant for more than 2 years. 
 
Use of antidepressants in the primary care population 
With the selection procedure as described in the method section, we can calculate 
what our findings mean for the total population of respondents (n=10,677) who 
returned the K 10 plus (table 1).  
In our sample there were 188 antidepressant users with justified 
antidepressant use of whom 95 (50.5%) with a definite justified reason, and 93 
(49.5%) with a possible justified reason: 2 among the respondents with a negative K 
10 plus (n=6085, of whom 506 participated in the study) and 186 among the 
respondents with a positive K 10 plus (n=4592, of whom 1023 participated). 
Recalculated to the respondents who completed the K 10, there are 24 (95% CI 0 to 
57) antidepressant users with a definite or possibly justified reason in the screen 
negative group and 835 (95% CI 726 to 943) in the screen positive group.Overtreatment with antidepressants 
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All 11 respondents who used an antidepressant without a definite or possible 
justified reason had a positive K 10 plus.  The total number of antidepressant users 
without a justified reason among all respondents with a positive K 10 plus can be 
recalculated at 49 (95% CI 20 to 78). As there were no antidepressant users without 
indication with a negative K 10 plus, the total number of respondents who used an 
antidepressant without indication among all 10,677 people who completed the K 10 
plus, is also 49 (95% CI 20 to 78). K 10 plus results were unknown for one 
respondent without antidepressant use.  
Combining the results of antidepressant users with and without justification, 
recalculated to the sample of 10,677 GP patients from 65 GPs who had consulted 
their GP in the past four months irrespective of reason for consultation and did return 
a completed screening questionnaire, 908 (8.5%), (95% CI 823 to 994), used an 
antidepressant of whom 859 (94.6% of the antidepressant users) with a definite 
(n=434, 47.8%) or possible (n=425, 46.8%) justification in accordance with the 
guideline and 49 patients (5.4% of the antidepressant users) without justification. 
 
Discussion 
Summary of main findings 
The main finding of our study is that overtreatment with antidepressants did not 
appear to be a very frequent problem in Dutch primary care. Of all GP patients (and 
after excluding patients who were treated in secondary care including hospitals, 
institutes for mental health care and psychiatrists with private practices) 8.5% 
received an antidepressant. When compared with the guidelines of the Dutch 
General Practitioner’s Association (NHG), 94.6% of the antidepressant use was in 
accordance with the guideline (47.8% definitely and 46.8% possibly) while only 5.4% 
was not. The latter was for the large part not due to treatment of mild forms of 
depression or patients without psychiatric diagnoses, but to non justified long 
continuation of antidepressant treatment in patients who at some earlier point in their 
life had a justified reason for treatment with an antidepressant. 
 
Strengths and limitations 
The current study has several very strong points. First, we used a screening method 
to recruit participants, which did not affect the awareness of patient’s psychiatric 
status for GPs in our study. This means that the GPs could only rely on their own Overtreatment with antidepressants 
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diagnostic judgments also for their prescription of antidepressants. The second 
strength of this study is its large sample size, which is rather rare in a primary care 
study. The third strength is that all patients were diagnosed based on a structured 
interview and not on the GPs’ records. 
However there are also limitations. First, the last mentioned strength is also a 
weakness, as the structured interview we used (the CIDI) does not assess the 
degree of suffering and dysfunction, which should be part of the GPs’ consideration 
for antidepressant treatment according to the guideline recommendations. Second, 
the representativeness of the population may be limited. The GPs in this study, and 
thus their patients, may not be representative for all Dutch primary care practices, as 
these practices/GPs agreed to participate in the NESDA study, and thus have 
interest in psychiatric research. This may be associated with a better compliance to 
the guidelines for depression and for anxiety disorders. Next to that, according to the 
SFK about 760,000 Dutchmen were prescribed an antidepressant (about 6.3% of the 
adult population) in the last 6 months of 2005. In our primary care sample we 
recalculated that 8.5% used an antidepressant. This higher percentage may be 
explained by the fact that respondents were selected among the patients who 
consulted their GP in the last four months. The non response to the screening 
questionnaire did not seem to be biased with regard to psychopathology (33).  
Fourth, we did not have access to the full electronic patient file from the GPs. 
Therefore we did not know why they prescribed an antidepressant. This might have 
been of interest, as antidepressants can also be prescribed for other indications than 
depression or anxiety disorder. Some antidepressants including TCAs at low dose for 
example are used for neuropathic pain. However, if any effect, this would result in an 
even lower estimation of overtreatment with antidepressants in our sample. In 
addition, we could not determine the ground on which the GPs based their treatment 
decisions, therefore we could not determine if a decision to (dis)continue an 
antidepressant was according to guideline recommendations. This applies especially 
to the category ‘possibly justified’ in patients who had recovered from a recurrent 
depressive episode more than two years ago, as we do not have information as to 
why the antidepressant was continued in these patients. Among them are definitely 
patients who continue their antidepressants for good reasons, e.g. patients who had 
stopped their antidepressant after a recurrent episode and who developed a new 
recurrence, and patients who tapered off and subsequently developed minor Overtreatment with antidepressants 
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symptoms and therefore restarted medication. This limitation also means that we 
were unable to estimate the severity of symptoms at the time the antidepressant was 
started. Table 3 showed that some respondents with a mild episode of MDD received 
treatment with antidepressants. The guideline at time of the study does not 
differentiate between mild and moderate to severe depressive episodes in its 
recommendations, but more recent guidelines do. For example the new Dutch 
multidisciplinary depression guideline is much more conservative and recommends 
reserving treatment with antidepressants for patients with more severe depressive 
states (42). It is unclear whether the patients with mild symptomatology at baseline 
had more severe symptomatology at the time the antidepressant treatment was 
initiated.  
A final limitation is the cross sectional design of the study, as a result of which 
the start of symptoms and time of remission could not be determined precisely. We 
allowed treatment with antidepressants in case of a MDD in the past year. In some 
cases treatment probably should have been stopped before the interview, because 
the patient had been in remission for (more than) 6 months. Because of the cross 
sectional design, we also had to rely on recall of symptoms of depression and anxiety 
during the past year and for lifetime diagnoses. Several researchers have questioned 
the reliability of retrospective recall of symptoms during a single interview in persons 
with a history of depression (43,44).  
 
Comparison with literature 
Several previous studies also looked at rates of overtreatment, with various 
outcomes. The major contrast with our study is that these studies only looked at 
relative small groups of GP patients and did not allow recalculation of the results to 
the total population of GP patients. Two of the previous studies found high rates of 
overtreatment: 25% (Sihvo et al.) and even 35% (Berardi et al.) (17,18). Berardi et al. 
described a group of 361 primary care patients of whom 82 used an antidepressant. 
They only considered treatment with antidepressants indicated for current 
depression, ignoring possible continuation or maintenance treatment and other 
indications for the use of antidepressants like anxiety disorders. This is a rather 
limited definition, as continuation treatment is a well established part of depression 
treatment and many antidepressants are also registered for anxiety disorders. Sihvo 
et al. described a group of 526 patients who used an antidepressant. They adopted a Overtreatment with antidepressants 
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definition of overtreatment slightly broader than ours. Treatment was considered 
“non psychiatric” in case there was no CIDI diagnosis of MDD, Dysth, anxiety 
disorder (generalised anxiety, social phobia, panic disorder or agoraphobia), bipolar 
disorder or alcohol dependence in the last 12 months.  
The third previous study (Cameron et al) reported a small percentage (exact 
percentage not mentioned) of overtreatment in a Scottish primary care sample of 120 
antidepressant users (19). They did not have a diagnosis based on a structured 
interview, but used a cutt off score of the Hospital Anxiety and Depression Scale 
(HADS). Of their sample 45 had “no depression”, 34 had a “possible depression” and 
41 had “probable depression.” In the respondents with “no depression”, they reported 
that 32 had a history of depression (as recorded by the GP), 5 had anxiety disorder, 
5 had neuropathic pain and for only 3 it remained unclear why they received an 
antidepressant.  
It can be argued that our definition of non justified antidepressant use is rather 
small, and that in reality more patients in our sample did not actually need an 
antidepressant. First, we defined lifelong treatment non justified only for patients 
without a definite or possible justification. This created the problem of how to classify 
the category ‘possible justified’ for treatment beyond two years of patients with a 
recurrent depression, while most guidelines recommend several years and only for a 
(non specified) subgroup lifelong treatment. Second, also in case of anxiety disorders 
it could be argued that lifelong treatment is unnecessary in many if not most cases. 
Third, the diagnosis chronic MDD was based on the self report of 24 months (of 
probably uninterrupted) symptoms of depression in the past five years according to 
the life chart and a lifetime diagnosis of MDD. It could very well be that these patients 
had no chronic MDD, but just symptoms of depression during two or more years. 
This would mean that in more patients antidepressants would be unnecessary. When 
we would have classified all possible justified cases as overtreatment the percentage 
would indeed rise substantially: from 5.4% to 52.2%, which is much higher than 
Berardi et al. and Sihvo et al. and clearly illustrates the importance of a clear 
definition of overtreatment. We think however that our definition including life long 
treatment for patients with recurrent depressive episodes is justifiable, considering 
the high recurrence rate of depression, especially after multiple episodes (45,46). As 
discussed above, at least part of the respondents with a possible justification will 
have a very good reason for the use of an antidepressant. Moreover, there could be Overtreatment with antidepressants 
  92 
patients without a justified reason for the use antidepressants, for whom the 
physician (or the patient himself) found an antidepressant needed, e.g. because of 
residual symptoms after a single episode of MDD. One could also argue that, 
although not indicated according to the guideline, this is justified treatment. 
If indeed the percentage of overtreatment is lower in the Netherlands than in 
other countries: what would be the explanation? A possible explanation is the 
difference in primary care systems. In the Netherlands, the GP is the gatekeeper to 
secondary and mental health care; patients need a reference from the GP before 
they can consult mental health care. Secondly, Dutch GPs have been trained during 
the last years in how to diagnose and treat depression and anxiety disorders, as part 
of the implementation of the Dutch primary care guidelines. This also implies that our 
results probably cannot be generalized globally, as primary healthcare systems vary 
across countries. 
Another explanation for the difference could be that antidepressant use in our 
study was based on drug container inspection in most patients and on self report in a 
minority of cases, while the Dutch Foundation for Pharmaceutical Statistics (SFK, 
www.sfk.nl) data are based on pharmacy prescription data. From previous studies it 
is known that many patients do not pick up their prescription or do not take their 
medication (47,48).  
In this study we focused on overtreatment with antidepressants, and therefore 
we looked at whether patients received an antidepressant without a justified reason. 
However, “justified” does not mean “needed”. Patients with a mild or even moderately 
severe episode of MDD do not necessarily need treatment (either an antidepressant 
or psychotherapy), although they do have a justified reason for treatment with an 
antidepressant. New guidelines like the recent 2009 update of the Dutch 
multidisciplinary guideline for depression recommend reserving antidepressants for 
patients with moderate to severe depression (42). Therefore, an alternative 
interesting question is: who needs an antidepressant, and how many of the patients 
who need an antidepressant do actually receive an antidepressant. This however, 
was not the focus of our study as undertreatment of depression has already been the 
focus of many studies in the past (11 16). Moreover, the NESDA study is not suitable 
for answering this question. It is a naturalistic study and part of the study population 
did not seek any help. It is therefore impossible to determine which patients are Overtreatment with antidepressants 
  93 
“undertreated” by their GP and which did not seek help for their psychological 
complaints. 
 
Implications for clinical practice and future research 
In conclusion, the current study provides a unique insight into the justification of the 
prescription of antidepressants in Dutch primary care. In contrast to the scarce 
literature, the rate of overtreatment with antidepressants in the present study was 
low. Another interesting finding is that overtreatment is not so much due to treatment 
of mild forms of depression or patients without psychiatric diagnoses, but rather to an 
excessive duration of antidepressant treatment in patients with remitted (recurrent) 
MDD. This latter finding presents several implications for clinical practice. First, 
projects on optimizing treatment with antidepressants in primary care, should not 
focus on reducing overtreatment but on identifying patients who do not need 
antidepressants anymore. Second, GPs should be aware that apparently many 
patients tend to continue the antidepressant over many years. Which of these 
patients might be able to stop the antidepressant is unclear. Therefore, further 
studies addressing this question are warranted before starting campaigns to reduce 
the use of antidepressants in primary care. 
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Patient case E "Maintenance treatment with antidepressants"  
Mrs. E. visits my practice for her half yearly appointment. She uses paroxetine since 
2008. In 2008 she had a major depressive disorder with a comorbid anxiety disorder. 
She attempted to stop the paroxetine in 2010, which resulted in a recurrence of 
mainly anxiety symptoms. She is very reluctant to try it another time.  
Mrs. E. is one of many patients with comorbid depressive and anxiety 
symptomatology that use maintenance treatment with antidepressants.  
 
In the following chapter we describe the patients on maintenance treatment with 
antidepressants and relate characteristics of these patients to guideline 
recommendations for maintenance treatment (whether they are evidence based or 
not). 
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Abstract 
Background 
There is hardly evidence on maintenance treatment with antidepressants in primary 
care. Nevertheless, depression guidelines recommend maintenance treatment i.e. 
treatment to prevent recurrences, in patients with high risk of recurrence, and many 
patients use maintenance treatment with antidepressants. This study explores the 
characteristics of patients on maintenance treatment with antidepressants in general 
practice, and compares these characteristics with guideline recommendations for 
maintenance treatment. 
Methods 
We used data (baseline, two year and four year follow up) of primary care 
respondents with remitted depressive disorder (≥6 months) from the Netherlands 
Study of Depression and Anxiety (n=776). Maintenance treatment was defined as the 
use of an antidepressant for ≥12 months. Multilevel logistic regression was used to 
describe the association between sociodemographic, clinical and care characteristics 
and use of maintenance treatment with antidepressants. 
Results 
Older patients, patients with a lower education, those using benzodiazepines or 
receiving psychological/psychiatric care and patients with a concurrent history of a 
dysthymic or anxiety disorder more often received maintenance treatment with 
antidepressants. 
Limitations 
Measurements were not made at the start of an episode, but at predetermined points 
in time. 
Conclusions 
Since patients with chronic or recurrent depression do not use maintenance 
treatment with antidepressants more often, characteristics of patients on 
maintenance treatment do not fully correspond with guideline recommendations. 
However, patients on maintenance treatment appear to be those with more severe 
disorder and/or more comorbidity. Characteristics of maintenance antidepressant users 
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Introduction 
Depression is a common condition that has a chronic or recurrent course in a 
significant proportion of cases (1). Most patients are treated in primary care (2,3). 
Treatment in primary care may consist of counselling by the general practitioner, 
various forms of psychotherapy and/or antidepressants (4). Many studies have 
provided evidence for continuation of antidepressants after remission to prevent 
relapses. Far less evidence is available for treatment after this continuation phase, to 
prevent recurrences, known as maintenance treatment (5,6). Most guidelines do 
recommend maintenance treatment, of various durations, in a subgroup of patients 
with high risk of recurrence. However, the various guidelines, such as the NICE 
guideline depression in adults, the ICSI Health Care guideline major depression in 
adults in primary care and the Dutch General practitioners guideline depression 
(NHG standaard Depressieve stoornis) use different indicators for patients at 
increased risk of recurrence (5,7 11). Almost all guidelines recommend maintenance 
treatment with antidepressants in case of recurrent depression, some also after a first 
episode if it was a severe or chronic episode. Less frequently the following criteria 
are used in some guidelines: residual symptoms, stressors or lack of support, 
concurrent other DSM IV axis I or II disorders, age <30 or >65, rapid relapse or 
recurrence in the past and family history of major depressive disorder (5). 
  In a previous paper based on data from the Netherlands Study on Depression 
and Anxiety (NESDA), we reported that only 5.4% of patients receiving 
antidepressants in Dutch primary care, do use their antidepressant without a justified 
indication according to the primary care guidelines depression and anxiety (12). In 
the same study we found that over half of the patients without a current justification 
had started to use antidepressants with a justification in the past. Apparently, a 
proportion of patients using antidepressants, decide to continue them for years after 
recovery.  
  Currently, we do not know which of these patients should indeed be advised to 
continue using their antidepressant to prevent recurrences and which patients could 
“safely” be advised to discontinue them. Studying the patients of our previous study 
in more detail may shed some light on the reasons behind their decision to continue 
or to discontinue their antidepressant. More specifically, we were interested to know 
whether patients using antidepressants as maintenance treatment have ‘valid’ 
reasons for that. Therefore, we decided to compare sociodemographic, clinical and Characteristics of maintenance antidepressant users 
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care characteristics of remitted patients (in remission for at least six months) with and 
without maintenance treatment (antidepressant use ≥12 months). Subsequently we 
compared these characteristics with guideline recommendations for maintenance 
treatment. We hypothesized a priori that most patients on maintenance treatment 
would meet one or more guideline criteria (Dutch primary care guideline depression 
2003) for maintenance treatment such as a recurrent or chronic depression and that 
these patients more often would have a comorbid anxiety disorder than patients 
without maintenance treatment.  
 
Methods 
This study was conducted with data from NESDA (www.nesda.nl), a large 
prospective cohort study (n=2981) on the course of depression and anxiety disorders 
among respondents aged 18 65 years, recruited from the community, primary care 
and secondary mental health care. Detailed information on the objectives, study 
population and methods of NESDA has been published (13). 
 
Study sample 
The current study used data from the baseline, two year and four year follow up 
measurements/interviews of NESDA on only respondents recruited from primary 
care. We decided to use data on these respondents only since we wanted a 
representative primary care sample. Recruitment was described in detail elsewhere 
(13). Briefly, recruitment in primary care went as follows. A written screener was sent 
to 23,750 primary care patients that consulted their general practitioner in the past 
four months, irrespective of the reason for consultation. The screener was returned 
by 10,706 persons (45%). The non responders showed no bias with regard to 
psychopathology (14). Those screening positive were approached for a telephone 
interview consisting of the Composite International Diagnostic Interview Short Form 
sections (CIDI SF), which has proven diagnostic quality for screening purposes 
(15,16). Respondents fulfilling criteria for a current disorder on the CIDI SF were 
invited to participate, as were a random selection of screen negatives, both from the 
written screener and the CIDI SF. In total, 1610 persons were recruited, who 
underwent an extensive baseline interview, including the CIDI (17,18). The GP was 
not aware of the results of the screening or the interview. After two years and after 
four years the interview, including the CIDI was repeated. Characteristics of maintenance antidepressant users 
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  We included those patients that had recovered from a major depressive 
disorder at least more than 6 months ago according to the CIDI at that moment 
(either baseline interview, two year follow up or four year follow up), i.e. those with a 
lifetime major depressive disorder but not in the past 6 months (n=776). Some 
patients fulfilled the criteria for inclusion on multiple occasions e.g. at baseline and 
two year follow up. We included them separately for each interview moment. In total 
we had 1571 observations of remitted depression. 
 
Definition of maintenance treatment and other long term treatment  
All depression guidelines mentioned in the introduction recommend continuation 
treatment with antidepressants, after having achieved remission with an 
antidepressant, to prevent relapses. The recommended duration for continuation 
treatment varies between four and twelve months. Maintenance treatment is defined 
as all treatment with antidepressants beyond this period. Therefore, in our analysis 
we define maintenance treatment as all treatment with antidepressants ≥12 months 
in patients with depression that has been in remission for at least six months. With 
short term use we refer to all use of antidepressants for less than 12 months.  
 
Determinants of maintenance use 
A detailed description of all measures applied in NESDA has been published (13). All 
characteristics were measured at each interview. 
  Sociodemographic characteristics including age, gender and education were 
self reported by the patient during the interview, work status was assessed with the 
Trimbos/iMTA questionnaire for assessment of Costs associated with Psychiatric 
illness (19 21).  
  Clinical characteristics including current and past (last 6 months, last year, 
lifetime) diagnoses of MDD and dysthymia, comorbid anxiety disorders (panic 
disorder with and without agoraphobia, agoraphobia, social phobia and generalised 
anxiety disorder) were all assessed with the CIDI and severity of depression with the 
IDS (Inventory of Depressive Symptomatology) and of anxiety with the BAI (Becks 
Anxiety Inventory) (22,23). The presence of suicide attempts in the past was 
measured with the Beck Suicide Ideation Scale (24).  
  Chronic depression, defined as a CIDI diagnosis of depression and symptoms 
of depression for more than 24 months and recurrent depression defined as more Characteristics of maintenance antidepressant users 
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than one episode of MDD in the past, were assessed during the interviews using the 
CIDI and life chart data. The life chart is a method for recalling depressive or anxious 
symptomatology, the respondent was asked during the interview to mention several 
important (personal) events from the last several years and was subsequently asked 
to recall if there was some depressive (or anxious) symptomatology at that point. The 
life chart has been proven useful to assess course of illness in patients with mood 
disorders (25 27).  
  Personality traits (neuroticism and extraversion) were assessed with the 
Neuroticism Extraversion Openness Five Factor Inventory (NEO FFI). The number 
of chronic somatic diseases was derived from the Trimbos/iMTA questionnaire for 
assessment of Costs associated with Psychiatric illness (19 21). 
  Care characteristics:  During the interviews the respondents were asked if they 
had had contact with the GP in the last six months, the number of contacts with the 
GP in the last six months, if any of these contacts with the GP had been about mental 
problems, the type of help they received (information, a referral to a specialist/mental 
health care professional, psychotherapy, practical support, skills training, other help 
or no help), if they had perceived need for more or any other form of treatment and if 
they had had contact with primary (social worker, social psychiatric nurse, first line 
psychologist, psychotherapist) or secondary (psychiatrist, professional from a mental 
health care organisation) mental health care. 
  The respondents had been asked to bring all medication they had used in the 
past month to the interview; the use of antidepressants and benzodiazepines was 
then recorded by the interviewer according to the World Health Organization 
Anatomical Therapeutic chemical (ATC) classification. 35.3% of all respondents had 
forgotten to bring their medication; antidepressant use was based on self report in 
these subjects. Use of antidepressants included selective serotonin reuptake 
inhibitors (ATC code N06AB), tricyclic antidepressants (N06AA) and other 
antidepressants (N06AF/N06AX). St. John’s wort was not considered an 
antidepressant. Past use of antidepressants and duration of use of currently used 
antidepressants was based on self report. 
 
Ethical considerations 
The study protocol of NESDA was approved centrally by the Ethical Review Board of 
the VU University Medical Center and subsequently by local review boards of each Characteristics of maintenance antidepressant users 
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participating center. After full verbal and written information about the study, written 
informed consent was obtained from all participants at the start of baseline 
assessment. A full ethics statement of NESDA is found elsewhere. 
 
Statistical methods 
The Statistical Package for the Social Sciences version 20.0 for Mac was used for 
the descriptive statistics to describe the study population (IBM Statistics, Chicago, 
USA). The definition “maintenance antidepressant treatment” as described above 
was used as the dependent variable. We chose to dichotomize this outcome variable 
(maintenance antidepressant use; n=271 versus no antidepressant use or 
acute/continuation antidepressant use n=1302) since a dichotomous outcome 
measure simplifies interpretation of the results and enabled us to calculate chances 
in terms of percentages on patient level in the final prediction model.  
  The prediction of all independent variables on our dependent variable 
“maintenance antidepressant treatment” were analysed with bivariate multilevel 
logistic regression. To prevent multicollinearity, we excluded from these one of each 
pair of continuous variables with a mutual correlation >0.7 and dichotomous variables 
with ≤5.0% of respondents in one of the categories.  
  To determine which variables independently predicted maintenance treatment 
or other long term treatment logistic multilevel analysis was conducted using MLwiN 
2.25. Multilevel models are hierarchical systems that estimate regression coefficients 
and their variance components while at the same time correct for the dependency of 
the repeated measurements (baseline, two year and four year follow up 
measurements). The first level was defined as observation (within patient), the 
second level as patient (between patients). The outcome variables represented the 
logit of the probability (i.e. natural log of the odds) of maintenance antidepressant 
treatment of depression. Regression coefficients were transformed into odds ratios 
by taking the EXP[regression coefficient]. The Wald test was used to obtain a p value 
for each regression coefficient. The Wald test was also used on the variance 
parameters to obtain an indication of the necessity for allowing a random intercept or 
regression coefficient into the model (28). Based on a stepwise backward selection 
procedure, a final model was fitted consisting of only significant factors that 
constituted the predictors for long term/maintenance treatment with antidepressants 
in the present study.Characteristics of maintenance antidepressant users 
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Results 
Study sample 
The first column of Table 1 lists the characteristics of the study sample. Several 
dichotomous characteristics had ≤5% in one category and were excluded and not 
listed in this table (the use of a tricyclic or other antidepressant, whether the 
respondent had received skills training, practical support, other help or no help and 
long term use of antidepressants in the past).  
 
Antidepressant and long term antidepressant use 
Out of 1610 primary care respondents, 776 had remitted depression (lifetime MDD 
and no depression in the past six months), these respondents had a total of 1571 
measurements of remitted depression. 1261 times no antidepressant was used, in 41 
occasions an antidepressant was currently used for less than 12 months and 271 
cases there was maintenance treatment with antidepressants (antidepressant use 
≥12 months). 
  The characteristics of each of these three groups are listed in the right three 
columns of table 1.  Characteristics of maintenance antidepressant users 
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Table 1 Characteristics of all primary care participants and those with remitted depression 
  All 
measurements 
(1571) 
No 
antidepressant 
use (1261) 
Acute/continuation 
antidepressant use 
(41) 
Maintenance 
antidepressant 
use (271) 
Sociodemographics 
Age in years, mean (SD)  48.1 (11.8)  47.5 (12.1)  45.2 (9.6)  51.3 (9.5) 
Gender (female)  1136 (72.3%)  912 (72.3%)  30 (73.2%)  195 (72.0%) 
Education (high)
1  700 (44.6%)  598 (47.4%)  16 (39.0%)  88 (32.5%) 
Working  1014 (64.5%)  823 (65.3%)  25 (61.0%)  168 (62.0%) 
Clinical characteristics 
No. chronic somatic 
diseases, mean (SD) 
0.9 (1.1)  0.9 (1.0)  1.0 (1.2)  1.0 (1.2) 
IDS
2 (moderate very 
severe) 
272 (17.3%)  198 (15.7%)  15 (36.6%)  60 (22.1%) 
BAI
3 (moderate severe)  174 (11.1%)  126 (10.0%)  8 (19.5%)  40 (14.8%) 
Neuroticism, mean (SD)  34.2 (7.7)  33.9 (7.7)  38.1 (7.1)  35.3 (7.8) 
Extraversion, mean (SD)  37.6 (6.7)  38.0 (6.5)  35.9 (7.3)  36.0 (7.0) 
Suicide attempt  113 (7.2%)  89 (7.1%)  4 (9.8%)  20 (7.4%) 
Dysthymia lifetime  453 (28.8%)  323 (25.6%)  13 (31.7%)  117 (43.2%) 
Recurrent MDD  888 (56.5%)  712 (56.5%)  23 (56.1%)  153 (56.5%) 
Chronic depression  252 (16.0%)  191 (15.1%)  5 (12.2%)  56 (20.7%) 
Anxiety
4 <12 months  434 (27.6%)  324 (25.7%)  22 (53.7%)  88 (32.5%) 
Anxiety
4 lifetime incl. 
<6months 
1070 (68.1%)  811 (64.3%)  32 (78.0%)  229 (84.5%) 
Care characteristics 
Contact with GP <6 
months 
1232 (78.4%)  982 (77.9%)  34 (82.9%)  217 (80.1%) 
No. of contacts GP <6 
months, mean (SD) 
2.2 (2.5)  2.1 (2.3)  3.3 (3.6)  2.6 (3.4) 
Contact GP about mental  219 (13.9%)  140 (11.1%)  24 (58.5%)  56 (20.7%) 
Received information  249 (15.8%)  171 (13.6%)  20 (48.8%)  59 (21.8%) 
Received referral  199 (12.7%)  128 (10.2%)  21 (51.2%)  51 (18.8%) 
Received psychotherapy  346 (22.0%)  252 (20.0%)  24 (58.5%)  71 (26.2%) 
Perceived need for more 
or other treatment 
388 (24.7%)  299 (23.7%)  8 (19.5%)  78 (28.8%) 
Psychological/psychiatric 
care past six months
5 
511 (32.5%)  358 (28.4%)  33 (80.5%)  121 (44.6%) 
Past antidepressant use  127 (8.1%)  100 (7.9%)  7 (17.1%)  20 (7.4%) 
Benzodiazepine use  178 (11.3%)  105 (8.3%)  10 (24.4%)  63 (23.2%) 
SSRI
6 current  248 (15.8%)  N/A  29 (70.7%)  219 (80.8%) 
 
All numbers are number of participants with characteristic (percentage) unless otherwise specified 
In all dichotomous variables 0=no/characteristic not present, 1=yes/characteristic present 
1 Low average (elementary (not completed), general intermediate, lower/intermediate vocational, or 
general secondary education) versus high (higher vocational, college or university education) 
2 Inventory of depressive symptomatology; depression severity. None mild disorder versus moderate 
to (very) severe disorder 
3 Beck’s anxiety inventory; anxiety severity, none mild disorder versus moderate to severe disorder 
4 Anxiety disorder (panic disorder with or without agoraphobia, agoraphobia, social phobia or 
generalized anxiety disorder) 
5 Primary mental health care/psychological care: social worker, social psychiatric nurse, first line 
psychologist, psychotherapist; secondary mental health care/psychiatric care: psychiatrist, 
professional from a mental health care organisation 
6 Selective Serotonin Reuptake Inhibitors 
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Determinants of maintenance antidepressant use in remitted patients 
Bivariate analysis 
After excluding variables with a mutual correlation >0.7 (received psychotherapy 
because of correlation with psychological/psychiatric care) and exclusion of the 
variable current SSRI use (this variable would obscure results as most 
antidepressants users used an SSRI and almost all antidepressant users were 
maintenance users), we did a bivariate multilevel logistic regression (table 2). Eight 
variables were significantly (p<0.05) associated with maintenance treatment with 
antidepressants.  
Sociodemographic characteristics: Increasing age led to more maintenance 
treatment, while a high education decreased the chances for maintenance treatment 
with antidepressants. Personality characteristics were also associated with 
maintenance treatment with antidepressants. Increasing extraversion led to less 
maintenance treatment. 
Clinical characteristics: A history of anxiety disorders or dysthymia also led to 
more maintenance treatment, as did a chronic depression in the past.  
Care characteristics: Receiving care from a mental health professional 
(psychological or psychiatric care) led to increased chance of maintenance treatment 
with antidepressants. Finally the use of benzodiazepines increased the ‘risk’ of 
receiving maintenance treatment with antidepressants. Contact with the GP whether 
or not about mental problems did not reach significance. Also receiving information or 
a referral to a specialist remained non significant.  
 Characteristics of maintenance antidepressant users 
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Table 2 Results of bivariate multilevel logistic regression in patients remitted depression with 
dependent variable ‘maintenance treatment with antidepressants’  (1571 observations in 776 
individual patients) 
  Remitted patients (1571 
observations) 
  Odds ratio (95% CI)  p-value 
Sociodemographics 
Age in years  1.035 (1.018-1.051)  0.000 
Gender (female)  1.016 (0.685 1.507)  0.937 
Education
1 (high)  1.742 (1.219-2.489)  0.002 
Working  0.863 (0.615 1.212)  0.395 
Clinical characteristics 
No. chronic somatic diseases  1.065 (0.916 1.239)  0.413 
IDS
2 (mod/severe)  1.293 (0.874 1.914)  0.199 
BAI
3 (mod/severe)  1.250 (0.779 2.004)  0.355 
Neuroticism  1.015 (0.993 1.037)  0.173 
Extraversion  0.965 (0.940-0.990)  0.006 
Suicide attempt  1.024 (0.570 1.841)  0.936 
Dysthymia lifetime  2.226 (1.537-3.223)  0.000 
MDD <12 months  1.209 (0.754 1.939)  0.430 
Recurrent MDD  1.043 (0.734 1.481)  0.814 
Chronic depression  1.587 (1.017-2.477)  0.042 
Anxiety
4<12 months  1.171 (0.836 1.641)  0.358 
Anxiety
4 lifetime  2.910 (1.902-4.452)  0.000 
Care characteristics 
Contact with GP <6 months  1.129 (0.779 1.635)  0.522 
No. of contacts GP <6 months  1.045 (0.987 1.106)  0.129 
Contact GP about mental problems  1.411 (0.938 2.121)  0.098 
Received information  1.406 (0.952 2.077)  0.087 
Received referral  1.496 (0.980 2.285)  0.062 
Received psychotherapy  1.232 (0.859 1.768)  0.256 
Perceived need for more or other 
treatment 
1.174 (0.833 1.654)  0.361 
Psychological/psychiatric care
5  1.584 (1.149-2.185)  0.005 
Past antidepressant use  0.660 (0.364 1.198)  0.172 
Benzodiazepine use  2.389 (1.528-3.735)  0.000 
 
In all dichotomous variables 0=no/characteristic not present, 1=yes/characteristic present 
1 Low average (elementary (not completed), general intermediate, lower/intermediate vocational, or 
general secondary education) versus high (higher vocational, college or university education) 
2 Inventory of depressive symptomatology; depression severity. None mild disorder versus moderate 
to (very) severe disorder 
3 Beck’s anxiety inventory; anxiety severity, none mild disorder versus moderate to severe disorder 
4 Anxiety disorder (panic disorder with or without agoraphobia, agoraphobia, social phobia or 
generalized anxiety disorder) 
5 Primary mental health care/psychological care: social worker, social psychiatric nurse, first line 
psychologist, psychotherapist; secondary mental health care/psychiatric care: psychiatrist, 
professional from a mental health care organisation, care in the past six months 
 
Multivariate analysis 
Next, multivariate multilevel logistic regression was performed (table 3). For 
multivariate analysis, we included all characteristics from the bivariate analyses with 
p<0.2. Six variables were retained in the final multivariate model. Age (in years), Characteristics of maintenance antidepressant users 
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education (0=low intermediate, 1=high), having a history of dysthymic disorder or an 
anxiety disorder (0=no, 1=yes), having received psychological or psychiatric care in 
the past six months and the current use of benzodiazepines (0=no, 1=yes).  
 
Table 3 Results of multivariate multilevel logistic regression in patients with remitted depression (1571 
observations in 776 individual patients) with dependent variable “maintenance treatment with 
antidepressants”  
  Odds ratio  95% CI for odds ratio  p-value 
Sociodemographics 
Age (in years)  1.033  1.014 1.051  0.000 
Education
1 (high)  0.645  0.440 0.945  0.024 
Clinical characteristics 
Dysthymia lifetime  1.891  1.290 2.771  0.001 
Anxiety lifetime
2  2.300  1.474 3.589  0.000 
Care characteristics 
Psychological/psychiatric 
care past six months
3 
1.644  1.164 2.321  0.005 
Benzodiazepine use  2.046   1.283 3.262  0.003 
 
In all dichotomous variables 0=no/characteristic not present, 1=yes/characteristic present 
1 Low average (elementary (not completed), general intermediate, lower/intermediate vocational, or 
general secondary education) versus high (higher vocational, college or university education) 
2 Anxiety disorder (panic disorder with or without agoraphobia, agoraphobia, social phobia or 
generalized anxiety disorder) 
3 Primary mental health care/psychological care: social worker, social psychiatric nurse, first line 
psychologist, psychotherapist; secondary mental health care/psychiatric care: psychiatrist, 
professional from a mental health care organisation 
 
Discussion 
Summary of main findings 
Several characteristics of the patient, disease and treatment were associated with 
maintenance use of antidepressants in remitted depressed patients. Remarkably, 
both recurrent depression and chronic depression were not, this hypothesis was 
rejected. Our other hypothesis that patients with a comorbid anxiety disorder would 
more often be on maintenance treatment with antidepressants was confirmed. A 
dysthymic disorder in previous history had the same effect, which was unexpected 
since acute treatment with antidepressants in this disorder is not first step treatment 
and should be considered as a trial. It could be that GPs view dysthymic disorder as 
a mild chronic depression, or that these patients are reluctant to stop their 
antidepressant because of frequent relapses. Older patients and those with a low or 
intermediate education more often had maintenance treatment with antidepressants. 
We think that older patients less often ‘ask’ their GP or another physician if a certain 
medication can be stopped. Patients with a higher education might favour Characteristics of maintenance antidepressant users 
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psychotherapy instead of antidepressant treatment, or GPs might think that patients 
with a lower education are less able to benefit from psychotherapy. The fact that 
patients on maintenance treatment more often use benzodiazepines is probably 
related to symptoms of anxiety for which these drugs are frequently prescribed.  
  Patients on maintenance treatment had received more often 
psychological/psychiatric care. We expected that this difference was due to the 
reception of more psychiatric care, since we had expected patients on maintenance 
treatment to be patients with recurrent, chronic or more severe depression. Therefore 
we performed a post hoc analysis and found that patients on maintenance 
antidepressant treatment had indeed received more psychiatric (19.5% versus 7.3%) 
and not more psychological (25.0% versus 22.5%) care. These patients could be 
more severely ill and therefore have a good reason for maintenance antidepressant 
treatment, or GPs have less insight in patients (previously) treated in secondary 
mental health care but do repeat their prescriptions as a result of which 
antidepressant treatment is not critically evaluated.  
  The number of contacts with the GP and whether the patient had had contact 
with the GP about mental problems in the last six months were not correlated to 
maintenance treatment, as we would have expected. An explanation for this could be 
that patients with a history of depression in general visit their GP frequently and not 
just those on maintenance treatment with antidepressants. 
  Severity (IDS) was not significant, probably since severity was not measured 
at the start of the episode, but instead at predetermined points in time during the 
interviews, at which time we selected patients in remission, i.e. without current 
disorder and therefore probably not a high severity score.  
 
Strengths and limitations 
The present study has several strong points. First, our study group was large, 
especially for a primary care study. Second, the data collected within NESDA is 
extensive, enabling us to examine many possible determinants. Third, since the GP 
was unaware of the study diagnosis, all treatment decisions were based on their own 
judgment, preventing bias. Fourth, since we had several measurements, we could 
quite accurately determine the time of remission and presence of maintenance 
antidepressant treatment with antidepressants. 
 Characteristics of maintenance antidepressant users 
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  This study also has some limitations that need addressing. First, since 
variables such as depression and anxiety severity were not measured at the start of 
the episode or start of the antidepressant, we could not be sure that no relationship 
between severity and maintenance treatment with antidepressants exists. Next to 
that, although the CIDI was administered at three different times, we could not be 
sure of the exact moment of remission and therefore had to use a slightly less 
accurate definition of maintenance treatment (treatment with antidepressants for ≥12 
months, while there was no depression in the past six months), because the 
guideline recommends continuation treatment for all patients for six months.  
 
Comparison with literature 
Only few articles report on determinants of maintenance treatment with 
antidepressants in primary care. A few researchers did study risk factors for non 
adherence to continuation and maintenance treatment. Burton et al. studied factors 
associated with the duration of antidepressant treatment, 40% of their patients 
continued their antidepressant for more than 180 days. They did not find an 
association between continuation and sociodemographic factors such as age, gender 
and socioeconomic deprivation. We did find an association between maintenance 
treatment with antidepressants and both age and education level.  Treatment >180 
days could be viewed as continuation or maintenance treatment but is probably in 
most cases shorter than our definition of maintenance treatment. It could be that the 
differences arise after longer treatment (29). Holma et al. found several indicators of 
receiving maintenance treatment in the univariate analyses: number of previous 
episodes, comorbid somatic disorders and comorbid mental disorders, severity of 
anxiety, anxiety disorders, positive medication attitude, personality disorder and good 
adherence during the acute phase of treatment. In their multivariate analysis only 
good adherence to acute phase antidepressant treatment remained significant, we 
did not study this, but did find a significant association between maintenance 
treatment and anxiety disorders as they did in their univariate analyses (30). Finally 
Ten Doesschate et al. examined potential predictors of non adherence to 
continuation and maintenance antidepressant use and found that in multivariate 
analysis personality (measured with the Personality Disorder Questionnaire 4+) and 
a higher education were associated with an increasing likelihood for non adherence. 
A higher education decreased likelihood of maintenance treatment in our study, Characteristics of maintenance antidepressant users 
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comparable to the result of ten Doesschate et al. (31). The personality characteristic 
extraversion was only significant in the bivariate analysis in our study. 
  We could not find any other studies that had studied or found dysthymia 
and/or benzodiazepine use to increase likelihood of receiving maintenance treatment 
with antidepressants.  
 
Comparison with guideline recommendations 
As mentioned in the introduction, it is also interesting to compare our results with 
guideline recommendations for maintenance treatment. Depression guidelines, 
including the Dutch General Practitioners guideline, recommend maintenance 
treatment with antidepressants for patients at high risk for relapse and/or recurrence 
or chronic depression. As we stated in a review in 2010, different guidelines have 
different indicators of patients at high risk for chronic or recurrent course of 
depression (5). The Dutch guideline we used, used the following indicators: recurrent 
or chronic depression and/or failure of non pharmacological treatment, or in case of 
residual or recurrent symptoms after phasing out antidepressants (4). We would 
expect these established risk factors for unfavourable course to be determinants of 
maintenance use.  
We were very surprised to find that recurrent and chronic depression were not 
more common in patients with maintenance antidepressant treatment, since these 
were the two key indications for maintenance antidepressant treatment in patients 
with depression according to the Dutch General practitioners guideline (and other 
guidelines).  Since chronic depression was significant in the bivariate analysis it could 
be that any effect was overshadowed in the multivariate analysis by the fact that 
these patients e.g. more often received psychological or psychiatric care since 
chronic depression is also an indication for referral (4). In an article about referral of 
depressed patients we did indeed find that chronically depressed patients were 
referred more often (32). Recurrent depression did not reach significance or even a 
trend towards significance in the bivariate analysis. We found it difficult to explain this 
unexpected finding. One explanation would be that maintenance treatment is 
prescribed more often only to patients with a high number of previous episodes 
instead of to all patients with a recurrent episode. Since recall bias of number of 
episodes is a problem, we decided not to analyse number of episodes. The new 
Dutch GP guideline depression (2012) even recommends reserving maintenance Characteristics of maintenance antidepressant users 
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treatment with antidepressants for patients with more than three episodes of 
depression (33).  
The presence of an anxiety disorder increased likelihood of receiving 
maintenance antidepressant treatment. All anxiety disorders tested in this study are 
legitimate indications for the prescription of an antidepressant and the guideline 
anxiety disorders recommends to continue the antidepressant for at least six to 
twelve months after remission (34). A significant proportion of our population 
probably do not use maintenance antidepressant treatment for remitted depression, 
but instead with a good indication for an anxiety disorder 
 
Implications for clinical practice and future research 
Not only patients with a comorbid anxiety disorder, but also those with a history of a 
dysthymic disorder, older patients, lower educated patients and those receiving 
psychiatric care or benzodiazepines more often use maintenance treatment with 
antidepressants and remarkably not patients with a recurrent or chronic disorder. 
GPs should be aware of patients with maintenance antidepressant treatment and 
individually weigh the risks of stopping versus the disadvantages of continuing the 
drug, together with the patient. As patients with a dysthymic disorder have a 
questionable indication for antidepressant use, the dubious advantages and more 
clear disadvantages of continuing should be critically discussed in these patients. In 
all patients, but maybe especially in older patients and those with a lower education, 
it might be necessary for the GP to initiate the discussion about continuation or 
discontinuation of antidepressant treatment, since these patients seem to use 
maintenance treatment more often while it is unclear if they have a higher risk of 
recurrence. Finally, in patients referred back from secondary mental health care on 
antidepressant treatment, the GP might propose a consultation once or twice yearly, 
as also proposed in the recent new Dutch GP guideline depression. This consultation 
could according to the new guideline not only be used to discuss the need to 
continue the antidepressant, but also to notice signs of impending relapse or 
recurrence at an early stage.  
  The role of views of the GP has not yet been studied. It would be interesting if 
a positive or negative attitude of GPs towards both depressed patients, their views of 
their task in treating depression and their views of the efficacy and place of 
antidepressants in depression treatment, influences treatment with antidepressants in Characteristics of maintenance antidepressant users 
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their patients. Next to that, additional analysis is needed among antidepressant users 
to identify those ‘at risk’ for long term treatment, since in our group also non users 
were present. Finally, another interesting group to study in more detail are patients 
with persisting depression that have been using an antidepressant for over a year. It 
would be interesting to find out who these, in some way undertreated, patients are 
and how we could help these patients to recover. Characteristics of maintenance antidepressant users 
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Introduction 
Depression is a common condition, causing great amounts of morbidity due to its 
often recurrent and sometimes chronic course. It is projected that depression will be 
the second leading cause of disability worldwide by 2020 and the leading cause of 
disease burden by 2030 (1,2). Most patients with depression are treated in primary 
care (3,4). This makes the care for depression in primary care a subject of great 
interest and importance.  
In past years both in the media and in the scientific literature there was a lot of 
attention for depression in primary care. In the (Dutch) media the discussion focused 
mainly on “overrecognition” and “overtreatment”. It was stated that patients with 
depressive symptoms, e.g. as a reaction to negative life events, are often incorrectly 
diagnosed with depression and are often unnecessarily treated with antidepressants, 
which are not or minimally effective in these patients while also causing serious side 
effects (5 7). In the scientific literature underrecognition and undertreatment seemed 
to be the main subject. Many patients with depression remain unrecognized and of 
those recognized, the large part does not receive adequate treatment e.g. 
psychotherapy or pharmacotherapy with an antidepressant.  
These discussions are not new. In the 1980s and 1990s care for depressed 
patients in primary care was a frequently studied subject, also in The Netherlands as 
illustrated by the appearance of many theses. 
The aim of this thesis was to investigate current care for depressed patients in 
primary care. This thesis could thereby form a possible starting point for further 
improvement in order to decrease burden of this disease. In this chapter we will 
summarize the findings from chapter 2 through 6 and discuss them in the light of 
previous as well as recent literature. We will conclude with a discussion about future 
practice and research.  
 
Main findings 
General conclusion 
Overall this thesis gives a rather optimistic picture of current care for depressed 
patients in primary care compared to previous literature and media reports. We 
conclude that, in general, the care for depression in primary care is, in most cases, 
adequate, i.e. in accordance with the recommendations of the ruling primary care Summary and general discussion 
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guideline for depression, as it existed in the years the studies were performed (2004 
2009).  
 
Recognition 
Recognition was adequate with 60.5 68.7% of depressed patients recognized by the 
general practitioner (GP) (chapter 2). Patients in this study were 484 participants of 
the Netherlands Study of Depression and Anxiety (NESDA) who were recruited from 
65 primary care practices in and around Amsterdam, Leiden and Groningen and who 
were found to have a life time diagnosis of major depressive disorders (MDD). Two 
risk factors (determinants) for non recognition were found, of which no mental health 
related reason for visiting the GP was the strongest. Patients without a comorbid 
anxiety disorder were less often recognized as well. A subgroup analysis was 
performed in a subgroup of 361 patients in which the GP used an International 
Classification for Primary Care code (ICPC code) (irrespective of the code used) in at 
least one contact with the patient. This subgroup therefore had more reliable GP 
diagnosis data, since in the total study population several GPs did not code any 
contact, making ICPC diagnosis of depression, which was an important part of our 
definition of recognition, impossible. In this subgroup, just as in the total study 
population, patients without a mental health related reason for visiting the GP or 
without a comorbid anxiety disorder were less often recognized. In addition, patients 
with fewer depressive symptoms and those with an increased appetite were 
recognized less often. 
 
Referral 
In chapter 3 we describe the referral of 344 depressed primary care patients to 
mental health care professionals by the GP. Also for this study, baseline data of 
primary care respondents, in this case with a depression in the past year, from 
NESDA were used. Interestingly, over half (58%) of depressed patients were 
referred; this was an unexpected high percentage. Equal percentages were referred 
to primary (first line psychologist, social psychiatric nurse or social worker affiliated 
with the GP practice) and secondary (psychiatrist or psychotherapist in free practice, 
or any health care professional affiliated with a hospital or institute for mental health 
care) mental health care. With logistic regression we tested whether guideline criteria 
for referral were independent predictors of referral. The Dutch primary care guideline Summary and general discussion 
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recommends to refer to secondary mental health care patients with psychotic 
features, with bipolar disorder, with severe depression with social impairment or with 
high suicide risk and patients with no or insufficient response to two or more 
antidepressants. In addition, several guidelines, including the Dutch primary care 
guideline, recommend referral for psychological interventions in certain cases, 
although the criteria differ between guidelines.  
In our study, younger patients, those with a perceived need for psychotherapy, 
those with suicidal tendency and with chronic depression were referred more often. 
Patients with chronic depression or who had used (and stopped) at least two 
antidepressants were more often referred to secondary mental health care compared 
to primary mental health care. Referred patients met on average more guideline 
criteria for referral compared to non referred patients. We can therefore conclude that 
GPs do take guideline recommendations into account in decision making for referral 
of depressed patients. However, other factors play a role as well, since we could only 
explain 8 11% of variance.  
 
Treatment with antidepressants 
In chapter 4 we report that guideline recommendations for treatment with 
antidepressants are thoroughly based on evidence when it comes to acute treatment 
(i.e. up to three months or until remission) and continuation treatment (from four to 
twelve months after remission to prevent relapses), also in primary care. In contrast 
however, evidence for maintenance treatment (the treatment phase after continuation 
treatment during another one, two or even more years to prevent recurrences) is 
almost completely lacking in primary care. The guideline recommendations for 
maintenance treatment in primary care are only based on uncontrolled studies mainly 
performed in secondary and tertiary care.  
In chapter 5 we presented a study showing that overtreatment is not a frequently 
encountered problem in Dutch general practice. We studied the use of 
antidepressants in a group of 1531 primary care patients, with and without 
depression and/or anxiety disorders. Of these patients 199 used an antidepressant at 
time of interview (baseline measurement of NESDA), of whom 188 (94.6%) with a 
(possibly) justified indication according to the Dutch depression primary care 
guideline for depression (and for anxiety disorders), leaving 11 patients without a 
justification. Six (54.5%) of these patients had a single episode of major depressive Summary and general discussion 
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disorder more than one year ago. This means that they did have an indication for the 
use of an antidepressant in the past, while the antidepressant had been continued 
too long according to guideline recommendations. The other five patients without a 
(possibly) justified indication never had a justified indication for the use of an 
antidepressant. As NESDA was designed to study depression and anxiety, patients 
with these disorders were oversampled. Therefore we recalculated our findings to the 
original population of primary care patients (n=10,677). The results were the same, 
only 5.4% of patients on antidepressants had no (possibly) justified indication for the 
use of these drugs. 
Chapter 6 describes the use of maintenance treatment in a sample of primary 
care patients. We studied the determinants of maintenance treatment of primary care 
patients with remitted depression. We used data on primary care respondents from 
NESDA, from the baseline, two year  and four year follow up measurements (n=776, 
1571 observations). Unexpectedly, we had to reject our first hypothesis that patients 
with a chronic and/or recurrent depression would more often use maintenance 
treatment. Our second hypothesis that patients with a history of anxiety disorder(s) 
more often were on maintenance antidepressant treatment was confirmed. 
Remarkably, also patients with a history of dysthymic disorder had an increased 
likelihood of maintenance treatment with antidepressants. Patients who used 
benzodiazepines or had had contact with a mental health professional in the past six 
months had an increased likelihood of maintenance treatment with antidepressants 
as well. The difference in mental health care use in the last six months was due to a 
higher percentage receiving secondary mental health care. The percentage receiving 
primary mental health care was comparable. Finally, older patients and those with a 
low or intermediate education had an increased chance of using maintenance 
treatment.  
 
Historical overview 
Discussion about depression care from 1980 till now 
In the 1980s and 1990s, there was a heavy scientific debate about recognition and 
treatment of depression. This discussion focused mainly on poor recognition and 
treatment in primary (medical) care, since researchers had just found that the 
majority of patients with depression presented and were treated in this setting. Many 
researchers studied risk factors for non recognition and consequences of non Summary and general discussion 
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recognition as well as treatment standards and adequacy of different treatments for 
depression in primary care (8 11). Different indicators of adequacy of antidepressant 
prescription were studied, such as the type of depression for which the 
antidepressants were prescribed and the dosages prescribed (10,12). Other 
treatments originating in primary care such as referral to primary and secondary 
mental health care or to various forms of psychotherapy and the effects of these 
treatments were less often studied (13,14).  
The past decade started with the World Health Report of the World Health 
Organization in 2001 that focused on mental health. In this report it was stated that 
depression would be the leading cause of disability in the developed world by 2020, 
and second only to ischaemic heart disease globally. The awareness of the 
importance of mental disorders grew. Many researchers started studying mental 
disorders, including depression. In fact, in the 12 years between 2000 and 2011 
almost as many articles on depression have been published in PubMed as in the 30 
years before the year 2000. By the time this thesis is published, the number of 
articles published since 2000 will almost certainly have exceeded the number 
published between 1970 and 2000.  
In 2001 the Dutch government launched a large research program called 
“Geestkracht” for research on mental disorders in order to increase available 
knowledge about these illnesses and to improve their treatment. The Netherlands 
Study of Depression and Anxiety (NESDA) started in 2004 and is funded by the 
“Geestkracht” program. This study was started with the main aim to investigate the 
long term course of depressive and anxiety disorders. Almost 3000 people with and 
without a disorder from the community, primary care and secondary mental health 
care were included.  
The increasing knowledge on depression also reached the media. The media 
especially picked up on articles questioning the efficacy of antidepressants, (patient) 
reports about serious side effects and prescription of antidepressants for mild 
depressive states (5 7,15,16).  
 
Recognition of depression in primary care from 1980 till now 
Recognition of depression in primary care was found to be poor in the 1980s and 
1990s. In most studies the majority of patients with a depressive disorder remained 
unrecognized, while at the same time a considerable number of patients not fulfilling Summary and general discussion 
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criteria for a depressive disorder, were given the diagnosis depression by the primary 
care physician (8 11). 
Recognition of depression has also been a subject of great interest in more 
recent years. Compared to the studies published in the 1980s and 1990s, these 
studies have more encouraging results (17 19). More patients are recognized in 
primary care, although there are large differences between studies. In some 
countries recognition still seems poor.  
 
Rate of recognition 
 In the 1980s, Perez Stable et al. from the United States (US), found that only just 
over a third of patients with major depressive disorder was recognized as such by the 
primary care physician and a considerable number without major depressive disorder 
was given the diagnosis of depression by the primary care physician (8).  
In the 1990s, Klinkman et al. also from the US came to the same conclusion. 
In their study 35% of depressed patients was diagnosed as such by their primary 
care physician, while almost 30% of patients without depression, was diagnosed as 
having depression by their primary care physician (9). Klinkman et al. concluded that 
false positives and false negatives occupied the middle ground in functioning and 
symptoms between true positives and true negatives. The primary care physician did 
diagnose patients with severe depression (9). In 1998, Lecrubier reported in a French 
study that only 54% of depressed patients were recognized by general practitioners 
as “psychological cases” and only 15% was recognized as being depressed (10).  
In a Dutch study Tiemens et al. considered false positives and false negatives 
in another way. They found that in many cases of psychological/psychiatric illness, 
the patients were recognized as having a mental disorder, but there was 
disagreement between the GP and the psychiatric assessment about the correct 
diagnosis or the severity of the illness. This applied especially to the false negative 
cases. Most of the false positive cases were true false positives (55%) (11). In The 
Netherlands this gave lead to the development of many refresher courses for GPs on 
the recognition of depression. 
After the year 2000, results became more encouraging. In addition, the focus 
widened. Recognition was no longer considered in yes and no terms and instead 
severity of depression and need for treatment were taken into consideration. In 2002, 
Kessler et al. reported a follow up study in the US on patients with depression  Summary and general discussion 
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according to a psychiatric assessment. The general practitioners had diagnosed 39% 
of patients with anxiety or depression at baseline. After three year follow up, 64% of 
patients with depression at baseline had received a diagnosis of depression. Of the 
patients without diagnosis, most had a spontaneous recovery. Only 14% had not 
received a diagnosis while still having a clinically severe condition. The authors 
concluded that general practitioners fail to recognize one out of every seven patients 
with treatable depression (20).  
Other studies reported similar percentages. In a German study by Wittchen et 
al. 75% of DSM depressed patients was recognized (of ICD 10 depressed patients 
59% was recognized) (17). In an Italian study, Berardi et al. found that almost 80% of 
depressed patients was recognized in primary care. However, they also found that 
45% of patients diagnosed with depression by the primary care physician did not fulfil 
ICD 10 criteria for this diagnosis. Over half of these false positives had a 
subsyndromal depression (19).  
Finally, in a study in the United Kingdom Mitchell et al. specifically studied 
accuracy of GPs in diagnosing mild depression and distress. GPs diagnosed only 
one in three patients with mild depression as such, although their specificity was over 
80%. They did better in diagnosing distress, as almost half of patients with distress 
got this “diagnosis”; specificity was the same, around 80%. They concluded that GPs 
have more difficulty identifying patients with mild compared to moderate severe 
depression. Their other conclusion was that although GPs seem to have 
considerable difficulty in diagnosing patients with mild depression, the implications 
are unclear, as some of these patients may not want help or do recover 
spontaneously (21).  
  The overall picture from the studies performed in the last decade is that the 
majority of patients are adequately recognized (17,19 21). In addition, awareness 
regarding the number of false positives and the consequences of “overrecognition” 
and consequent “overtreatment” has risen (11,18,19). False negatives/false positives 
and recognition are studied in more detail, acknowledging the fact that depression 
often coincides with other psychiatric disorders, especially anxiety disorders and that 
depressive symptomatology is a spectrum and a distinct difference between healthy 
and depressed does not (always) exist (9,11). Summary and general discussion 
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Determinants of (non-)recognition 
Several researchers studied risk factors for non recognition. In several studies low 
severity was found to be a risk factor, as was younger age (10,11,21,22). 
Coyne et al. found that severity was a major indicator of recognition: 73.3% of 
severely depressed patients were recognized, compared to 18.4% of patients with a 
mild depression. Younger patients more often remained undetected, as did those 
without comorbid anxiety disorder. Undetected patients also did less often have 
several specific depression symptoms such as low energy, feeling worn out or failing 
to get 6 or more hours of sleep. There was also a trend toward less disturbance of 
appetite in the undetected group (22).   
Lecrubier studied factors influencing recognition as well and found that a 
psychological reason for encounter with the GP made recognition more likely, as did 
female gender and older age. Recognition increased with increasing severity. 
Patients with chronic medical conditions were less often recognized (10). 
Tiemens et al. compared patient characteristics of true false negative patients 
and concordant positive patients and found that the true false negatives were on 
average younger, and visited their physician less often for psychological reasons 
(11). Reason for encounter was also found by several other researchers to be 
correlated to recognition. More specifically, a psychological reason for encounter led 
to higher recognition rates while somatic reasons for encounter led to lower 
recognition rates (23 25). Patients with both acute and chronic somatic diseases are 
also less often recognized according to studies by Furedi et al. and Henriques et al. 
(25,26). 
  Finally, having had prior episodes was found to be associated with better 
recognition in the studies by Fernandez et al. and by Wittchen et al. (24,27). 
 
Referral of depressed patients to primary and secondary mental health care from the 
1980s till now 
In previous literature a consistent small minority of patients with psychological 
complaints was referred to mental health care. Patients with more serious psychiatric 
diagnoses such as psychosis were more often referred, as were males and younger 
patients. The GP referred only 5.5% of patients with depressive or anxiety diagnoses 
according to Verhaak in 1993 (13). Creed et al. found that the number of referrals to 
psychiatric services by a general practitioner was negatively correlated to the amount Summary and general discussion 
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of detail in the referral letter; while in referrals to psychologists there was a positive 
correlation (14). The number of referrals has increased by a factor 4.5 from the 
1970’s to the late 1990’s (28).  
  More recent studies focused on barriers preventing referral and patient factors 
influencing referral. Patients more often had a history of depression and an acute or 
chronic stressor according to Miller et al. (29). Younger patients were more often or 
older patients less often referred (30,31). Trude and Stoddard investigated whether 
primary care physicians experienced barriers in referring to mental health care. They 
found that over half of primary care physicians did experience barriers in the 
availability of mental health care (32). Physician factors influencing referral behaviour 
were therapeutic confidence and personal experience according to Kravitz et al. (33). 
According to Van den Boogaard et al. severity of depression, marital status and also 
causal attributions related to intrapsychic fears and childhood were associated by 
being in therapy for 3 sessions or more. Being in therapy meant that referral had 
taken place (34). Anthony et al. even state that the decision to refer a patient with 
depression, is a complex one. Practice setting and environment play a role, but also 
clinician comfort in treating depression, perceived severity and complexity of the 
disorder, patient preference and patient financial resources are important (35).  
 
Treatment with antidepressants in primary care from 1950s till now 
In 1958, the first two antidepressant drugs were discovered: the first tricyclic 
antidepressant imipramine by Kuhn and the first monoamine oxidase inhibitor 
iproniazid by Kline. Within several years more antidepressants were developed and 
marketed. As these antidepressants could have serious side effects and achieving an 
adequate dose could be difficult, the numbers of patients using these drugs remained 
stable at quite a low level. With the introduction of zimeldine, fluvoxamine and 
especially fluoxetine, the first serotonin reuptake inhibitors (SSRIs), this changed in 
the 1980s. These drugs had fewer side effects and were easier to be dosed at an 
adequate level. At the same time the introduction of DSM III (1980) made it easier to 
make a diagnosis of depression. As a result the prescription of antidepressants, 
especially the SSRIs, began to grow and experiences became more widely available. 
It then became apparent that depressive disorders did not behave like a “common 
cold” and that antidepressants should not be used just until recovery (“acute 
treatment”) but instead should be continued after remission for at least several Summary and general discussion 
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months (“continuation treatment”) to prevent relapses. Continuation treatment was 
promoted for all patients. Even longer treatment for one of more years (“maintenance 
treatment”) became promoted to prevent recurrences, though only for patients with a 
high recurrence risk. However, it remained unclear which patients did have an 
increased risk and how long maintenance treatment should last.  
While continuation treatment has been widely studied and guideline 
recommendations for primary care can be considered evidence based, maintenance 
treatment cannot (chapter 4). There are several reasons for this. First, studies with 
long follow up are expensive. And as in all medical specialties, most research is 
funded by pharmaceutical companies, whose goal it is to make profit from the sales 
of medications. For registration of an antidepressant, only positive data from acute 
and continuation studies are needed (36).  
This means that when short term and medium term results are positive, the 
antidepressant can be brought on the market. Long term studies (i.e. studies into the 
use as maintenance treatment) are at that point not necessary. In the case of 
antidepressants this is further complicated by the fact that existing guidelines already 
recommend long term/maintenance treatment for certain patients (and for some 
patients even lifelong treatment). Therefore, the expected extra profit for 
pharmaceutical companies in case of positive results is minimal.  
 
Undertreatment 
Undertreatment has long been the focus of almost all research on antidepressant use 
in primary care. In addition to all studies from the 1980s and 1990s reporting 
underrecognition, many if not most recognized patients did also not get treatment 
with antidepressants. For example, Lecrubier reported that among the low 15% of 
patients with a recognized depression in his study, only about 50% was treated with 
antidepressants (10). Furthermore, antidepressants were often prescribed at 
inadequate dosages in a significant percentage of cases as shown in a UK study 
(12). The same authors also discussed monitoring of patients on antidepressants, as 
about a fifth of patients that had been taking antidepressants for more than six 
months had depression at the syndromal level, suggesting insufficient care by the 
general practitioner.  
Simon et al. from the US did a broader study on the treatment of depressed patients 
(37). They found that 66% of patients with major depressive disorder at Summary and general discussion 
  131 
baseline had received some form of treatment (either a visit to a mental health 
professional and/or a prescription for antidepressants) from their primary care 
physician. Likelihood of treatment was strongly related to severity of illness, patients 
receiving antidepressants or using specialty mental health services were more 
symptomatic and more disabled at baseline. Dosage and duration of antidepressants 
met current standards (Agency for Health Care and Policy Research; AHCPR) in 
61% of cases with an antidepressant prescription (38,39). This seemed like an 
encouraging result, it should be noted however, that Simon et al. used a prevalent 
sample of depressed patients. It is well known that most patients that discontinue 
antidepressants, do so in the first weeks of treatment. These patients are probably 
underrepresented in their study. 
Since the year 2000, more articles about undertreatment of depression were 
published. Lecrubier wrote in a review of three large epidemiologic studies (WHO 
study, INSERM and ESEMeD) that in all three studies, the majority of patients with 
depression did not receive an antidepressant (85%; 79% and 78.8% respectively) 
(40). In an Italian study 20.9% of patients who would benefit from an antidepressant, 
received this treatment (41). Most patients who did receive an antidepressant, 
received a SSRI at therapeutic dosage, while two thirds of tricyclic antidepressants 
were prescribed at sub therapeutic dose (41).  
 
Overtreatment? 
Overtreatment has long been an underexposed subject compared to undertreatment. 
As far as we know, the first studies were done in the UK by Sireling et al. (1985) 
reporting that only 56% of patients treated with antidepressants by the general 
practitioner because of depressive symptoms, had a major depressive disorder, while 
23% had milder depressive diagnoses (42). In patients receiving other treatments 
such as benzodiazepines, or who were referred to a social worker, only 19% had a 
major depressive disorder, while 31% had milder depressive diagnoses (43). 
In the last few years, more attention has been focused on overtreatment, as it 
became apparent that antidepressants have side effects and that, especially in 
primary care, a substantial percentage of patients recovers spontaneously within the 
first few months. In the Netherlands the general public got interested in the subject 
because Trudy Dehue’s best seller “De depressie epidemie” (The depression 
epidemic) in 2008 (5). This book describes that depression is not increasingly Summary and general discussion 
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common, but just more noted and moreover, considered a disease as opposed to a 
transient state of mind. She suggested that depression was often overtreated, 
because patients and physicians alike were influenced by the pharmaceutical 
industry and antidepressants were readily asked for and prescribed. In her opinion it 
could not be true that over a million Dutch citizens (8% of the Dutch population) were 
using an antidepressant with a valid indication. Since then, the media picked up on 
this subject and television programs like “Iedereen depressief” (everybody 
depressed) were made, as well as a broadcast of the consumer programma “Radar” 
reporting that antidepressants were prescribed unnecessarily for many kinds of 
complaints while having serious side effects that were ignored by the pharmaceutical 
industry and prescribers (6,7). In other countries the media also paid attention to the 
subject (15,16,44). 
  As previously mentioned in the paragraph about recognition, several 
researchers came to the conclusion that not all patients diagnosed with depression 
by the GP, had a major depressive disorder (MDD). Some researchers also found 
that some of these “false positive depressed patients”, i.e. patients without an 
indication for an antidepressant, actually did receive antidepressants (11,22). A study 
in Spanish primary care by Pinto Meza et al. (2008) in 333 primary care patients 
starting antidepressants after diagnosis of depression by the GP showed that only 
118 of these patients had MDD and 15 dysthymia, while 81 had minor depression 
and 119 other forms of depression (45). At least the prescription of antidepressants 
to patients with minor depression could be considered overtreatment, rendering a 
percentage of overtreatment of at least 24%. Sihvo et al. from Finland and Berardi et 
al. from Italy also found high percentages of overtreatment of 25% and 35%, 
respectively (19,46). Some of these studies have also methodological limitations. 
Pinto Meza made the diagnosis with a telephone interview and did not consider other 
diagnoses such as anxiety disorders as indications for antidepressant treatment. 
Berardi et al. did not only not consider anxiety disorders as an indication but also 
‘forgot’ continuation treatment as indicated treatment. Sihvo et al. did, but still found a 
high percentage of overtreatment, all in patients without any known psychiatric 
disease (19,46). A more recent study by Cameron et al. was the only mentioning “a 
low percentage” of overtreatment, however, without mentioning an exact percentage 
(47).   Summary and general discussion 
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Comparison of the findings from this thesis with previous literature 
Recognition 
Determinants of recognition   
When comparing determinants of (non )recognition from our study to previous 
studies, our results were in line with the results of Wilhelm et al., Furedi et al. and 
Fernandez et al.; patients without a psychological reason for encounter were at risk 
for non recognition (23 25).  
Of the specific depression symptoms, increased appetite led to decreased 
recognition although only in the subgroup. In contrast, Coyne et al. reported 
correlations between low energy/feeling worn out or sleep disturbance and non 
recognition and a trend towards less disturbance of appetite in the undetected group 
(22). We could not fully compare our results to those of Wittchen et al. since we did 
not study loss of confidence as a symptom (27). 
Finally, we found that patients with a comorbid anxiety disorder were more 
often recognized, although this may have been an artefact caused by our definition of 
recognition, which included the use of antidepressants and the diagnostic codes for 
anxiety disorder and feelings of anxiety.  
 
Recognition rate 
Comparing the recognition rate in our study to recognition in previous studies, 
recognition is significantly higher, especially compared to the studies in the 1980s 
and 1990s. In the older studies only about one third of depressed patients was 
recognized, while in our study two thirds were recognized. These differences are 
probably at least partly due to the implementation of guidelines and extra training of 
the Dutch GPs. Also important is the fact that depression is less of a taboo compared 
to 20 or 30 years ago. As a result patients are better informed about the diagnosis 
and more often bring it up as a possible diagnosis themselves.  
Unfortunately in some countries recognition is still poor according to a recent review 
by Mitchell et al. from 2009. They performed a meta analysis about recognition of 
depression in primary care by pooling results of 41 studies with over 50,000 patients. 
Overall recognition was 47.3% (41.7 53.0%), although recognition highly varied 
between studies (6.6% 78.8%) (18). This is probably due to differences between 
studies in definition of recognition and to differences between countries in training ofSummary and general discussion 
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primary care physicians and health care systems.  
The importance of the definition of recognition is well illustrated by the study of 
Joling et al. (48). They found that recognition was best defined by a combination of 
the following indicators of recognition: free text words strongly related to depression 
and/or the use of antidepressants and/or referral according to the electronic medical 
record from the GP. The addition of the diagnostic codes for depression and 
depressive feelings did not further improve diagnostic accuracy. This is a very 
important finding, as many studies in the past solely used these codes as evidence 
for recognition. In our study, we used a wide definition of recognition including the 
diagnostic codes for depression (International Classification for Primary Care; ICPC) 
and the use of antidepressants or referral according to the electronic medical record. 
In our opinion this leads to a more accurate estimation of recognition by the GP as 
Joling et al. demonstrated.  
Next to that, large differences exist between countries, which could be due to 
differences in health care systems. As is obvious from the WHO study and several 
more recent studies, in some countries (especially in Asia) recognition is still poor, 
while in Europe recognition seems to have improved (40,49 51). In the Netherlands 
general practitioners are gatekeepers to secondary care, i.e. patients cannot visit 
secondary (mental) health care without a referral from their general practitioner. The 
GP knows his patients and is therefore able to diagnose depression even when a 
patient consults with all kinds of different (somatic) complaints. If a patient would visit 
several separate specialists, the whole picture (the depression) is more easily 
overlooked. Moreover, GPs have to follow a postgraduate training of three years, 
including a specific training in psychiatry consisting of a three month internship. Next 
to that, many postgraduate courses about mental disorders exist. In the last ten 
years, several guidelines for the treatment of mental disorders in primary care have 
been updated and together with postgraduate training on mental health have led to 
better awareness on mental disorders among general practitioners. Short 
questionnaires have been developed such as the INSTEL screen (intervention study 
primary care screenings questionnaire) to help the GP to screen for depression very 
quickly during their busy consultation hours (52). 
 Summary and general discussion 
  135 
Referral 
In chapter 3 we found that 58% of patients with depression was referred. In the 
1980s and 1990s only a small proportion of patients with depression was referred 
according to Verhaak (13). It could be that depression was more of a taboo in those 
days, or that psychiatric care was less accessible. In a later study Verhaak found that 
percentage of referrals increased by a factor 4.5 from the 1970s until the 1990s (28).  
We studied determinants of referral as well and found that GPs base their 
referral decisions partly on guideline recommendations. Patients with a preference for 
psychotherapy were referred more often, as were patients with chronic depression, 
patients with suicidal tendency, younger patients and those with more severe 
depression. Those with non response to two or more antidepressants or chronic 
depression were more often referred to secondary mental health care. These results 
are in line with those of Kendrick et al., Wang et al. and Van den Boogaard et al. who 
also found that younger patients and those with more severe depression were 
referred more often (31,34,53). Patient preference influenced referral not only in our 
study, but also in the study by Anthony et al. (35). 
Interestingly, Anthony et al. and Kravitz studied other determinants and found that 
therapeutic confidence / physician confidence in managing patients with depression 
and also personal experience were determinants of referral (33,35). Unfortunately, 
we did not study physician opinions as possible determinants. 
Our finding that also non response to antidepressants was a determinant of 
referral, was a new finding.  
 
Treatment with antidepressants 
Undertreatment 
We did not study undertreatment. This was a deliberate decision. At first glance 
undertreatment seems easy to define. According to many depression guidelines that 
have been published in the last 10 20 years, all patients with a major depressive 
disorder could benefit from the prescription of an antidepressant. And possibly some 
patients with other conditions, such as dysthymia would benefit too. On the other 
hand, fifty percent of patients in the general population with a depression recover 
spontaneously within three months. Consequently, several guidelines consider 
“watchful waiting” or a minimal intervention as an option in the first few months, 
especially for patients with a first and mild depression (54 56). Hence, patients who Summary and general discussion 
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have an indication for the use of an antidepressant, do not necessarily need an 
antidepressant. Moreover, some patients who are not treated with antidepressants, 
do actually receive psychotherapy or another form of psychological support, which 
are also potentially effective strategies for treating depression. Third, a substantial 
percentage of patients with depression do not visit their GP, or do not present with 
mental problems, because they do not think they need help for these problems. All 
these patients could be considered undertreated if we would strictly follow a definition 
that states that every patient with an indication for an antidepressant should use an 
antidepressant.  
The more recent guidelines such as the new Dutch multidisciplinary 
depression guideline and the new Dutch general practice guideline depression have 
added another dimension to this discussion. These guidelines now recommend 
reserving antidepressants for the patients with more severe MDD instead of all 
patients with MDD (54,57). This could be viewed as a partial return to the past. 
Before the DSM III and IV, physicians discerned several types of depression. 
Antidepressants were indicated for depression with ‘vital’ (i.e. melancholic) symptoms 
only. The DSM III started defining depression as a cluster of a certain number of 
symptoms, unregardless of which symptoms a patient displayed.  
In 1994 the first NHG standaard (Dutch College of General Practitioners 
guideline) “Depressive disorder” was published. Although this guideline wrote that 
antidepressants could be prescribed to all patients with depression, it was 
recommended to be reticent in prescribing these drugs (58).  
The new trend is not prescribing antidepressants in case of certain symptoms 
(e.g. melancholic symptoms), but in more severe cases, defined as patients with a 
higher degree of suffering and/or dysfunctioning. Most of the time these patients 
have more symptoms as well. These changes are based on the most recent 
literature, showing that patients with mild and even moderately severe depression do 
not profit more from antidepressants than from placebo (59,60). 
 
Overtreatment 
By the time the Dutch media started publishing about overtreatment in primary care, 
we were already planning the study from chapter 5, since literature about this subject 
was scarce at the time. Our results were unexpected and for us a real surprise: only 
5.4% of antidepressant treatment was not in accordance with recommendations from Summary and general discussion 
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current guidelines. Earlier studies had studied overtreatment from two different 
viewpoints:  First, some studies focused on recognition of depression (both false 
negatives and false positives) reporting the use of antidepressants among false 
positives. Most of these patients had depressive symptoms, without fulfilling criteria 
for a MDD. This led to the conclusion that GPs prescribed antidepressants for too 
mild depressive symptoms/disorders (27,53,61). Second, some studies did focus 
directly on the prescription of antidepressants and possible overtreatment. The 
Finnish study by Sihvo et al. and the Italian study by Berardi et al. were already 
mentioned above. They found a high percentage of overtreatment (19,46). In 
contrast, Cameron et al. reported that in Scotland overtreatment was not a large 
problem (47). This is remarkable, as the Scottish primary care/health care system is 
comparable to that in the Netherlands with the GP as gatekeeper to secondary 
(mental) health care. Finally, our finding that most overtreatment was due to (too) 
long continuation of antidepressants in patients with a previous indication/justification 
according to the primary care guideline, was never reported before, while it is 
possible that it has also never been taken into account before.  
 
Future research and practice 
Future practice 
New guidelines 
Less than a year before the completion of this manuscript, the second revision of the 
Dutch general practice guideline depression was published (57). For the first time this 
guideline not only provides GPs with recommendations for the diagnosis and 
treatment of patients with major depressive disorder (MDD), but also with 
recommendations for patients with milder depressive symptoms. Recommendations 
about antidepressant prescription had been a bit vague in the previous guideline, 
they could be prescribed to patients with MDD depending on degree of 
dysfunctioning, degree of suffering and patient preference. In the new guideline it is 
stated that in all but the most severe cases of depression, treatment should start with 
baseline interventions (psychoeducation, structuring of daily life, activity planning and 
monitoring) plus first step interventions (e.g. guided self help or short psychological 
interventions). Only when this has proven to be ineffective, antidepressants are an 
option as well as psychotherapy. Maintenance treatment with antidepressants and/or 
psychotherapy is recommended after more than three episodes or after a single Summary and general discussion 
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severe episode. No specific duration for maintenance treatment is mentioned in the 
new guideline. 
In conclusion, from now on, according to this guideline, GPs should reserve 
antidepressants for those with (very) severe depression, and to patients with 
mild/moderate severe depression only after little or no response to other treatments. 
Some patients could benefit from maintenance treatment, especially after multiple 
episodes with relapses/recurrences after the discontinuation of antidepressants.  
 
Recognition 
In chapter 2, we studied determinants of recognition of depression. We found a trend 
towards less recognition of certain atypical features (increased appetite). It seems 
that more awareness of atypical features is still needed. Unfortunately, the new 
general practitioners guideline does not pay specific attention to atypical features.  
 
Treatment with antidepressants 
When taking into account the results of this thesis, it is unclear how clinical practice 
for the treatment of depression and especially for the use of antidepressants should 
change. In our study, almost all patients who use an antidepressant (i.e. prevalent 
users) have (or had) a major depressive disorder or an anxiety disorder at the time 
the antidepressant was started. The recommendation from the new guideline not to 
prescribe an antidepressant to patients with minor depression, already appears to be 
standard practice. What is partly new compared to the previous guideline, is to 
restrict prescription to patients with (very) severe MDD and not to start an 
antidepressant in patients with mild to moderate severe MDD. However, the new 
guideline allows them also in these patients when baseline interventions and first 
step interventions have failed. It is unknown how many of the patients with MDD who 
got an antidepressant in our study, would have fulfilled this additional criterion. 
Therefore, although the new guideline is far more explicit in it’s recommendations for 
treatment with antidepressants, it is probable that prescription numbers will not 
decrease.  
In the new guideline, only a little bit more attention is paid to the 
discontinuation of antidepressants. In the previous guidelines, it was stated that 
patients should discontinue their antidepressants within four weeks after a 
continuation period of six months. In the new guideline they add that tapering off Summary and general discussion 
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should be dependent on the specific antidepressant used and that attention should 
be paid to potential relapses.  
We think that the new guideline should have paid even more attention to the 
discontinuation of antidepressants, as we found in chapter 5 that most patients using 
antidepressants without a current justification/indication according to the guideline, 
were patients with a history of a single episode of a major depressive disorder. The 
new guideline e.g. should have stated that periodic consultations are recommended 
for all patients using antidepressants in which (dis)continuation should be discussed. 
The new guideline does recommend these check ups for patients referred back to the 
GP from secondary mental health care. In our opinion these check ups should be 
recommended for all patients. 
 
Referral 
It is difficult to give recommendations for referral, since evidence is scarce. It seems 
that quite a large proportion of depressed patients is referred. We think the guideline 
recommendations for referral in the new guideline were already followed.  
 
Future research 
Future research should focus on the subjects that can further improve care for 
depressed patients in primary care/general practice. In specific, the following subjects 
could be of interest: 
 
Recognition of depression  
Improving recognition rate in itself should not be a goal, outcome is more important. 
In the last few years several researchers already studied the outcome of depression 
in patients that had gone unrecognized (39,62). They found that outcome was the 
same for recognized and unrecognized patients. It was stated that unrecognized 
patients often had less severe depression and therefore a better chance of 
spontaneous recovery (39,63). In our study in chapter 2 we came across another 
major issue in studying recognition: the definition. If a depression goes unrecognized 
in patients not consulting their GP, or consulting only once or maybe even a few 
times for unrelated subjects, could this be called failure to recognize depression? If 
we would answer this question with yes, it would mean that screening for depression 
among all patients visiting the GP would be necessary. Several studies already found Summary and general discussion 
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that random screening for depression in general practice does not improve outcome 
of depression (63,64). Therefore, random screening seems unnecessary and even 
pointless.  
Another point in recognition is the patient perspective. Are patients willing to 
accept treatment? Do they want to discuss their depression? A study performed with 
NESDA data by van Beljouw et al., showed that patients without a perceived need for 
care/treatment often had less severe depression and a better chance of spontaneous 
recovery (65). It seems that a good proportion of patients is able to make valid 
judgments about their condition and their ability to sort it out for themselves.  
Do we then need research on recognition of depression? The answer still 
should be yes. Depressive disorder and especially depressive symptoms are very 
common and cause a lot of suffering and dysfunctioning. Loss of work hours due to 
depression is very high, bringing with it very high costs for society. Preventing 
morbidity is important and recognition is the first step. Future research on recognition 
should focus on exploring barriers to recognition, and determinants of recognition in 
relation to risk factors for chronic or recurrent course of depression.  
 
Primary care versus secondary care  
Although the number of studies on depression in primary care has increased 
substantially in recent years, still most recommendations in primary care guidelines 
stem from studies performed in secondary and tertiary care (66). It is sometimes 
stated that patients with depression in primary and secondary care are not very 
different. However, this may not be the case in all countries. In The Netherlands a 
referral from a GP is necessary to consult secondary (mental) health care. In chapter 
3 we showed that the GP takes guideline recommendations into consideration in 
decision making about referral. It is therefore, at least in The Netherlands, doubtful if 
patients in primary and secondary can be considered the same. It could be that 
recommendations for patients in primary and secondary care should be different. 
Consequently, future research should focus on the exploration of possible differences 
between patients and if risk factors for e.g. relapse/recurrence are the same and 
therefore if treatment should be the same.  
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The role of the practice nurse for mental health care  
A new phenomenon in The Netherlands is the psychiatric nurse working in the GP 
practice. It would be interesting to study care by these nurses and outcome of 
patients treated by them. Especially since the new GP guideline recommends short 
psychological interventions in a large proportion of cases, which can be provided by 
psychiatric practice nurses. And even more so since the Dutch government limited 
reimbursement of psychological and psychiatric care since January 2012. Patients 
now have to pay a contribution per session for psychological care and a fixed 
contribution for psychiatric care. Care by the psychiatric practice nurses in the GP 
practices is still fully reimbursed. If care by these nurses is cost effective and the 
patient outcomes are good, treatment by the psychiatric nurse in the GP practice will 
probably play an important role in depression treatment in primary care in the future 
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Depressie en behandeling 
Algemeen 
Depressie is een veelvoorkomende aandoening. Gedurende het gehele leven krijgt 
ongeveer 20% van de mensen ooit een depressieve stoornis of depressieve 
klachten. Depressie heeft een grote invloed op de kwaliteit van leven en gaat ook 
gepaard met veel kosten voor de maatschappij. Dat laatste is niet alleen het gevolg 
van kosten die gemaakt worden voor behandeling van de depressie, maar vooral ook 
door verlies van werkcapaciteit. Dit effect wordt versterkt doordat in een flink 
percentage van de gevallen depressie een recidiverend of chronisch karakter heeft. 
De meeste patiënten met een depressie worden behandeld in de eerste lijn, dat wil 
zeggen in de huisartspraktijk, eventueel met hulp van andere zorgverleners in de 
eerste lijn zoals maatschappelijk werkers en eerstelijns psychologen.  
 
Diagnose en classificatie 
De diagnose depressieve stoornis wordt gesteld met behulp van criteria uit de DSM 
IV, patiënten moeten tenminste vijf symptomen van depressie hebben, waarvan 
tenminste één hoofdsymptoom, zie onderstaande tabel. Daarnaast moeten deze 
symptomen tenminste twee weken aanwezig zijn gedurende de meeste dagen en het 
grootste deel van de dag. De klachten mogen niet het gevolg van middelengebruik 
(alcohol, drugs of medicijnen) of een lichamelijke ziekte zijn en moeten lijdensdruk 
veroorzaken bij de patiënt en belemmeren in activiteiten (werk, sociale contacten). 
Tot slot mogen de klachten niet het gevolg zijn van rouw bijvoorbeeld na het verlies 
van een naaste. Indien niet wordt voldaan aan deze criteria voor een depressieve 
stoornis, maar een patiënt wel één of meerdere symptomen van depressie heeft, kan 
gesproken worden van een milde depressie of depressieve klachten. 
  Er zijn diverse indelingen van depressieve stoornis, zo kun je spreken van een 
milde, matig ernstige of ernstige episode, maar ook van melancholische, vitale, 
atypische of psychotische kenmerken. Melancholische depressie wordt gekenmerkt 
door vitale symptomen zoals gewichtsverlies of verlies van eetlust, bewegingsonrust 
of juist bewegingsarmoede (bijvoorbeeld weinig mimiek) en slaapproblemen zoals 
vroeg in de morgen wakker worden. Atypische kenmerken zijn juist het 
tegenovergestelde: toegenomen eetlust, gewichtstoename, overmatig slapen. 
Psychotische depressie is een ernstige vorm van depressie waarbij wanen en 
hallucinaties ontstaan, vaak met een zeer sombere of negatieve inhoud. Nederlandse samenvatting 
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  Vrouwen krijgen twee keer zo vaak een depressie als mannen. De helft van de 
mensen die een depressie krijgen, hersteld spontaan binnen drie maanden. Zoals 
eerder genoemd krijgt een aanzienlijk percentage een recidief. De minderheid (15 
20%) heeft een chronische depressie, dat wil zeggen meer dan 2 jaar. 
 
Behandeling van depressie 
Zoals eerder gezegd worden de meeste patiënten behandeld in de eerste lijn. Daar 
een deel van de patiënten spontaan herstelt, wordt in de eerste drie maanden vaak 
gekozen voor een behandeling bestaande uit informatie en eventueel enkele 
adviezen betreffende activiteiten en dagindeling. In geval van langer bestaande 
depressie of een ernstige depressie is intensievere behandeling aangewezen. 
Grofweg zijn er twee behandelingsmogelijkheden: antidepressiva en diverse vormen 
van psychotherapie. Beide zijn effectief gebleken. De NHG standaard depressie 
(huisartsenrichtlijn) adviseert behandeling met antidepressiva en/of psychotherapie 
afhankelijk van lijdensdruk en voorkeur van de patiënt. Als voor antidepressiva 
gekozen wordt, moeten deze altijd nog zes maanden worden door gebruikt nadat de 
patiënt beter is om te voorkomen dat een terugval optreedt, deze behandeling 
noemen we “terugvalpreventie”. Bij patiënten met een recidiverende of chronische 
depressie kan gekozen worden de antidepressiva nog langer voort te zetten om ook 
recidieven te voorkomen, dit wordt onderhoudsbehandeling of “recidief preventie” 
genoemd.  
 
Nederlandse Studie naar Depressie en Angst (NESDA) 
De meeste studies in dit proefschrift zijn uitgevoerd met data uit NESDA. NESDA is 
een grote studie waaraan 2981 patiënten tussen 18 en 65 jaar met en zonder 
depressie en angst deelnemen. Doel is het verkrijgen van meer inzicht in het 
ontstaan en verloop van angst en depressie. De studie is in 2004 van start gegaan, 
bij de start, na 1 jaar, 2 jaar, 4 jaar en inmiddels ook na 6 jaar zijn deze mensen 
onderzocht. Bij elke meting is gekeken naar symptomen van angst en depressie, 
maar ook naar bijvoorbeeld behoefte aan zorg, lichamelijke ziekten, gebruik van 
medicijnen waaronder antidepressiva en nog veel meer.  Nederlandse samenvatting 
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Samenvatting van dit proefschrift 
Introductie 
In het verleden is vaak geroepen dat herkenning en behandeling van depressie in de 
eerste lijn onder de maat was. Er is veel literatuur over onderherkenning en 
onderbehandeling, voornamelijk uit de jaren ’80 en ’90 van de vorige eeuw. De 
laatste jaren is er, vooral in de media, veel aandacht geweest voor ‘overherkenning’ 
en ook overbehandeling, dat wil zeggen het aanmerken van mensen zonder 
depressie als depressief en/of ze behandelen met antidepressiva terwijl daarvoor 
geen indicatie bestaat.  
  Doel van dit proefschrift was het onderzoeken van de ‘zorg rondom depressie 
in de huisartspraktijk’ op dit moment. Dit proefschrift zou daarmee een startpunt 
kunnen gaan vormen voor het verder verbeteren van de zorg voor depressieve 
patiënten in de huisartspraktijk.  
 
Herkenning van depressie 
Wij vonden dat depressie adequaat werd herkend door de huisarts. 60,5% 68,7% 
van de patiënten met depressie werd herkend in onze studie in hoofdstuk 2. Wij 
maten herkenning in een groep van 484 patiënten met depressie uit de nesda studie. 
We hebben daarnaast gekeken of er kenmerken waren die de niet herkende 
patiënten onderscheidden van de wel herkende patiënten. Het bleek dat patiënten 
die naast de depressie ook een angststoornis hadden en diegenen die als reden om 
naar de huisarts te gaan opgaven dat ze psychische klachten hadden, beter herkend 
werden dan patiënten zonder angststoornis of psychische reden voor contact met de 
huisarts. Daarnaast leek te gelden dat bij patiënten met minder depressieve klachten 
en patiënten met een toegenomen eetlust de depressie minder vaak werd herkend 
door de huisarts. Het leek daarmee dat de huisarts de ‘ziekere’ patiënten beter 
herkende dan de minder zieke (minder symptomen, geen bijkomende psychische 
ziekte), een goed teken, immers hoe ernstiger de depressie, hoe minder kans op 
spontaan herstel. Opvallend was dat patiënten met een toegenomen eetlust minder 
goed herkend werden, mogelijk dat huisartsen atypische symptomen zoals 
toegenomen eetlust minder snel herkennen als symptoom van depressie. Het zou 
echter ook kunnen dat specifiek toegenomen eetlust door huisartsen gezien wordt 
als een lichamelijke klacht en niet een symptoom van depressie.  
 Nederlandse samenvatting 
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Behandeling van depressie 
Verwijzing naar de geestelijke gezondheidszorg 
In hoofdstuk 3 hebben we gekeken of het verwijsgedrag van huisartsen bij een 
groep van 344 depressieve patiënten overeenkwam met de aanbevelingen uit de 
huisartsenrichtlijn voor depressie (NHG standaard depressie 2003). Ten eerste bleek 
dat 58% van de patiënten met depressie door de huisarts werd verwezen naar de 
geestelijke gezondheidszorg. Dit percentage was veel hoger dan verwacht, in het 
verleden werden veel lagere percentages gevonden in studies. Het bleek dat 
huisartsen inderdaad de aanbevelingen uit de NHG standaard gebruiken bij hun 
beslissingen rondom verwijzing.   
Patiënten die behoefte hadden aan psychotherapie, patiënten met suïcidale 
neigingen en met een chronische depressie werden vaker verwezen, net als jongere 
patiënten. Conform de richtlijn werden patiënten met een chronische depressie of 
zonder effect van twee of meer verschillende antidepressiva vaker naar de tweede 
lijn (psychiater, instelling voor geestelijke gezondheidszorg) verwezen ten opzichte 
van de eerste lijn (eerstelijns psycholoog, maatschappelijk werk, sociaal 
psychiatrisch verpleegkundige in de eerste lijn). Patiënten die verwezen waren 
voldeden gemiddeld aan meer criteria voor verwijzing uit de NHG standaard dan 
patiënten die niet verwezen werden. Uit onze studie bleek tot slot dat andere factoren 
ook een rol lijken te spelen in het verwijsgedrag van huisartsen. 
 
Behandeling met antidepressiva 
In hoofdstuk 4 beschrijven we dat de aanbevelingen in de richtlijnen rondom het 
gebruik van antidepressiva evidence based (gebaseerd op bewijs uit 
wetenschappelijke studies) zijn voor wat betreft behandeling in de acute fase tot 
remissie (het moment waarop de patiënt beter is) en “terugvalpreventie” gedurende 
enkele maanden na remissie. Echter, er is geen bewijs voor onderhoudsbehandeling 
in de eerste lijn. De aanbevelingen hierover in de richtlijnen blijken gebaseerd op 
ongecontroleerde studies uit de tweede en derde lijn ((academische) 
ziekenhuizen/psychiatrische ziekenhuizen). 
  In hoofdstuk 5 gaan we in op de door de media de laatste jaren vermeende 
overbehandeling met antidepressiva in de Nederlandse huisartsenpraktijk. We 
concluderen dat dit helemaal geen groot probleem is. Wij onderzochten een groep 
van 1531 patiënten met en zonder depressie en/of angststoornis uit de Nederlandse samenvatting 
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huisartsenpraktijk die in de laatste vier maanden hun huisarts bezochten (ongeacht 
of dit vanwege psychische klachten was). In deze groep gebruikten er 199 een 
antidepressivum op het moment van de eerste meting van de nesda studie. Van 
deze 199 bleken er 188 (94,6%) een gegronde reden voor dit gebruik te hebben 
volgens de NHG standaard depressie en de NHG standaard angststoornissen. 11 
(5,4%) patiënten hadden volgens de NHG standaarden angststoornis en depressie 
geen indicatie voor het gebruik van een antidepressivum op dat moment. Zes van 
hen (54,5%) hadden een éénmalige depressieve episode gehad meer dan een jaar 
geleden. Zij hadden daarmee dus in het verleden een goede indicatie voor het 
gebruik van een antidepressivum, maar hadden daar volgens de NHG standaard 
inmiddels mee kunnen stoppen. De andere 5 patiënten zonder indicatie hadden ook 
nooit een indicatie gehad. Bij hen was het antidepressivum zonder indicatie/geldige 
reden volgens de NHG standaard voorgeschreven. Omdat nesda tot doel had 
depressie en angst te bestuderen, was er in deze studie ten opzichte van de 
reguliere huisartsenpopulatie een overschot aan patiënten met een depressie en/of 
angststoornis. Daarom berekenden wij wat onze resultaten betekenden voor de 
gehele huisartsenpopulatie waaruit de selectie voor de nesda studie was gemaakt 
(10.677 patiënten). De resultaten waren hetzelfde, slechts 5,4% van de patiënten die 
antidepressiva gebruikten, deden dit zonder een op dat moment geldige indicatie.  
  Tot slot beschrijft hoofdstuk 6 de kenmerken van een groep patiënten die een 
onderhoudsbehandeling met antidepressiva gebruikten. Ook in deze studie werden 
data uit de nesda studie gebruikt, in dit geval van de eerstelijns patiënten met een 
depressie die gedurende tenminste een half jaar in remissie was. We vergeleken 
kenmerken van deze patiënten met en zonder onderhoudsbehandeling met 
antidepressiva (antidepressivagebruik >12 maanden). Het betrof 776 patiënten, 
waarin wij 1571 metingen tot onze beschikking hadden, daar we meerdere 
meetmomenten meenamen in de analyse en sommige patiënten op meerdere 
meetmomenten aan onze inclusiecriteria voldeden. Van tevoren stelden wij 
hypothesen op; wij verwachtten dat patiënten die voldeden aan één of meer criteria 
voor onderhoudsbehandeling uit de NHG standaard (dat wil zeggen dat zij een 
chronische of recidiverende depressie hadden) ook vaker een 
onderhoudsbehandeling met antidepressiva zouden ontvangen. Daarnaast was onze 
verwachting dat patiënten met een comorbide angststoornis vaker een 
onderhoudsbehandeling met antidepressiva zouden krijgen. Alleen de laatste Nederlandse samenvatting 
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hypothese werd bevestigd, patiënten met een comorbide angststoornis gebruikten 
vaker antidepressiva als onderhoudsbehandeling, net als patiënten met een 
comorbide dysthyme stoornis. Ook oudere patiënten, patiënten met een lagere 
opleiding, diegenen die ook benzodiazepines gebruikten en patiënten die 
psychologische of psychiatrische zorg hadden ontvangen in het laatste half jaar 
gebruikten vaker een onderhoudsbehandeling met antidepressiva. Daar patienten 
met een recidiverende of chronische depressie niet vaker onderhoudsbehandeling 
met antidepressiva kregen dan patienten zonder deze kenmerken, konden we 
concluderen dat het gebruik van een onderhoudsbehandeling antidepressiva niet 
overeenkomt met de aanbevelingen uit de richtlijn. Het lijkt echter wel alsof het de 
patienten met een meer ernstige depressie zijn die een onderhoudsbehandeling 
krijgen, daar wij vonden dat deze patienten vaker een comorbide angststoornis of 
dysthyme stoornis hadden en ook vaker benzodiazepinen gebruikten of 
psychologische of psychiatrische zorg ontvingen. 
 
Conclusie 
De algemene conclusie van dit proefschrift is dat de zorg voor depressieve patiënten 
in de eerste lijn in de meeste gevallen adequaat is, dat wil zeggen in 
overeenstemming met de aanbevelingen uit de (toen) geldende richtlijnen. 
  Wanneer we dit beeld vergelijken met studies uit het verleden blijkt het 
percentage herkende patiënten flink toegenomen sinds de jaren ’80 en ’90 van de 
vorige eeuw, toen slechts ongeveer een derde van de patiënten werd herkend.  
  Ook de behandeling lijkt een stuk verbeterd. Verwijzing voor depressie en 
angst was zo’n 30 jaar geleden een uitzondering, terwijl nu meer dan de helft van de 
patiënten verwezen lijkt te worden. Overbehandeling met antidepressiva is een 
onderwerp dat nog maar kort in de belangstelling staat. Ten opzichte van studies in 
andere landen lijkt het alsof Nederlandse huisartsen adequaat antidepressiva 
voorschrijven, daar slechts in 5,4% van de gevallen sprake was van 
overbehandeling, ten opzichte van percentages als 25 of zelfs 35% in studies uit 
andere landen.  Nederlandse samenvatting 
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Toekomstvisie 
Praktijk 
Nieuwe richtlijnen 
Vlak voor de afronding van dit proefschrift, kwam in juni 2012 de nieuwe NHG 
standaard depressie uit. Deze standaard beperkt de indicatie voor het voorschrijven 
van antidepressiva in het algemeen en onderhoudsbehandeling met antidepressiva 
ten opzichte van de vorige standaard.  
 
Herkenning 
Daar in hoofdstuk 2 bleek dat patiënten met atypische symptomen (toegenomen 
eetlust) minder goed herkend werden, lijkt meer aandacht voor atypische symptomen 
nodig. Jammer genoeg wordt hieraan geen aandacht besteed in de nieuwe richtlijn. 
 
Behandeling met antidepressiva 
Het is onduidelijk hoe het gebruik of het voorschrijven van antidepressiva door 
huisartsen zou moeten veranderen wanneer we kijken naar de resultaten van dit 
proefschrift. In alle behalve de meest ernstige gevallen dient een patiënt met 
depressie nu eerst begeleiding te krijgen alvorens over te gaan op het voorschrijven 
van antidepressiva. Het is onduidelijk in welk percentage van de gevallen dit nu het 
geval is en dus in hoeverre de behandeling moet veranderen. 
  Antidepressiva afbouwen lijkt wel een punt van aandacht, daar de meeste 
overbehandeling het gevolg lijkt van het langdurig doorgebruiken van antidepressiva 
terwijl er geen indicatie meer voor is. Helaas besteedt de nieuwe richtlijn nauwelijks 
aandacht aan dit onderwerp. Ik vind dat alle patiënten die een antidepressivum 
gebruiken, moeten worden beschouwd als chronische patiënten en daarom 
bijvoorbeeld halfjaarlijks voor controle zouden moeten komen. Tijdens deze controle 
kan dan het gebruik van het antidepressivum besproken worden, naast de actuele 
situatie om ook alert te zijn op eventuele terugval of recidief. 
 
Verwijzing 
Aanbevelingen voor verwijzing zijn niet echt te geven, er is weinig onderzoek naar 
gedaan. Wij denken dat de aanbevelingen in de richtlijn al opgevolgd worden.  
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Onderzoek 
Toekomstig onderzoek moet zich richten op onderwerpen die de zorg voor 
depressieve patiënten in de eerste lijn verder kunnen verbeteren. 
  Onderzoek naar herkenning zou zich moeten richten op factoren die 
herkenning kunnen verhinderen en kenmerken van patiënten die leiden tot minder 
herkenning in relatie tot risicofactoren voor ongunstig beloop. Immers, herkenning op 
zichzelf zou geen doel moeten zijn, het gaat om de uitkomst voor de patiënt.  
  Daarnaast is onderzoek naar de verschillen tussen depressieve patiënten in 
de eerste en tweede lijn nodig. Veel aanbevelingen in de richtlijnen voor de 
behandeling van depressie in de eerste lijn zijn gebaseerd op studies onder 
patiënten in de tweede lijn. Men beroept zich hierbij op het feit dat deze patiënten 
niet substantieel zouden verschillen. Echter in veel landen kunnen patiënten 
rechtstreeks naar de specialist, zonder tussenkomst van een huisarts. In Nederland 
is dit niet het geval en het is daarmee maar zeer de vraag of ook in Nederland 
patiënten in de eerste en tweede lijn niet van elkaar verschillen. Wellicht dat de 
aanbevelingen voor de eerste lijn anders moeten zijn omdat bijvoorbeeld de 
risicofactoren voor terugval of recidief anders zijn of de te verwachten reactie op 
behandeling. 
  Tot slot is de laatste jaren de praktijkverpleegkundige op het gebied van de 
geestelijke gezondheidszorg in de Nederlandse huisartsenpraktijk in opmars. Er is 
nog maar weinig onderzoek gedaan naar de (kosten )effectiviteit van deze vorm van 
geestelijke gezondheidszorg. Dit is wel belangrijk, daar deze zorg, althans voorlopig, 
nog volledig wordt vergoed in tegenstelling tot andere eerste  en tweedelijns 
geestelijke gezondheidszorg. 
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Dankwoord 
 
Een makkelijk stukje om te schrijven, dacht ik nog toen ik aan dit dankwoord begon. 
Nu ik begonnen ben, begin ik te twijfelen. Ik mag natuurlijk niemand vergeten en er 
zijn de afgelopen jaren veel mensen geweest die op de een of andere manier aan dit 
proefschrift of mijn persoonlijke ontwikkeling hebben bijgedragen.  
 
Allereerst natuurlijk mijn promotoren; Klaas van der Meer en Willem Nolen. Zonder 
jullie had ik hier nu niet gestaan. Klaas, bedankt voor het vertrouwen dat je in mij 
toonde toen ik, inmiddels bijna zes jaar geleden, bij je aanklopte als student 
geneeskunde met de mededeling dat ik promotie onderzoek wilde gaan doen. 
Ondanks mijn beperkte ervaring met onderzoek, die op dat moment slechts bestond 
uit de verplichte wetenschappelijke stage in het kader van de studie geneeskunde, 
hielp je me aan een aanstelling bij de afdeling huisartsgeneeskunde. Tijdens de 
bijeenkomsten rondom de voortgang van de artikelen in dit proefschrift, waardeerde 
ik je creativiteit, waarbij je veel nieuwe ideeën tentoonspreidde. Je zorgde ook altijd 
dat ik het perspectief van de huisarts voor ogen hield, dat dit proefschrift 
huisartsgeneeskundig zou blijven en geen pure psychiatrie. Willem, ook jij durfde het 
aan om dit project te starten met mij als zeer onervaren onderzoekster. In het begin 
waardeerde ik vooral je tekstuele input, die ik zeker kon gebruiken. Later ben ik ook 
steeds meer je inzicht in de klinische relevantie van onderzoek gaan waarderen, 
haarfijn wist je vaak de vinger op de zere plek van een voorgenomen onderzoek te 
leggen. Aan te wijzen waarom de resultaten weinig zouden bijdragen en suggesties 
te doen voor een alternatieve werkwijze of een ander doel, zonder de besluiten ooit 
voor mij te nemen.  
 
Als vanzelfsprekend ben ik natuurlijk ook de leden van de beoordelingscomissie zeer 
dankbaar voor het beoordelen van dit manuscript, Prof. Dr. H.E. van der Horst, Prof. 
Dr. P.F.M. Verhaak en Prof. Dr. R.A. Schoevers. 
 
Daarnaast alle co auteurs van de diverse artikelen die zijn opgenomen in dit 
manuscript. Brenda Penninx, bedankt voor het ter beschikking stellen van de NESDA 
database en alle hulp die je gegeven hebt bij de 4 artikelen in dit proefschrift die uit 
NESDA zijn voortgekomen. Ik kon altijd rekenen op een zeer snelle en kritische Dankwoord 
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beoordeling van een concept artikel. Karlijn Joling wil ik bedanken voor al het 
voorwerk dat zij deed voor het artikel over herkenning van depressie, onze 
samenwerking was helaas van korte duur, maar heb ik als zeer prettig ervaren. Hein 
van Hout en Harm van Marwijk wil ik in dat kader bedanken voor het vertrouwen dat 
ze me gaven door hun een deel van hun project over herkenning van depressie aan 
mij uit te besteden. Witte Hoogendijk, bedankt voor de kritische input in het artikel 
over overbehandeling met antidepressiva. Boudewijn Kollen, tot wij elkaar 
ontmoetten dacht ik dat ik de statistiek van mijn artikelen best zelf kon doen. Jij liet 
mij zien dat je sommige statistiek beter aan een specialist kunt overlaten. Bedankt 
voor je altijd snelle en nauwkeurige analyses voor de artikelen in hoofdstuk 2 en 6. 
Tot slot Peter Verhaak, ik hoop in de toekomst nog vele onderzoek(strajecten) 
samen te kunnen starten. Laat het artikel waaraan jij in dit proefschrift hebt 
bijgedragen daarvan het begin zijn. 
 
Niet te vergeten Klaas Groenier, bij wie ik altijd kon aankloppen voor statistisch 
advies. En alle medewerkers en deelnemers van NESDA, bedankt voor bieden van 
deze schat aan informatie.  
 
Doordat ik mijn werkzaamheden veelal vanuit huis heb verricht, heb ik weinig directe 
onderzoekscollega’s gehad. Toch wil ik alle promovendi binnen NESDA en de 
afdeling huisartsgeneeskunde op deze plaats bedanken. Zo af en toe kwamen we 
elkaar tegen en ik heb van jullie veel geleerd over het doen van onderzoek en jullie 
waren een welkom klankbord voor de frustraties van een promovendus.  
 
Vervolgens alle collega’s uit de diverse huisartspraktijken waar ik de afgelopen jaren 
heb gewerkt. In het bijzonder Michiel Andriessen, mijn eerste opleider, die door zijn 
vertrouwen in mij, mijn zelfvertrouwen veel goed heeft gedaan. Je bood me de 
flexibiliteit die ik voor de combinatie van opleiding en onderzoek zo hard nodig had. 
Het was een fantastisch jaar in Ommen. Dan Kees Huttenga, mijn huisartsopleider 
voor het derde jaar, waar ik een week te vroeg kwam voor het 
kennismakingsgesprek. Toen al vertelde je dat je weinig affiniteit had met de 
wetenschap. Mijn parttime AIOS schap vond je echter prima. Waar nodig kon ik mijn 
uren schuiven voor mijn onderzoek en de broodnodige extra tijd hieraan besteden. 
Ook nadat ik mijn huisartsopleiding had afgerond heb ik me als waarnemer altijd zeer Dankwoord 
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welkom gevoeld in de praktijk. De ruimte die ik kreeg om vanwege privé  en 
wetenschappelijke redenen vrij te nemen heb ik erg gewaardeerd. Marco Blanker en 
Mischa Thiele bij wie ik thans met veel plezier als vaste waarnemer werk. Marco, 
ondanks dat we elkaar nauwelijks kenden in het begin, heb ik gevoeld dat je erg je 
best deed om mij in Groningen te houden. Het is leuk om ook tijdens de “gewone 
praktijkuren” af en toe over wetenschap en dilemma’s en frustraties hierin te kunnen 
discussiëren. Mischa, het lijkt vaak of jij nooit stress hebt, hoe druk het ook kan zijn in 
de praktijk op sommige momenten. Ik zou willen dat die rust besmettelijk was. Tot 
slot natuurlijk alle andere medewerkers van de huisartspraktijk Blanker/Thiele: 
Marieke, Gerda, Cobie, Karen, Lilian, Bart en ook Pauline en Ewa en huisartspraktijk 
Huttenga: Jennitha, Danielle, Anja en Anneke. Bedankt voor de fijne samenwerking. 
 
Tenslotte de mensen die buiten het werk om hebben bijgedragen aan dit proefschrift. 
In dat kader natuurlijk allereerst mijn man. Bas, ik kan me de frustraties van het 
eerste jaar als onderzoeker nog goed herinneren. Hoe vaak heb ik niet achter mijn 
computer in ons kleine flatje in Almelo op het punt gestaan het op te geven? Elke 
keer praatte je mij weer moed in, zei je dat het echt wel zou gaan lukken. Nooit had 
ik toen gedacht hier te staan, en toch, mede dankzij jou, sta ik hier nu toch. Niet 
alleen het begin was moeilijk, ook bij de laatste loodjes was jij het weer die ondanks 
je eigen nieuwe en drukke baan mij geholpen hebt de lay out perfect te maken. Privé 
hebben we de laatste jaren ook aardig wat voor onze kiezen gehad. Jij bleef, 
ondanks alles, naast me staan. Samen zijn we hard bezig ook die problemen te 
overwinnen. Jouw foto op het omslag geeft niet alleen de inhoud van dit proefschrift, 
maar ook onze huidige privésituatie akelig goed weer “achter de wolken schijnt de 
zon!” Dan mijn ouders, omdat ze me altijd gesteund hebben om mijn talenten te 
ontplooien en dromen te verwezenlijken. Ook mijn schoonouders, mijn beide zusjes 
Inge en Sanne, mijn schoonzus en zwager wil ik bedanken. Er zijn, en zoals ook jullie 
weten niet alleen in dit promotie traject, de afgelopen jaren veel moeilijke perioden 
geweest. Mede dankzij jullie heb ik het vol kunnen houden en door kunnen gaan.  
 
Een aantal vrienden en vriendinnen wil ik op deze plaats ook nog bedanken voor alle 
ontspannende momenten die we de afgelopen jaren samen beleefd hebben. 
Francina en Marc, Marjan en Marcel, Jose, Frank en Lotte, Marten en Lisanne, Loes, 
Marjet en Patrick en alle anderen die ik nu dreig te vergeten, bedankt daarvoor. 
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